http://www.vioxxadvisor.com Get the ultimate advice for Vioxx users! Fri, 27 Aug 2010 16:01:02 +0000 http://backend.userland.com/rss092 A total of 1500 people have come forward claiming they have had a heart attack after taking the anti-arthritis drug Vioxx. Click here for more info http://www.vioxxadvisor.com/4774.html IPSWICH people who took the anti-inflammatory drug Vioxx and suffered a heart attack have only one day left to register for a class action. More... http://www.vioxxadvisor.com/4773.html Mayer, co-head of the litigation group, and Gerard Cruse , who joined the firm as chief operating officer last month from Apollo Global Management LLC , will take over Scherers duties Jan. 1, Hughes Hubbard Chairwoman Candace Beinecke said today in a statement. More... http://www.vioxxadvisor.com/4772.html APCO Worldwide, the public relations firm that advised Hewlett-Packard's board after accusations of harassment against its chief executive officer, has handled crises from Merck's Vioxx scandal to WorldCom's fraud and now is helping Wall Street earn back America's trust. Read more here http://www.vioxxadvisor.com/4771.html NEW YORK APCO Worldwide, the public relations firm that advised Hewlett-Packard's board after accusations of harassment against its chief executive officer, has handled crises from Merck's Vioxx scandal to WorldCom's fraud and now is helping Wall Street earn back America's trust. Link to original article http://www.vioxxadvisor.com/4770.html APCO Worldwide, the public relations firm that advised Hewlett-Packard Co. s board after accusations of harassment against its chief executive officer, has handled crises from Merck & Co. s Vioxx scandal to WorldCom Inc.s fraud and now is helping Wall Street earn back Americas trust. More... http://www.vioxxadvisor.com/4769.html Australians who had a heart attack after taking the arthritis drug Vioxx have just weeks to join a class action against the drug's maker. Click here for more info http://www.vioxxadvisor.com/4766.html Australians who took the drug Vioxx, and had a heart attack, have just weeks to join a class action against the drug's maker. Read more here http://www.vioxxadvisor.com/4767.html HUNDREDS of NSW victims of the arthritis drug Vioxx could miss out on compensation because they have not registered for a class action, lawyers Slater & Gordon say. More... http://www.vioxxadvisor.com/4768.html AP FILE PHOTO Merck & Co. paid claims to the families of 3,468 users of its Vioxx painkiller who died of heart attacks or strokes, a court-appointed administrator told a judge today. A $4.85 billion settlement fund made payments to More... http://www.vioxxadvisor.com/4765.html Merck & Co. paid claims to the families of 3,468 users of its Vioxx painkiller who died of heart attacks or strokes, a claims administrator told a judge today. More... http://www.vioxxadvisor.com/4764.html The Federal Court should expedite the cases of Australians who had heart attacks after taking the anti-arthritis drug Vioxx, a Melbourne barrister says. Read more here http://www.vioxxadvisor.com/4762.html THE Federal Court should expedite the cases of hundreds of Australians who had heart attacks after taking the anti-arthritis drug Vioxx so they do not die before receiving compensation, a barrister has argued. Read more here http://www.vioxxadvisor.com/4763.html The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. Click here for more info http://www.vioxxadvisor.com/4761.html The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. Link to original article http://www.vioxxadvisor.com/4760.html The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. Link to original article http://www.vioxxadvisor.com/4759.html The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. So, when is a drug too risky to stay on the market? Click here for more info http://www.vioxxadvisor.com/4758.html A federal judge ruled in favor of Merck & Co. Tuesday in a lawsuit brought by Louisiana trying to recoup what it paid when Medicaid patients used the company's withdrawn painkiller Vioxx, The Associated Press reports. James R. Dugan II, "the lead attorney representing Louisiana, said his team would be ... http://www.vioxxadvisor.com/4757.html Merck & Co., Inc. said today that it had prevailed in all respects in a trial of claims brought by the State of Louisiana related to Vioxx. The case was tried before federal district court Judge Eldon E. Fallon without a jury. More... http://www.vioxxadvisor.com/4756.html VIOXX RULING: Merck & Co. wins the first trial over Vioxx brought by a state trying to recoup what it paid for residents to take the painkiller withdrawn from the market because it doubled cardiovascular risks. Link to original article http://www.vioxxadvisor.com/4752.html Drugmaker Merck & Co. on Tuesday won the first trial over withdrawn painkiller Vioxx brought by a state trying to recoup what it paid for residents to take the drug, arguing it wouldn't have been covered had its risks been better known. Read more here http://www.vioxxadvisor.com/4753.html Drugmaker Merck & Co. on Tuesday won the first trial over withdrawn painkiller Vioxx brought by a state trying to recoup what it paid for the former blockbuster drug. More... http://www.vioxxadvisor.com/4754.html WHITEHOUSE STATION, N.J. - Drugmaker Merck & Co. has won the first lawsuit over withdrawn painkiller Vioxx brought by a state trying to recoup what it paid for the former blockbuster drug. Click here for more info http://www.vioxxadvisor.com/4755.html Merck & Co. doesnt have to refund money the state of Louisiana paid for the withdrawn Vioxx painkiller, a federal judge ruled. Link to original article http://www.vioxxadvisor.com/4751.html Healthy people who take NSAIDs, such as Advil, Motrin, Voltaren, Cataflam or Vioxx, to relieve aches and pains may raise their risk of dying from heart-related problems, a Danish study finds. Click here for more info http://www.vioxxadvisor.com/4750.html Baycol, Vioxx, Bextra, and now Celebrex. Who's responsible for these unsafe drugs? Well, there's more than enough blame to go around. Here's an overview . . . Click here for more info http://www.vioxxadvisor.com/4747.html WASHINGTON - THE US Supreme Court on Tuesday authorised Merck shareholders to sue the pharmaceutical giant for fraud for 'knowingly' misrepresenting the risk of heart attacks from the use of the anti-inflammatory drug Vioxx. The nation's top judges ruled unanimously in the case, which involves millions of dollars in damages. ... http://www.vioxxadvisor.com/4748.html In a rare boost for securities fraud class actions, the U.S. Supreme Court on Tuesday closed off a "statute of limitations" defense for Merck & Co. in its battle against Vioxx-related shareholder suits. Click here for more info http://www.vioxxadvisor.com/4749.html In a rare boost for securities fraud class actions, the Supreme Court on Tuesday closed off a statute of limitations defense for Merck & Co. in its battle against Vioxx-related shareholder suits. Plaintiffs and shareholder groups applauded the decision for sweeping away a morass of conflicting lower-court decisions on statute ... http://www.vioxxadvisor.com/4746.html The biggest oil spill ever. The biggest financial crisis since the Great Depression. The deadliest mine disaster in 25 years. One recall after another of toys from China, of vehicles from Toyota, of hamburgers from roach-infested processing plants. The whole Vioxx fiasco. And let's not forget the biggest climate threat ... http://www.vioxxadvisor.com/4745.html After the makers of Vioxx and a similar drug called Bextra yanked them from the market because of potentially deadly side effects, people with sore hips and knees had to turn somewhere. Read more here http://www.vioxxadvisor.com/4744.html We see Vimovo as a $500+ million product in the U.S. alone. Cox-II drugs such as Vioxx and Celebrex, designed to provide safer gastrointestinal profile, peaked sales at over $7 billion worldwide. More... http://www.vioxxadvisor.com/4743.html The US Supreme Court Tuesday authorized Merck shareholders to sue the pharmaceutical giant for fraud for "knowingly" misrespresenting the risk of heart attacks from the use of the anti-inflammatory drug Vioxx. More... http://www.vioxxadvisor.com/4742.html The Supreme Court said Tuesday that investors who lost millions when Merck & Co. pulled its blockbuster drug Vioxx off the market can go ahead with a lawsuit against the pharmaceutical giant. More... http://www.vioxxadvisor.com/4740.html WASHINGTON The Supreme Court said Tuesday that investors who lost millions when Merck & Co. pulled its blockbuster pain drug Vioxx off the market can go ahead with a lawsuit against the pharmaceutical giant. Click here for more info http://www.vioxxadvisor.com/4741.html The high court agreed with a lower court's decision to allow a class-action securities lawsuit. Investors lost tens of billions of dollars in shareholder value overnight after Merck withdrew Vioxx. Click here for more info http://www.vioxxadvisor.com/4738.html The Supreme Court ruled Tuesday that investors who lost millions when Merck pulled its blockbuster pain drug Vioxx off the market can go ahead with a lawsuit against the pharmaceutical giant. More... http://www.vioxxadvisor.com/4739.html WASHINGTON - The Supreme Court said Tuesday that investors who lost millions when Merck & Co. pulled its blockbuster pain drug Vioxx off the market can go ahead with a lawsuit against the pharmaceutical giant. Click here for more info http://www.vioxxadvisor.com/4735.html WASHINGTON, April 27 (Reuters) - The U.S. Supreme Court ruled on Tuesday that a securities fraud lawsuit can proceed against Merck & Co Inc over the pharmaceutical company's disclosures to investors about its withdrawn Vioxx pain drug. The justices unanimously upheld a ruling by a U.S. appeals court that allowed ... http://www.vioxxadvisor.com/4736.html WASHINGTON - The U.S. Supreme Court says investors who lost huge amounts of dollars when Merck & Co. pulled Read more here http://www.vioxxadvisor.com/4737.html US High Court Allows Shareholders To Sue Merck In Vioxx Case Click here for more info http://www.vioxxadvisor.com/4734.html Supreme Court says investors' Vioxx lawsuit can move forward Supreme Court of the United States - United States - Government - Supreme Court - Judicial Branch More... http://www.vioxxadvisor.com/4733.html The U.S. Supreme Court relaxed the deadlines for shareholder fraud suits, saying a suit can go forward with accusations that Merck & Co. misled the public about the risks posed by its now-withdrawn Vioxx painkiller. More... http://www.vioxxadvisor.com/4732.html April 13 (Bloomberg) -- Merck & Co. never informed Louisiana health officials about the heart-attack risks posed by its withdrawn Vioxx painkiller, a former state agency chief testified in court. More... http://www.vioxxadvisor.com/4731.html The settlement by Merck of a shareholder lawsuit over Vioxx represent what may turn out to be a pivotal moment in the corporate governance arena. DealBook's full coverage of the court-appointed examiner's autopsy of the investment bank. Read more here http://www.vioxxadvisor.com/4730.html Merck’s Australian unit failed to warn a doctor about heart risks associated with its painkiller Vioxx, a court in Melbourne found. Read more here http://www.vioxxadvisor.com/4729.html The popular painkiller Vioxx doubled the risk of a heart attack and was not fit to be on the market, a court ruled yesterday. In the world's first successful class action against the makers of the drug, judges found the subsidiary of the US pharmaceutical giant Merck had failed in ... http://www.vioxxadvisor.com/4728.html The popular painkiller Vioxx doubled the risk of a heart attack and was not fit to be on the market, a court ruled yesterday. In the world's first successful class action against the makers of the drug, judges found the subsidiary of the US pharmaceutical giant Merck had failed in ... http://www.vioxxadvisor.com/4727.html MELBOURNE, Australia (Reuters)—Merck & Co.'s one-time blockbuster arthritis drug Vioxx doubled the risk of heart attacks and was not fit for sale, an Australian court said on Friday in a ruling against the U.S. group's Australian unit. More... http://www.vioxxadvisor.com/4726.html SHARES in the law company Slater & Gordon jumped more than 3 per cent yesterday after it won a damages trial involving anti-arthritis drug Vioxx. Read more here http://www.vioxxadvisor.com/4725.html We just wrote that Merck & Co. made a final $4.1 billion payment to its Vioxx settlement fund. According to a recent Associated Press (AP) report, final payouts to former Vioxx users or their survivors should be made by the end of June. Now, Bloomberg News is reporting that Merck ... http://www.vioxxadvisor.com/4724.html FILE - In this Sept. 30, 2004 file photo, Vioxx is arranged on a counting tray, laying on top of the bottle, at The Pennington Apothecary in Pennington, N.J. Drugmaker Merck & Co. said Monday, March 1 Link to original article http://www.vioxxadvisor.com/4723.html The once-popular painkiller Vioxx doubled the risk of heart attack and was unfit for consumption, an Australian court ruled Friday, awarding a man leading a class action suit against the drug's maker 287,000 Australian dollars ($259,000) in compensation . Rofecoxib - Myocardial infarction - Health - Diseases & Conditions - ... http://www.vioxxadvisor.com/4720.html March 5 (Bloomberg) -- Merck & Co. ’s Australian unit failed to warn a doctor about heart risks associated with its painkiller Vioxx, a court in Melbourne found, and may be ordered to pay almost A$290,000 ($261,000) in damages. Link to original article http://www.vioxxadvisor.com/4721.html An Australian judge on Friday found arthritis drug Vioxx doubled the risk of heart attacks and was not fit for sale, opening the way for hundreds of lawsuits against US pharmaceutical giant Merck. Read more here http://www.vioxxadvisor.com/4722.html HUNDREDS of people could sue Merck after a judge found its arthritis drug Vioxx was not fit for sale because it doubled the risk of heart attack. Read more here http://www.vioxxadvisor.com/4719.html Sydney - An Australian court Friday cleared the way for a class action against US pharmaceuticals company Merck & Co Inc after the judge declared arthritis drug Vioxx doubled the risk of heart attacks among users. Melbourne resident Graeme Peterson, Link to original article http://www.vioxxadvisor.com/4718.html UPDATE 2.20pm: DRUG makers face huge Aussie payouts over Vioxx after a court awarded a Melbourne man $287,000. Link to original article http://www.vioxxadvisor.com/4715.html The arthritis drug Vioxx was not fit for sale because it doubled the risk of heart attacks, a judge has found. More... http://www.vioxxadvisor.com/4716.html The arthritis drug Vioxx has been found not fit for sale, allegedly doubling the risk of heart attack. More... http://www.vioxxadvisor.com/4717.html http://www.vioxxadvisor.com/4714.html The arthritis drug Vioxx was not fit for sale because it doubled the risk of heart attacks, a judge has found. More... http://www.vioxxadvisor.com/4711.html The Federal Court has ruled the makers of the controversial arthritis drug Vioxx put a defective drug on the market, which doubled the risk of heart attacks. Click here for more info http://www.vioxxadvisor.com/4712.html Judge rules drug doubles risk of heart attacks after awarding compensation to victim. Link to original article http://www.vioxxadvisor.com/4713.html Merck & Co. has made a final $4.1 billion payment to its Vioxx settlement fund. According to an Associated Press report, final payouts to former Vioxx users or their survivors should be made by the end of June. Vioxx was approved for use in 1999, and quickly became a bestseller ... http://www.vioxxadvisor.com/4710.html Drug maker has made final $4.1 billion payment into fund to settle tens of thousands of U.S. claims that withdrawn painkiller Vioxx caused heart attacks or strokes. Link to original article http://www.vioxxadvisor.com/4709.html TRENTON, New Jersey: Drugmaker Merck & Co. has made its final, US$4.1 billion payment into a fund to settle tens of thousands of U.S. claims that withdrawn painkiller Vioxx caused heart attacks or str Read more here http://www.vioxxadvisor.com/4708.html Merck: Last Vioxx payouts coming soon from $4.85B fund to settle heart attack, stroke lawsuits Rofecoxib - Myocardial infarction - Health - Diseases & Conditions - Cardiovascular Disorders More... http://www.vioxxadvisor.com/4706.html WHITEHOUSE STATION, N.J. - Drugmaker Merck & Co. says it's finished paying $4.85 billion into its fund to settle tens of thousands of claims that withdrawn painkiller Vioxx caused heart attacks or st Read more here http://www.vioxxadvisor.com/4707.html Dr. Scott S. Reuben, former chief of acute pain at the Bay State Hospital in Springfield, Massachusetts, has pleaded guilty to one count of health care fraud. As we’ve reported previously, Reuben was charged in federal court last month with falsifying studies involving the post-surgical benefits of drugs like Vioxx, ... http://www.vioxxadvisor.com/4705.html A Massachusetts doctor has pleaded guilty to one count of health care fraud stemming from accusations that he faked research for a dozen years in published studies that suggested after-surgery benefits from painkillers including Vioxx and Celebrex. More... http://www.vioxxadvisor.com/4704.html BOSTON A Massachusetts doctor pleaded guilty to one count of health care fraud stemming from accusations that he faked research for a dozen years in published studies that suggested after-surgery benefits from painkillers including Vioxx and Celebrex. Dr. Scott Reuben, an anesthesiologist, also agreed to repay $361,932 of research grants ... http://www.vioxxadvisor.com/4703.html BOSTON (AP) — A Massachusetts doctor has pleaded guilty to one count of health care fraud stemming from accusations that he faked research for a dozen years in published studies that suggested after-surgery benefits from painkillers including Vioxx and Celebrex. Click here for more info http://www.vioxxadvisor.com/4702.html Merck & Co. has agreed to pay $12.15 million in plaintiffs' legal fees to settle two shareholder derivative suits over its painkiller Vioxx -- one in state court in New Jersey and the other in the 3rd U.S. Circuit Court of Appeals. Link to original article http://www.vioxxadvisor.com/4701.html Merck & Co. has agreed to pay $12.15 million in plaintiffs' legal fees to settle two shareholder derivative suits over its painkiller Vioxx -- one in state court in New Jersey and the other in the 3rd U.S. Circuit Court of Appeals. As part of the settlement, Merck agreed to ... http://www.vioxxadvisor.com/4700.html AP PHOTO In hopes of settling two lingering lawsuits over its pain drug Vioxx, Merck is proposing to pay up to $12.1 million in legal fees and put a newly appointed chief medical officer in charge of strengthening its drug More... http://www.vioxxadvisor.com/4699.html Merck & Co. has agreed to pay fees and to improve its drug safety supervision in a settlement related to Vioxx. Read more here http://www.vioxxadvisor.com/4698.html Closing another chapter in the painful saga over withdrawn arthritis pill Vioxx, Merck & Co. has agreed to settle lawsuits brought by shareholders who lost billions. Link to original article http://www.vioxxadvisor.com/4697.html Latest chapter for Merck's ex-painkiller Vioxx ends with settlement on drug safety monitoring Read more here http://www.vioxxadvisor.com/4695.html Summary Box: Merck to settle Vioxx suits with new executive, committees to monitor drug safety Click here for more info http://www.vioxxadvisor.com/4696.html Feb. 10 (Bloomberg) -- Merck & Co. agreed to settle shareholder lawsuits over the withdrawn Vioxx painkiller by strengthening its drug-safety procedures, appointing a new chief medical officer and paying $12.2 million in legal fees. Read more here http://www.vioxxadvisor.com/4694.html AP FILE PHOTOIn this May 22, 2008 photo, the Merck logo is seen on the doors of a building at the company's headquarters in Readington, N.J. TRENTON — Merck & Co. must appoint two new independent committees and a chief Link to original article http://www.vioxxadvisor.com/4691.html Drug maker Merck (MRK) must appoint two new independent committees and a chief medical officer to monitor the safety of its medicines and drugs in development, under a proposed settlement to end long-running shareholder suits over the company's former painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4692.html NEW YORK (Reuters)—Merck & Co. has agreed to make corporate governance changes and create internal committees to address potential safety issues with its products under a proposed settlement of shareholders lawsuits related to its withdrawn Vioxx painkiller. Click here for more info http://www.vioxxadvisor.com/4693.html WHITEHOUSE STATION, N.J. - Merck & Co. must appoint two new independent committees and a chief medical officer to monitor safety of its medicines and drugs in development. Link to original article http://www.vioxxadvisor.com/4690.html Feb. 10 (Bloomberg) -- Merck & Co. agreed to settle shareholder lawsuits over the withdrawn Vioxx painkiller by strengthening its drug-safety procedures, appointing a new chief medical officer and paying $12.2 million in legal fees. Link to original article http://www.vioxxadvisor.com/4689.html An Ohio man who accepted an approximately $100,000 settlement for his Vioxx personal injury claim has filed a negligence suit against three Houston firms and three Houston lawyers, alleging the defendants made paperwork errors in his case file that reduced the size of his settlement. Craig Pingle alleges that he ... http://www.vioxxadvisor.com/4688.html The International Herald Tribune profiles Steven Nissen , the Cleveland Clinic scientist best known for his early warnings about the safety of Vioxx, long before the drug was taken off the market. Click here for more info http://www.vioxxadvisor.com/4687.html (Corrected to change "last year" to "in 2007" in the fourth paragraph.) Link to original article http://www.vioxxadvisor.com/4686.html Federal prosecutors announced Thursday that they have filed a health care fraud charge against a doctor accused of faking research for a dozen years in published studies that suggested after-surgery benefits from painkillers including Vioxx and Celebrex. More... http://www.vioxxadvisor.com/4685.html Every year, millions of observant Jews fast on their holiest day, Yom Kippur, and millions of Muslims fast for the month of Ramadan. And every year, as many as 40 percent of those who fast develop serious headaches. Read more here http://www.vioxxadvisor.com/4684.html Dr. Julie Gerberding LEARN MORE Merck & Co. Web site Merck News Room announcing appointment Merck responds to Archives of Internal Medicine article on Vioxx – November 2009 IMAGE SOURCE: Dr. Julie Gerberding / on Web site Adventures in Autism Former Centers for Disease Control and Prevention (CDC) director, Dr. ... http://www.vioxxadvisor.com/4683.html Breast cancer risk not so easy to gauge; Thanksgiving meal tips for people with diabetes or allergies. Read more here http://www.vioxxadvisor.com/4682.html In the proposed class action, brought on behalf of an estimated 2.4 million Californians—out of about 20 million Vioxx users nationwide—the plaintiffs did not seek damages for any adverse health effects, but sought reimbursement for the difference between what they paid for Vioxx and what they would have paid for ... http://www.vioxxadvisor.com/4681.html VAIL, Colorado - It hasn't been that long since the arthritis drug Vioxx was taken off the market for increased risk of stroke and heart attack in some patients. Currently, the manufacturer of the drug Fosamax, which is used in the treatment or prevention of osteoporosis, is involved in a ... http://www.vioxxadvisor.com/4680.html Personalized medicine, says this article in T he Scientist , could breathe new life into failed drug candidates . "If Merck could have known in advance who would have cardiovascular problems from Vioxx, they may not have had to withdraw it from the market," Personalized Medicine Coalition's Edward Abrahams says. ... http://www.vioxxadvisor.com/4679.html The Vioxx scandal, and the Food & Drug Administration’s (FDA) role in it, has not brought about much change at the agency, according to a new government report. Vioxx was approved for use in 1999, and quickly became a bestseller for Merck, with annual sales of $2.5 billion; however, the ... http://www.vioxxadvisor.com/4678.html GAO: Post-Vioxx Scandal, Agency Gives Decision-Making Power to Wrong Scientists Click here for more info http://www.vioxxadvisor.com/4676.html The FDA still hasn't restructured its staff to better monitor drug safety, more than three years after experts recommended key changes in the wake of the Vioxx scandal. Click here for more info http://www.vioxxadvisor.com/4677.html The Food and Drug Administration still hasn't restructured its staff to better monitor drug safety, more than three years after experts recommended key changes in the wake of the Vioxx scandal. Click here for more info http://www.vioxxadvisor.com/4675.html Readers of this blog are, by now, aware of the many issues surrounding Merck’s blockbuster nonsteroidal, anti-inflammatory medication Vioxx (rofecoxib) and negative cardiac events. The cardiac problems associated with Vioxx, and its subsequent withdrawal from the market, spawned scores of lawsuits. These include Merck shareholder lawsuits, which were recently the ... http://www.vioxxadvisor.com/4674.html Lawyers for Merck & Co. told the Supreme Court on Monday that investors waited too late and didn’t do all of the necessary investigations to sue the drugmaker over whether it properly warned about the risks of its blockbuster painkiller Vioxx. More... http://www.vioxxadvisor.com/4673.html ASSOCIATED PRESS Lawyers for Merck & Co. told the Supreme Court on Monday that investors waited too long and didn't do all of the necessary investigations to sue the drug maker over whether it properly warned about the risks of its blockbuster painkiller Vioxx. Whether the high court agrees with ... http://www.vioxxadvisor.com/4672.html Rates edge up The Treasury Department auctioned $30 billion in three-month bills on Monday at a discount rate of 0.060 percent, up from 0.040 percent last week. Another $31 billion in six-month bills was auctioned at a discount rate of 0.150 percent, up from 0.140 percent last week. Separately, the ... http://www.vioxxadvisor.com/4670.html U.S. Supreme Court justices seemed reluctant Monday to give the pharmaceutical company Merck & Co. a "statute of limitations" way out of defending against a securities fraud class action involving Vioxx. The Court heard arguments in the latest round in a continuing battle over how easy or hard it should ... http://www.vioxxadvisor.com/4671.html Lawyers for Merck & Co have told the US Supreme Court that investors shouldn't have waited so long to sue the drug maker over warnings about the risks of its painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4669.html (Updates with additional detail.) Read more here http://www.vioxxadvisor.com/4667.html Lawyers for Merck told the Supreme Court Monday investors waited too late and didn't do all of the necessary investigations to sue the drugmaker over whether it properly warned about the risks of its blockbuster painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4668.html WASHINGTON -(Dow Jones)- The U.S. Supreme Court voiced skepticism Monday of Merck & Co. Inc.'s (MRK) arguments that shareholders waited too long to file securities lawsuits alleging the drug maker misrepresented the safety of painkiller drug Vioxx, which it removed from the market in 2004. Read more here http://www.vioxxadvisor.com/4665.html Drugmaker says investors should have known there could be problems with pill Link to original article http://www.vioxxadvisor.com/4666.html Lawyers for Merck & Co. have told the Supreme Court that investors waited too long to sue over its warnings about the risks of its former blockbuster painkiller Vioxx before it was pulled from the market. More... http://www.vioxxadvisor.com/4664.html Evidence of cardiovascular risks associated with taking Vioxx, the popular, nonsteroidal anti-inflammatory drug (rofecoxib), could have been identified nearly four years before its manufacturer, Merck & Co. Inc., voluntarily pulled the drug from the market. More... http://www.vioxxadvisor.com/4663.html NEW YORK, Nov. 24 (UPI) -- Merck & Co. is disputing it knew Vioxx significantly increased the risk of heart attacks at least three years before it was pulled off the market. Read more here http://www.vioxxadvisor.com/4662.html We have long been writing about the links between Merck’s blockbuster nonsteroidal, anti-inflammatory medication Vioxx (rofecoxib) and negative cardiac events. Now, according to Science Daily, a study has found that evidence of cardiovascular risks linked to Vioxx might have been realized almost four years before Merck & Co. Inc., pulled ... http://www.vioxxadvisor.com/4661.html The risks of taking anti-inflammatory drug Vioxx could have been detected nearly four years before the drug was pulled from the market, according to analysis of nearly 30 clinical trials. Click here for more info http://www.vioxxadvisor.com/4660.html The red flags about the pain reliever Vioxx were present at least three years before the drug was taken off the market, U.S. researchers say. Read more here http://www.vioxxadvisor.com/4658.html Heart risks from taking Merck & Co Inc's painkiller Vioxx could have been detected more than three years before the company withdrew the drug from the market in September 2004, had the data been openly available, U.S. researchers said on Monday. Read more here http://www.vioxxadvisor.com/4657.html A study of data revealed in lawsuits suggests Merck should have known Vioxx was deadly years before they pulled the drug from the market. Merck says the study is flawed. Read more here http://www.vioxxadvisor.com/4659.html MONDAY, Nov. 23 (HealthDay News) -- Problems with the popular arthritis drug Vioxx, including increased risk for heart attack, stroke and death, were known for years before the drug's voluntary withdrawal from the market in 2004, a new report says. More... http://www.vioxxadvisor.com/4655.html Evidence of cardiovascular risks associated with taking Vioxx, the popular, nonsteroidal anti-inflammatory drug (rofecoxib), could have been identified nearly four years before its manufacturer, Merck & Co. Inc., voluntarily pulled the drug from the market. Link to original article http://www.vioxxadvisor.com/4656.html A district court judge in Travis County, Texas, dismissed all claims in a Medicaid lawsuit over the discontinued painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4654.html A Texas court has dismissed a lawsuit brought by the state against drugmaker Merck & Co that sought a refund for money spent on the withdrawn Vioxx pain treatment, the company said on Monday. More... http://www.vioxxadvisor.com/4653.html Merck said today that Travis County, Texas District Court Judge Scott H. Jenkins granted Merck's motion for summary judgment, dismissing all claims in a VIOXX-related lawsuit filed on behalf of the State of Texas. Link to original article http://www.vioxxadvisor.com/4651.html Drug maker said Monday a district court judge in Texas dismissed all claims in a state Medicaid lawsuit over the painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4652.html http://www.vioxxadvisor.com/4649.html Merck & Co. said Monday a district court judge in Texas dismissed all claims in a state Medicaid lawsuit over the painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4650.html ( University of Western Ontario ) He was the first to predict the popular anti-inflammatory drug, Vioxx would increase the risk of strokes and heart attacks, and it was his discovery that led to the adoption of low dose aspirin for every day cardio-protection. For these and other outstanding scientific ... http://www.vioxxadvisor.com/4648.html WASHINGTON, Nov. 2 (UPI) -- The Obama administration filed a brief with the U.S. Supreme Court siding with investors hoping to sue Merck and Co. over its now-withdrawn painkiller Vioxx. More... http://www.vioxxadvisor.com/4647.html When the pain drug Vioxx was pulled from the market in September 2004 due to concerns about heart and stroke risks, every Cleveland Clinic patient taking the drug got an e-mail within an hour of the recall. So did their doctors. Read more here http://www.vioxxadvisor.com/4646.html Oct. 22 (Bloomberg) -- Merck & Co. lost a bid for a hearing before Canada’s highest court to determine whether competing class-action lawsuits can proceed over claims that the painkiller Vioxx caused heart attacks and strokes. Read more here http://www.vioxxadvisor.com/4644.html Oct. 22 (Bloomberg) -- The Canadian Supreme Court has turned down requests for a hearing of appeals involving competing class-action lawsuits that claim Merck & Co. More... http://www.vioxxadvisor.com/4645.html When Richard Clark was named CEO and president of Merck in 2005, the drug behemoth was reeling in the wake of the Vioxx scandal, which in 2004 forced the company to withdraw the blockbuster painkiller for safety reasons. Link to original article http://www.vioxxadvisor.com/4643.html When the pain drug Vioxx was pulled from the market in September 2004 over concerns about heart and stroke risks, every Cleveland Clinic patient taking the drug got an e-mail within an hour of the recall. So did their doctors. Read more here http://www.vioxxadvisor.com/4642.html In May, Margaret Hamburg became the 21st commissioner of the Food and Drug Administration, a beleaguered agency that has long been criticized for its mishandling of food crises and for drug recalls such as the Vioxx debacle. Link to original article http://www.vioxxadvisor.com/4641.html Pharmacovigilance has been expanding in recent years, as companies are required to monitor drug safety post launch. Drug safety issues, such as those raised by Vioxx earlier this decade, have led to increased risk-averseness by regulators, with greater post-marketing assessment of drugs. Read more here http://www.vioxxadvisor.com/4640.html Merck’s appeal of a $4.5 million jury award to a New Jersey man who blamed his heart attack on the company’s Vioxx painkiller was dismissed by an appeals court, lawyers for the man’s family said. The New Jersey Supreme Court Link to original article http://www.vioxxadvisor.com/4639.html Merck & Co.'s appeal of a $4.5 million jury award to a New Jersey man who blamed his heart attack on the company's Vioxx painkiller was dismissed by an appeals court, lawyers for the man's family said. Link to original article http://www.vioxxadvisor.com/4638.html Sept. 29 (Bloomberg) -- Merck & Co. ’s appeal of a $4.5 million jury award to a New Jersey man who blamed his heart attack on the company’s Vioxx painkiller was dismissed by an appeals court, lawyers for the man’s family said. Link to original article http://www.vioxxadvisor.com/4637.html AP Photo/Daniel HulshizerA 2004 file photo of Vioxx arranged on a counting tray, laying on top of the botttle, at The Pennington Apothecary.TRENTON -- The Supreme Court of New Jersey backed a $4.5 million award to the widow of a Click here for more info http://www.vioxxadvisor.com/4635.html The Supreme Court of New Jersey backed a $4.5 million award to the widow of a Park Ridge man who suffered heart problems after using Merck’s painkiller Vioxx, ending of the last unresolved lawsuits related to the drug. Click here for more info http://www.vioxxadvisor.com/4636.html The Supreme Court of New Jersey backed a $4.5 million award to the widow of a man who suffered heart problems after using Merck's painkiller Vioxx, ending of the last unresolved lawsuits related to the drug. Link to original article http://www.vioxxadvisor.com/4634.html http://www.vioxxadvisor.com/4633.html Merck & Co. was sued Monday by Kentucky Attorney General Jack Conway in a complaint alleging the company violated the state's Consumer Protection Act in marketing its painkiller Vioxx before pulling it from the market in 2004. Link to original article http://www.vioxxadvisor.com/4632.html Merck is paying claims by the families of more than 3,100 users of its Vioxx painkiller who died of heart attacks or strokes blamed on the drug, according to a law firm administering a $4.85 billion settlement fund. The fund Link to original article http://www.vioxxadvisor.com/4631.html Sept. 25 (Bloomberg) -- Merck & Co. is paying claims by the families of more than 3,100 users of its Vioxx painkiller who died of heart attacks or strokes blamed on the drug, according to a law firm administering a $4.85 billion settlement fund. Read more here http://www.vioxxadvisor.com/4630.html The drug more than doubled the risks of heart attacks and strokes among patients who used it to ease arthritis pain, according to clinical studies. One scientist estimated that it had caused as many as 138,000 heart attacks and 55,000 deaths in the United States. . more Share This Click ... http://www.vioxxadvisor.com/4629.html US claimants won billions so why can't British victims have their day in court? Click here for more info http://www.vioxxadvisor.com/4628.html This article is provided to FT.com readers by Pharmawire —a news service focused on providing insight into the most price sensitive issues in the global pharmaceutical market. More... http://www.vioxxadvisor.com/4627.html For a trip down memory lane, visit Organizedwisdom.com. You’ll be told that despite osteoarthritis, Olympic gold medalist Dorothy Hamill skates “five days a week for up to three hours,” thanks to Vioxx -- and can even “continue touring with the show Champions on Ice!” Click here for more info http://www.vioxxadvisor.com/4626.html Tough economic times are usually no problem for trial lawyers. Pain, suffering and liability abound even in a bad economy. Vioxx, defective products, bad hip replacement joints, video games that "cause" violence, perhaps even foods that "make" people fat -- you name it. More... http://www.vioxxadvisor.com/4625.html NEW YORK (Reuters)—Merck & Co has agreed to pay $80 million to settle 190 outstanding claims involving its withdrawn Vioxx pain drug, the company disclosed Monday. Click here for more info http://www.vioxxadvisor.com/4624.html Health insurers, unions and other private groups that paid for prescriptions for withdrawn painkiller Vioxx have reached an $80 million settlement with its maker, ending another part of the multipronged litigation. Such third-party payers had filed about 190 claims against Link to original article http://www.vioxxadvisor.com/4623.html Woodward & Curran names Joe Geary associate; ZoomInfo president named to Who's Who in marketing; State gas prices reverse course with 2-cent hike; SEC  wants ex-Kmart head to pay for misleading investors; Insurers settle Vioxx claims for $80 million; Report: Fewer online job ads are posted for July Click here ... http://www.vioxxadvisor.com/4622.html WHITEHOUSE STATION, N.J. — Health insurers, unions and other private groups that paid for prescriptions for withdrawn painkiller Vioxx have an agreement with its maker to settle their claims for $80 million. More... http://www.vioxxadvisor.com/4621.html Hagens Berman Sobol Shapiro LLP today announced certain parties reached a $65 million settlement with Merck and Company, Inc. on behalf of health benefit providers who purchased Vioxx in a suit claiming the pharmaceutical giant launched misleading marketing campaigns for its drugs. Click here for more info http://www.vioxxadvisor.com/4620.html Health insurers, unions and other private groups that paid for prescriptions for withdrawn painkiller Vioxx have an agreement with its maker to settle their claims for $80 million. More... http://www.vioxxadvisor.com/4619.html Merck & Co. (MRK) anticipates paying $80 million to settle litigation in which drug-benefit plans sought to recover their costs in paying for the former pain drug Vioxx, Merck disclosed Monday. More... http://www.vioxxadvisor.com/4618.html By AARON KESSLER Judge Eldon E. Fallon, who rose to national prominence by handling the complex Vioxx litigation, is fast-tracking the numerous Chinese drywall cases to a pace rarely seen in the plodding federal court system. Click here for more info http://www.vioxxadvisor.com/4617.html Joan Petty claims to have suffered three heart attacks and two strokes after she started taking the painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4616.html Drug company Merck failed in its duty to warn patients of a heart risk attached to its anti-arthritis drug Vioxx, the Federal Court has been told. Click here for more info http://www.vioxxadvisor.com/4615.html THE international pharmaceutical giant behind anti-arthritis drug Vioxx claims the class action against it fails to prove that its blockbuster product materially increased the risk of patients having a heart attack. Link to original article http://www.vioxxadvisor.com/4612.html A MAN suing the drug company Merck over claims its anti-arthritis drug Vioxx caused him to have a heart attack had not proven the drug was responsible over other risk factors, the Federal Court has heard. Read more here http://www.vioxxadvisor.com/4613.html Man suing drug company Merck over claims its anti-arthritis drug Vioxx caused his heart attack has not proved drug responsible, Federal Court hears. Read more here http://www.vioxxadvisor.com/4614.html SEVEN Network presenter David Koch hosted an education program for GPs produced by pharmaceutical giant Merck & Co. Read more here http://www.vioxxadvisor.com/4611.html PHARMACEUTICAL giant Merck & Co planned to set up patient loyalty programs with the public goal of increasing "quality of life" but privately to "improve patient compliance" and double the "sales potential" of its anti-arthritis drug Vioxx. Click here for more info http://www.vioxxadvisor.com/4610.html A U.S. federal appeals court in Texas Thursday reaffirmed a decision that reversed millions of dollars in damages against Merck & Co. (MRK) in litigation tied to pain and arthritis drug Vioxx. Link to original article http://www.vioxxadvisor.com/4609.html The U.S. Supreme Court will decide whether shareholders can sue Merck & Co. over whether the drug maker provided adequate information about the risks of its former blockbuster painkiller Vioxx before it was pulled from the market. Link to original article http://www.vioxxadvisor.com/4608.html The Supreme Court will decide whether shareholders can sue Merck & Co. over whether the drugmaker provided adequate information about the risks of its former blockbuster painkiller Vioxx before it was pulled from the market. Click here for more info http://www.vioxxadvisor.com/4607.html The U.S. Supreme Court will decide whether shareholders can sue Merck & Co. over whether the drugmaker provided adequate information about the risks of its former blockbuster painkiller Vioxx before it was pulled from the market. The high court agreed Tuesday to review Merck’s challenge to a federal appeals court’s ... http://www.vioxxadvisor.com/4606.html The Supreme Court on Tuesday agreed to hear Merck & Co.'s challenge to a shareholder suit linked to litigation over the painkiller Vioxx. Company lawyers say the suit was filed outside the two-year statute of limitations and should not be permitted to go forward. The 3rd Circuit last year reversed ... http://www.vioxxadvisor.com/4605.html May 26 (Bloomberg) -- The U.S. Supreme Court agreed to consider Merck & Co. ’s bid to stop a shareholder lawsuit over the now-withdrawn Vioxx painkiller in a case that might mean tighter deadlines for investor fraud lawsuits. Link to original article http://www.vioxxadvisor.com/4604.html The U.S. Supreme Court said on Tuesday that it would hear an appeal by Merck & Co Inc of a ruling that reinstated a securities fraud lawsuit involving the company's disclosures to investors about its withdrawn Vioxx pain drug. Click here for more info http://www.vioxxadvisor.com/4603.html The U.S. Supreme Court said on Tuesday that it would hear an appeal by Merck & Co Inc of a ruling that reinstated a securities fraud lawsuit involving the company's disclosures to investors about its withdrawn Vioxx pain drug. Link to original article http://www.vioxxadvisor.com/4602.html The Supreme Court said on Tuesday that it would hear an appeal by Merck & Co. of a ruling that reinstated a securities fraud lawsuit involving the company's disclosures to investors about its withdrawn Vioxx pain drug. More... http://www.vioxxadvisor.com/4601.html Taking on a major securities fraud case growing out of the controversy over the pain medicine Vioxx, the Supreme Court agreed on Tuesday to clarify when an investor must go to court to make a fraud claim. The Justices granted review of Merck & Co., et al., v. Reynolds, et ... http://www.vioxxadvisor.com/4600.html The Supreme Court will decide whether shareholders can sue pharmaceutical company Merck & Co. because of the failure of its former blockbuster painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4597.html May 26 (Bloomberg) -- The U.S. Supreme Court agreed to consider Merck & Co. ’s bid to stop a shareholder lawsuit over the now-withdrawn Vioxx painkiller in a case that might mean tighter deadlines for investor fraud lawsuits. Link to original article http://www.vioxxadvisor.com/4598.html The U.S. Supreme Court will decide whether shareholders can sue international pharmaceutical maker Merck & Co. because of the failure of its former blockbuster painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4599.html MARKETING documents reveal Australian staff at pharmaceutical giant Merck planned to spend $14.5 million on promotional "tactics" for its anti-arthritis drug Vioxx in one year, including $6 million on free samples. Link to original article http://www.vioxxadvisor.com/4596.html AUSTRALIAN marketing staff from pharmaceutical giant Merck & Co paid specialist nurses half-a-million dollars to "hunt" through patient records for potential candidates for their blockbuster anti-arthritis drug Vioxx. Click here for more info http://www.vioxxadvisor.com/4595.html Documents have been revealed in court which apparently show that Merck created fake medical journals with names such as 'The Australasian Journal of Bone and Joint Medicine' to publish favourable reports on its painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4594.html Once hailed as a wonder drug, the anti-inflammatory Vioxx is at the centre of a high-stakes court case over whether it is linked to cardiovascular problems such as heart attacks and strokes. Click here for more info http://www.vioxxadvisor.com/4593.html Testimony accuses drugmaker Merck of paying for scientific journal lookalikes. Link to original article http://www.vioxxadvisor.com/4592.html A class-action lawsuit over the strategies that Merck used to market its painkiller Vioxx in Australia is earning the American drug maker some bad publicity. Click here for more info http://www.vioxxadvisor.com/4591.html WHITEHOUSE STATION, N.J. - A California state judge rejects a proposed class-action lawsuit brought on behalf of state residents who took the painkiller Vioxx before it was pulled from the market in 2004. Read more here http://www.vioxxadvisor.com/4590.html TORONTO - The Ontario Court of Appeal has given Merck Frosst Canada Ltd. until May 21 to consider an appeal in a class-action lawsuit involving the painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4589.html May 11 (Bloomberg) -- Merck & Co. won an extension to appeal the certification of an Ontario group lawsuit, claiming the painkiller Vioxx caused heart attacks and strokes, because certification of a similar suit was overturned in Saskatchewan. Click here for more info http://www.vioxxadvisor.com/4588.html A California state judge has rejected a proposed class-action lawsuit brought on behalf of state residents who took the painkiller Vioxx before it was pulled from the market in 2004. Read more here http://www.vioxxadvisor.com/4587.html AP Photo/Daniel HulshizerA 2004 file photo of Vioxx arranged on a counting tray, laying on top of the botttle, at The Pennington Apothecary. Today, a California judge rejected a class-action lawsuit by former Vioxx users against N.J. drugmaker Merck.WHITEHOUSE STATION More... http://www.vioxxadvisor.com/4585.html May 8 (Bloomberg) -- Merck & Co. won’t face a class-action lawsuit filed by consumers seeking reimbursement for costs tied to the painkiller Vioxx, a California judge ruled, denying plaintiffs’ request to sue as a group. Read more here http://www.vioxxadvisor.com/4586.html May 8 (Bloomberg) -- Merck & Co. won’t face a class-action lawsuit filed by consumers seeking reimbursement for costs associated with its painkiller Vioxx, a California judge ruled, denying plaintiffs’ request to sue as a group. Read more here http://www.vioxxadvisor.com/4584.html PHARMACEUTICAL giant Merck & Co named an Australian arthritis expert as an editorial board member of the phoney medical journal it used to promote its drug Vioxx without even telling him. Click here for more info http://www.vioxxadvisor.com/4583.html THE world's largest medical publisher, Elsevier, has expressed embarrassment at its role in a deceptive marketing ploy by the giant drug company Merck after it was revealed in a Melbourne court. Link to original article http://www.vioxxadvisor.com/4582.html A woman prescribed a controversial drug for arthritis which was withdrawn amid serious health fears believes she could be among hundreds of “forgotten patients” from Northern Ireland still fighting for compensation. Read more here http://www.vioxxadvisor.com/4581.html Private lobbying by an American pharmaceutical company saw government ministers back down from supporting British people who claim one of its failed drugs caused them heart attacks and strokes. Read more here http://www.vioxxadvisor.com/4580.html THE international pharmaceutical giant behind anti-arthritis drug Vioxx maintains there is not enough scientific proof to link the drug to heart attacks, despite the company withdrawing it from the market almost five years ago. Link to original article http://www.vioxxadvisor.com/4579.html Philip K Dickhead sends in a piece from the Australian media, a couple of weeks old, that hasn't seen much discussion here. In a class-action lawsuit in Australia against Merck for its Vioxx anti-arthritis drug, information has come out that the company developed a "hit list" of doctors who had ... http://www.vioxxadvisor.com/4578.html THERE are two battles being waged in the case between Graeme Peterson and Merck & Co over whether Vioxx caused his heart attack. Click here for more info http://www.vioxxadvisor.com/4577.html A SENIOR Merck scientist questioned whether the conclusion of the company's research that found its anti-arthritis drug Vioxx did not increase the risk of heart attacks was "wishful thinking" rather than a "critical interpretation" of the data. Read more here http://www.vioxxadvisor.com/4576.html THE drug company Merck had a cardiologist sign his name to a medical journal article it wrote claiming there was no evidence of any heart risk attached to its drug Vioxx, court documents allegedly show. Link to original article http://www.vioxxadvisor.com/4575.html A MERCK scientist involved in developing the company's anti-arthritis drug Vioxx admitted in an internal email two years before the drug was released that the possibility of increased heart attacks was "of great concern". More... http://www.vioxxadvisor.com/4574.html IT started with "a cunning plan". Link to original article http://www.vioxxadvisor.com/4572.html Australian boss of drug company played down heart-attack risk attached to anti-athrisis drug Vioxx. Read more here http://www.vioxxadvisor.com/4573.html SALES staff for Merck&Co were allegedly given instructions to convince concerned doctors Vioxx doesn't cause heart attacks. More... http://www.vioxxadvisor.com/4571.html SALES representatives for pharmaceutical giant Merck & Co were given line-by-line instructions on how to convince doctors about Vioxx. Click here for more info http://www.vioxxadvisor.com/4570.html THE drug company Merck tried to persuade doctors they could be recognised as heroes if they prescribed its anti-arthritis drug Vioxx, the Federal Court heard yesterday. Read more here http://www.vioxxadvisor.com/4569.html THE Melbourne doctor who prescribed Vioxx to a man suing the manufacturer on the grounds the anti-arthritis drug allegedly triggered a heart attack, was visited 124 times in three years by drug company representatives spruiking the product. Click here for more info http://www.vioxxadvisor.com/4568.html WARRINGTON — No one has to tell Robert J. Capetola how hard it is to get a new product approved by the Food and Drug Administration in the post-Vioxx era. Click here for more info http://www.vioxxadvisor.com/4567.html A DOCTOR who prescribed the anti-arthritis drug said he didn't know of the risks. More... http://www.vioxxadvisor.com/4566.html MONTREAL, March 30, 2009 - Merck Frosst Canada Ltd. has learned that the Court of Appeal for Saskatchewan has issued a decision allowing Merck's appeal and quashing an order of the Court of Queen's Bench that had certified a class proceeding on behalf of Canadian residents of all provinces except ... http://www.vioxxadvisor.com/4565.html REGINA - The Saskatchewan Court of Appeal has overturned a decision that certified a class-action lawsuit over the painkiller Vioxx, but experts say it doesn't mean the legal battle is over for the plaintiffs or the drug maker. More... http://www.vioxxadvisor.com/4564.html Saskatchewan's highest court has declared that a lawsuit against the makers of the painkiller Vioxx can't proceed as a class action. Link to original article http://www.vioxxadvisor.com/4563.html REGINA - The Saskatchewan Court of Appeal has overturned a decision that certified a class-action lawsuit over the drug Vioxx. Read more here http://www.vioxxadvisor.com/4562.html March 31 (Bloomberg) -- Merck & Co. , after settling most of its Vioxx lawsuits in the U.S., said it won reversal of a judge’s decision certifying a group lawsuit against it in Canada. Read more here http://www.vioxxadvisor.com/4560.html Merck Frosst Canada Ltd. has learned that the Court of Appeal for Saskatchewan has issued a decision allowing Merck's appeal and quashing an order of the Court of Queen's Bench that had certified a class proceeding on behalf of Canadian residents of all provinces except Quebec who purchased or ingested ... http://www.vioxxadvisor.com/4561.html March 30 (Bloomberg) -- Merck & Co. , which has settled most of its U.S. Vioxx lawsuits, said it won reversal of a Canadian judge’s decision certifying a group lawsuit against it. Read more here http://www.vioxxadvisor.com/4559.html THOUSANDS of Australians taking a popular painkilling drug were at increased risk of heart attack and potential death because the manufacturer misled the public, a Melbourne court heard yesterday. Link to original article http://www.vioxxadvisor.com/4558.html Company denies it knew Vioxx increased risk of heart attack as class action begins. More... http://www.vioxxadvisor.com/4556.html THE long-awaited Australian class action against the manufacturers of the anti-inflammatory drug Vioxx will begin today in the Federal Court. Read more here http://www.vioxxadvisor.com/4557.html Merck & Co, Inc has received a letter from the US Attorney's Office for the District of Massachusetts advising the company that it is a target of a previously-disclosed federal grand jury investigation. Click here for more info http://www.vioxxadvisor.com/4555.html Merck & Co., Inc. recently reported that it has received a letter from the U.S. Attorney's Office for the District of Massachusetts advising the company that it is a target of a previously-disclosed federal grand jury investigation. Click here for more info http://www.vioxxadvisor.com/4554.html Merck & Co said on Monday that it has been advised it is a target of a U.S. grand jury investigation involving its withdrawn pain drug Vioxx. Link to original article http://www.vioxxadvisor.com/4553.html TORONTO - A U.S. government plan to buy up toxic banking assets and provide a boost to lending could rejuvenate both the American and Canadian More... http://www.vioxxadvisor.com/4552.html A New Jersey judge on Tuesday denied a request to certify a class action against Merck & Co. on behalf of consumers for their out-of-pocket expenses for the painkiller Vioxx, withdrawn from the market in 2004 after a medical study linked it to heart disease. Superior Court Judge Carol Higbee ... http://www.vioxxadvisor.com/4551.html A New Jersey judge Tuesday denied a request to certify a class action against Merck & Co on behalf of consumers who sought reimbursement of out-of-pocket expenses for their use of the withdrawn Read more here http://www.vioxxadvisor.com/4550.html Merck & Co., Inc. recently said it was pleased that a New Jersey state court denied plaintiffs' request to certify a class of consumers who sought reimbursement for out-of-pocket VIOXX costs. Click here for more info http://www.vioxxadvisor.com/4549.html March 17 (Bloomberg) -- Merck & Co. need not defend a lawsuit in which the company is accused of defrauding millions of users of its painkiller Vioxx, a New Jersey judge ruled, dealing a “death knell” to class-action claims by consumers. Click here for more info http://www.vioxxadvisor.com/4546.html By Bill Berkrot Link to original article http://www.vioxxadvisor.com/4547.html A New Jersey judge has rejected efforts by consumers who took the painkiller Vioxx to be able to sue as a group to recover their out-of-pocket costs, drugmaker Merck & Co. said Tuesday. Click here for more info http://www.vioxxadvisor.com/4548.html BOSTON — A Massachusetts anesthesiologist has been accused of fabricating results in nearly two dozen published studies that claimed to show after-surgery benefits from painkillers including Vioxx and Celebrex. More... http://www.vioxxadvisor.com/4545.html A Massachusetts anesthesiologist has been accused of fabricating results in nearly two dozen published studies that claimed to show benefits from painkillers like Vioxx and Celebrex. Link to original article http://www.vioxxadvisor.com/4544.html A Massachusetts anesthesiologist has been accused of fabricating results in nearly two dozen published studies that claimed to show benefits from painkillers like Vioxx and Celebrex. Read more here http://www.vioxxadvisor.com/4543.html A prominent Massachusetts anesthesiologist allegedly fabricated 21 medical studies that claimed to show benefits from painkillers like Vioxx and Celebrex, according to the hospital where he worked. Click here for more info http://www.vioxxadvisor.com/4542.html Merck & Co Inc CEO Richard Clark, once viewed as a behind the scenes manufacturing guru expected to merely steer the company through its Vioxx legal woes, has emerged as a major dealmaker. Link to original article http://www.vioxxadvisor.com/4541.html In one of the largest prescription drug recalls in U.S. history, worldwide sales of the popular arthritis drug Vioxx were halted today after new data pointed to an increased patient risk for heart attacks and stroke. Click here for more info http://www.vioxxadvisor.com/4540.html Merck & Co has posted higher net earnings of $7,808 million during the year ended December 2008 as compared to $3,275 million in the previous year mainly on account of gain of $2,194 million on distribution from AstraZeneca LP and provision of $4,850 million for Vioxx settlement agreement in the ... http://www.vioxxadvisor.com/4539.html Diet pills laced with anti-seizure medicine. Soda "fortified" with vitamins and minerals. "Sexual enhancement" supplements pumped up with illegal drugs. The U.S. Food and Drug Administration has started to crack down on these and other products recently - moves we applaud, because this important agency has taken a lot of ... http://www.vioxxadvisor.com/4538.html Gupta downplays safety risks in treatments, and was criticized for his reporting on Vioxx, a pain medication that was withdrawn from the market in 2004 because it causes heart attacks. ... http://www.vioxxadvisor.com/4537.html Diet pills laced with anti-seizure medicine. Soda "fortified" with vitamins and minerals. "Sexual enhancement" supplements pumped up with illegal drugs. The U.S. Food and Drug Administration has started to crack down on these and other products recently — moves we applaud because this important agency has taken a lot of ... http://www.vioxxadvisor.com/4536.html Two area women who suffered heart attacks after taking the arthritis drug Vioxx have been notified that they are receiving hundreds of thousands of dollars in a settlement from the manufacturer of the medication. Read more here http://www.vioxxadvisor.com/4535.html NEW YORK—Insurers that had been trying to tap into payments to Vioxx claimants participating in a $4.85 billion global settlement reached in 2007 with Merck & Co. have agreed to settle their claims for less than they originally were seeking. More... http://www.vioxxadvisor.com/4534.html Former Vioxx users getting part of a $4.85 billion settlement ending most personal injury suits over the withdrawn painkiller will get a bigger piece of the pie, thanks to an unusual settlement Thursday with their health insurers. Link to original article http://www.vioxxadvisor.com/4533.html http://www.vioxxadvisor.com/4532.html QUESTION: To my surprise, I've had great results with grape juice and pectin. For the past 15 years, I've tried numerous medications for joint pain in my knees and hips, including Advil, Tylenol, Vioxx and Celebrex, but nothing else has helped so much. Link to original article http://www.vioxxadvisor.com/4531.html Merck said it was weighing an appeal to the state Supreme Court but was pleased the misconduct finding meant plaintiffs were at best at square one. Read more here http://www.vioxxadvisor.com/4530.html Family Sued Merck after 71 year-old Man Died of Heat Attack Click here for more info http://www.vioxxadvisor.com/4529.html A Texas appeals court has vacated its May decision that tossed out a $7.75 million judgment in a case in which Felicia Garza alleged that taking the prescription drug Vioxx caused her 71-year-old husband, Leonel Garza, to suffer a fatal heart attack. The court remanded the case for a new ... http://www.vioxxadvisor.com/4528.html A state appeals court has reversed its earlier decision and sent a landmark case against the makers of the painkiller Vioxx back to a Starr County court. Read more here http://www.vioxxadvisor.com/4527.html Drugmaker Merck & Co. is considering an appeal after a Texas state appeals court reversed its own prior dismissal of a $7.75 million judgment in a Vioxx personal injury lawsuit against the drugmaker. Read more here http://www.vioxxadvisor.com/4526.html A retired Cambridge professor has won the right to compensation from Merck, the US pharmaceutical group, for severe side effects developed after he took Vioxx, its painkiller, in a clinical trial for prostate cancer. Read more here http://www.vioxxadvisor.com/4525.html In the wake of Vioxx's withdrawal and strong warning labels on all NSAIDs, health conscious consumers are looking for safer alternative anti-inflammatory products. Latest natural remedies for inflammation relief are now available at Amazon.com. Read more here http://www.vioxxadvisor.com/4524.html Four years ago skeptical eyes were turned toward the Food and Drug Administration after the arthritis drug Vioxx was voluntarily recalled by its manufacturer, Merck & Co. Tests by Merck showed that people taking the drug were far more susceptible to having heart attacks than the general population. Read more ... http://www.vioxxadvisor.com/4523.html As you might expect, ever since the Vioxx and Guidant issues, FDA Commissioner Andrew von Eschenbach often gets asked whether FDA has tightened its approval standards. More... http://www.vioxxadvisor.com/4522.html Merck, a Dow component and the world's No. 8 drugmaker by revenue, reports earnings for the third quarter on Wednesday morning. The following is a summary of key developments and analyst opinion related to the period. More... http://www.vioxxadvisor.com/4521.html Q:What are the prospects for my shares of Merck & Co.? I'm devastated. -- J.B., via the Internet A: The drug giant has suffered setbacks from continued litigation and a disappointing new-product pipeline. It is experiencing the finan cial aftershocks of Vioxx, the painkiller used by millions of people that ... http://www.vioxxadvisor.com/4520.html Pfizer , the world’s largest pharmaceutical company, has paid $894m to settle most outstanding litigation around its two painkillers sparked by safety concerns after the withdrawal of Merck ’s similar drug Vioxx in 2004. More... http://www.vioxxadvisor.com/4519.html Drug maker Pfizer Inc. has reached an $894 million deal to settle most of the lawsuits over its withdrawn pain reliever Bextra, following the lead of rival Merck & Co., which is spending five times as much to settle Vioxx suits. The agreement also would end lawsuits over Pfizer's Celebrex, ... http://www.vioxxadvisor.com/4512.html TRENTON, N.J. — Drug giant Pfizer Inc. has reached an $894 million deal to settle the bulk of the lawsuits over its withdrawn pain reliever Bextra, following the lead of rival Merck & Co., which is spending five times as much to settle Vioxx suits. The Pfizer agreement would also ... http://www.vioxxadvisor.com/4517.html Drug company Pfizer Inc. has reached an $894 million deal to settle most of the lawsuits over its withdrawn pain reliever Bextra, following the lead of rival Merck & Co., which is spending five times as much to settle Vioxx suits. Read more here http://www.vioxxadvisor.com/4518.html $894 million agreement will also settle cases over Celebrex Drug giant Pfizer Inc. has reached an $894 million deal to settle the bulk of the lawsuits over its withdrawn pain reliever Bextra, following the lead of rival Merck & Co., which is spending five times as much ... http://www.vioxxadvisor.com/4511.html TRENTON, N.J. -- Drug giant Pfizer Inc. has reached an US$894 million deal to settle the bulk of the lawsuits over its withdrawn pain reliever Bextra, following the lead of rival Merck & Co., which is spending five times as much to settle Vioxx suits. More... http://www.vioxxadvisor.com/4513.html The real aim was to lure physicians into the habit of prescribing Vioxx Read more here http://www.vioxxadvisor.com/4514.html Drug giant Pfizer has reached an $894 million deal to settle most of the lawsuits over withdrawn pain reliever Bextra, following the lead of rival Merck & Co., which is spending five times as much to settle Vioxx lawsuits. Click here for more info http://www.vioxxadvisor.com/4515.html Pfizer Inc. has reached an $894 million deal to settle the bulk of the lawsuits over its withdrawn pain reliever Bextra, following the lead of rival Merck & Co., which is spending five times as much to settle Vioxx suits. The Pfizer agreement also would end lawsuits over its popular ... http://www.vioxxadvisor.com/4516.html Florida Attorney General Bill McCollum has filed suit again Merck & Co. for alleged deceptive marketing and promotion of the prescription drug Vioxx. Link to original article http://www.vioxxadvisor.com/4510.html Oct. 1 (Bloomberg) -- Florida's state government sued Merck & Co. over alleged false marketing of Vioxx, a painkiller the company withdrew before agreeing to pay $4.85 billion to resolve lawsuits claiming it caused heart attacks and strokes. Read more here http://www.vioxxadvisor.com/4509.html Merck & Co. (MRK) was sued by the state of Florida over alleged false marketing of Vioxx, a painkiller that the company withdrew before agreeing to pay $4.85 billion to resolve lawsuits claiming it caused heart attacks and strokes. Link to original article http://www.vioxxadvisor.com/4508.html QUESTION: My mother is 82 and is suffering from arthritis . She's in very good health except for that. She was on Vioxx until it was taken off the market, and now she is in pain again. Click here for more info http://www.vioxxadvisor.com/4507.html Joseph Steele, senior partner in the high-profile personal injury law firm Siegfried & Jensen, will tell you that combined decades of experience made him and fellow attorney Matthew Garretson the natural choice to help represent the State of Utah in a massive class-action lawsuit against the makers of the drugs ... http://www.vioxxadvisor.com/4506.html Dear Scott: I've owned shares of Merck & Co. for a long time and suffered through the Vioxx scandal. But now I'm wondering what the future holds since the stock has sold off sharply this year and whether I should sell it. Can you tell me what's going on with ... http://www.vioxxadvisor.com/4505.html An insider speaks up on the Vioxx scandal—and reveals common tactics that dupe patients and doctors. Read more here http://www.vioxxadvisor.com/4504.html Merck's shareholders get their case reinstated. More... http://www.vioxxadvisor.com/4503.html Merck & Co. said Tuesday it is considering challenging a federal appeals court's reinstatement of a dismissed shareholders' lawsuit Read more here http://www.vioxxadvisor.com/4502.html A federal appeals court has revived a securities fraud action against Merck that accuses the pharmaceutical giant of hiding the truth about Vioxx, a pain reliever that was withdrawn from the market in September 2004 because of concerns that it caused heart problems. Read more here http://www.vioxxadvisor.com/4501.html Merck & Co. of Whitehouse Station must face a consolidated class-action lawsuit claiming the pharmaceutical company defrauded investors before withdrawing the painkiller Vioxx from the market in September 2004, a federal appeals court ruled. Click here for more info http://www.vioxxadvisor.com/4500.html NEW YORK (Reuters)—A U.S. federal appeals court has reinstated an investor class action suit against Merck & Co. Inc. related to disclosures involving its withdrawn Vioxx pain drug, the drug maker said Tuesday. Click here for more info http://www.vioxxadvisor.com/4499.html Pharmaceutical company Merck & Co. said Tuesday it is considering challenging a federal appeals court's reinstatement of a dismissed shareholders' lawsuit over its former blockbuster painkiller Vioxx. More... http://www.vioxxadvisor.com/4498.html Drug developer Merck today said it is considering challenging an appeals court's reinstatement of a dismissed shareholders' lawsuit over the former blockbuster painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4497.html Merck May Appeal Decision To Reinstate Vioxx Investor Suit Link to original article http://www.vioxxadvisor.com/4494.html http://www.vioxxadvisor.com/4495.html Drug developer Merck & Co. said Tuesday it is considering challenging an appeals court's reinstatement of a dismissed shareholders' lawsuit over the former blockbuster painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4496.html Maine canada, cialis has this without any delay. Vioxx an anti-arthritis drug and ill powder. Thus the consummate create problems in, a class of the drug is. Happiness is not understand. Levitra comes best liquid cialis and generic, cialis and talk to your primary care doctors. Read more here http://www.vioxxadvisor.com/4493.html Since Rofecoxib (Vioxx) was withdrawn from the worldwide market based on the safety findings of the Adenomatous Polyp Prevention on Vioxx (APPROVe) study, the uncertainty around the cardiovascular safety of NSAIDs and COX-2 inhibitors remains and leaves practitioners with difficult management decisions for the hundreds of millions of patients worldwide ... http://www.vioxxadvisor.com/4492.html At the same time that Merck's first payments are going out to people affected by side effects from the anti-inflammatory drug , more questions have arisen about Merck's marketing methods. More... http://www.vioxxadvisor.com/4491.html The federal judge overseeing much of the massive litigation over withdrawn painkiller Vioxx on Wednesday capped fees for plaintiffs' attorneys at a relatively low 32 percent of the $4.85 billion settlement, saying he had to ensure fees were reasonable. Link to original article http://www.vioxxadvisor.com/4490.html Vioxx judge caps legal fees at 32 percent Read more here http://www.vioxxadvisor.com/4489.html http://www.vioxxadvisor.com/4488.html The federal judge overseeing much of the massive litigation over withdrawn painkiller Vioxx yesterday capped fees for plaintiffs' attorneys at a relatively low 32 percent of the $4.85 billion settlement, saying he had to ensure fees were reasonable. Click here for more info http://www.vioxxadvisor.com/4487.html TRENTON, N.J. - The U.S. judge overseeing much of the massive litigation over withdrawn painkiller Vioxx on Wednesday capped fees for plaintiffs' lawyers at a relatively low 32 per cent of the US$4.85 billion settlement, saying he had to ensure fees were reasonable. Read more here http://www.vioxxadvisor.com/4485.html (AP:TRENTON, N.J.) The federal judge overseeing much of the massive litigation over withdrawn painkiller Vioxx on Wednesday capped fees for plaintiffs' attorneys at a relatively low 32 percent of the $4.85 billion settlement, saying he had to ensure fees were reasonable. More... http://www.vioxxadvisor.com/4486.html Aug. 25 (Bloomberg) -- Merck & Co .'s debt rating outlook was raised to stable from developing by Moody's Investors Service, which cited the drugmaker's decision to begin making payments on its $4.85 billion Vioxx painkiller settlement. Link to original article http://www.vioxxadvisor.com/4483.html Moody's Investors Service raised Merck's outlook Monday following the drugmaker's decision to begin paying off a massive settlement with patients who used its drug Vioxx. Link to original article http://www.vioxxadvisor.com/4484.html Partial payments for people claiming withdrawn painkiller Vioxx caused heart attacks will go out starting Aug. 28 under the $4.85 billion settlement between drugmaker Merck & Co. and plaintiffs' lawyers, the claims administrator said Wednesday. Those payments will amount to about 40 percent of each plaintiff's estimated total payout, but ... http://www.vioxxadvisor.com/4482.html Partial payments for people claiming withdrawn painkiller Vioxx caused heart attacks will go out starting Aug. 28 under the $4.85 billion settlement between drugmaker Merck & Co. and plaintiffs' lawyers, the claims administrator said today. Click here for more info http://www.vioxxadvisor.com/4481.html Partial payments for people claiming withdrawn painkiller Vioxx caused heart attacks will go out starting Aug. 28 under the $4.85 billion settlement between drug maker Merck and plaintiffs' lawyers, the claims administrator said Wednesday. Read more here http://www.vioxxadvisor.com/4480.html TRENTON - Partial payments for people claiming the withdrawn painkiller Vioxx caused heart attacks will go out starting Aug. 28 under the $4.85 billion settlement between drug maker Merck & Co. and plaintiffs' lawyers, the claims administrator said Wednesday. Click here for more info http://www.vioxxadvisor.com/4479.html Partial payments for people claiming the painkiller Vioxx caused heart attacks will go out starting Aug. 28 under the $4.85 billion settlement between drugmaker Merck and plaintiffs' lawyers, the claims administrator said yesterday. Click here for more info http://www.vioxxadvisor.com/4478.html Partial payments for people claiming withdrawn painkiller Vioxx caused heart attacks will go out starting Aug. 28 under the $4.85 billion settlement between drugmaker Merck & Co. and plaintiffs' lawyers, the claims administrator said today. Read more here http://www.vioxxadvisor.com/4477.html Starting Aug. 28, the Whitehouse Station, N.J.-based drugmaker will send the first round of checks to claimants who charged its drug Vioxx caused heart attacks and strokes. Nearly 50,000 claims have been filed. Read more here http://www.vioxxadvisor.com/4476.html TRENTON - Partial payments for people claiming that withdrawn painkiller Vioxx caused heart attacks will go out starting Aug. 28 under the $4.85 billion settlement between drugmaker Merck & Co. and plaintiffs' lawyers, the claims administrator said today. Click here for more info http://www.vioxxadvisor.com/4475.html Partial payments for people claiming withdrawn painkiller Vioxx caused heart attacks will go out starting Aug. 28 under the $4.85 billion settlement between drugmaker Merck & Co. and plaintiffs' lawyers, the claims administrator said Wednesday. Read more here http://www.vioxxadvisor.com/4474.html TRENTON, N.J. — A 1999 Merck & Co. study of its since-withdrawn painkiller Vioxx, touted to participating doctors and patients as meant to show whether Vioxx caused fewer stomach problems than another drug, was primarily a stealth marketing strategy, researchers report. Read more here http://www.vioxxadvisor.com/4473.html The latest twist in Merck's ongoing troubles from its since-withdrawn painkiller Vioxx took another painful turn Monday for the drugmaker. Click ... http://www.vioxxadvisor.com/4472.html Report cites Merck memos on painkiller Merck & Co.'s marketing department devised a study on the painkiller Vioxx to persuade 600 doctors involved in the trial to prescribe the drug and recommend it to their peers, researchers said. ... http://www.vioxxadvisor.com/4471.html Merck & Co.'s marketing department devised a study on the painkiller Vioxx to convince 600 doctors involved in the trial to prescribe the drug and recommend it to their peers, researchers say. Link to original article http://www.vioxxadvisor.com/4470.html TRENTON, N.J. – A 1999 Merck Co. study of its since-withdrawn painkiller Vioxx, touted to participating doctors and patients as showing that Vioxx caused fewer stomach problems than another drug, was primarily a stealth marketing strategy, researchers report. More... http://www.vioxxadvisor.com/4469.html Trenton, N.J. - A 1999 Merck & Co. study of its since-withdrawn painkiller Vioxx, touted to participating doctors and patients as a way to show whether Vioxx caused fewer stomach problems than another drug, was primarily a stealth marketing strategy, More... http://www.vioxxadvisor.com/4468.html Merck & Co.'s marketing department devised a study on the painkiller Vioxx to persuade 600 doctors involved in the trial to prescribe the drug and recommend it to their peers, researchers say. Read more here http://www.vioxxadvisor.com/4465.html A 1999 Merck & Co. study of its since-withdrawn painkiller Vioxx was primarily a stealth marketing strategy, researchers report. Link to original article http://www.vioxxadvisor.com/4466.html TRENTON, N.J. . A 1999 Merck . Co. study of its since-withdrawn painkiller Vioxx . touted to participating doctors and patients as meant to show whether Vioxx caused fewer stomach problems than another drug . was primarily a stealth marketing strategy, researchers report. The true purpose ... http://www.vioxxadvisor.com/4467.html A 1999 clinical study that Merck & Co Inc said was done to test side effects of painkiller Vioxx was conducted primarily to support a marketing campaign before the drug's launch, The Wall Street Journal said, citing a study. More... http://www.vioxxadvisor.com/4461.html Aug. 19 (Bloomberg) -- A Merck & Co. study of Vioxx that the company said showed whether the painkiller was easier on the stomach than an older drug was actually a marketing tool to boost sales, according to researchers. Read more here http://www.vioxxadvisor.com/4462.html A 1999 Merck study of its since-withdrawn painkiller Vioxx, presented to participating doctors and patients as a trial designed to show whether Vioxx caused fewer stomach problems than another drug, was primarily a stealth marketing strategy, researchers report. More... http://www.vioxxadvisor.com/4463.html TRENTON, N.J. (AP) -- A 1999 Merck & Co. study of its since-withdrawn painkiller Vioxx, meant to show whether Vioxx caused fewer stomach problems than another drug, was primarily a stealth marketing strategy, researchers report. Link to original article http://www.vioxxadvisor.com/4464.html For the third time in three years, a prominent medical journal has criticized Merck & Co. for misrepresenting research on its now-withdrawn painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4460.html A 1999 Merck & Co. study of its since-withdrawn painkiller Vioxx, touted to participating doctors and patients as meant to show whether Vioxx caused fewer stomach problems than another drug, was primarily a stealth marketing strategy, researchers report. Click here for more info http://www.vioxxadvisor.com/4459.html Our weekly wrap-up of our online "Ask the Experts" questions looks at tax answers from IRS expert Kathy Howell and estate issues from trust attorney Trudy Nearn. Trudy Nearn The founder of Generations law firm is an expert on wills, trusts and estate ... http://www.vioxxadvisor.com/4458.html Two painkillers pulled from the market in recent years -- Vioxx (also known as rofecoxib) and Bextra (also known as valdecoxib) - increase the risk of stroke, new research indicates. More... http://www.vioxxadvisor.com/4457.html Americans are likely to be exposed to unacceptable side effects of FDA-approved drugs such as Vioxx in the future because of fatal flaws in the way new drugs are tested and marketed, according to research to be presented at the annual meeting of the American Sociological Association (ASA). More... http://www.vioxxadvisor.com/4456.html BOSTON — Americans are likely to be exposed to unacceptable side effects of FDA-approved drugs such as Vioxx in the future because of fatal flaws in the way new drugs are tested and marketed, according to research to be presented today at the annual meeting of the American Sociological Association ... http://www.vioxxadvisor.com/4455.html Justice Maurice Cullity of the Ontario Superior Court of Justice ordered that an action relating to the prescription drug VIOXX be certified as a national class action excluding residents of Quebec and Saskatchewan. Link to original article http://www.vioxxadvisor.com/4454.html A Canadian court has certified another class-action lawsuit against Merck & Co. over its former painkiller Vioxx, for which the U.S. drug maker is doling out billions of dollars to cover American settlements. Link to original article http://www.vioxxadvisor.com/4453.html Plaintiffs attorneys say a recent surge in lawsuits involving two recalled drugs, generic blood thinner heparin and prescription medication Digitek, could signal a clean break from past actions that were far less successful against Vioxx and Paxil. Click here for more info http://www.vioxxadvisor.com/4452.html Merck , the US pharmaceuticals group, played down the risks of taking its painkiller Vioxx in reports in academic journals and early submissions to regulators, according to a study to be published on Wednesday. More... http://www.vioxxadvisor.com/4451.html People who suffered heart attacks while taking Vioxx could receive a partial settlement check as early as next month. Merck & Co., the maker of Vioxx, said more than 97 percent of nearly 50,000 claimants agreed to terms of the $4.85 billion settlement announced last fall. Read more here http://www.vioxxadvisor.com/4450.html Alabama Attorney Jere Beasley Helped Bring Settlement for People who Took Vioxx Click here for more info http://www.vioxxadvisor.com/4449.html Merck & Co. will start cutting checks for former users of its withdrawn painkiller Vioxx next month after announcing it will fund a $4.9 billion settlement expected to resolve 50,000 lawsuits. Link to original article http://www.vioxxadvisor.com/4447.html TRENTON, N.J. -- Merck & Co.'s $4.85 billion fund to settle legal claims over the withdrawn painkiller Vioxx will begin making payments next month to former users or surviving family members who say the drug caused heart attacks or strokes. Merck will contribute its first installment of $500 million into ... http://www.vioxxadvisor.com/4448.html Merck will begin making payouts next month to consumers who agreed to settle lawsuits over injuries they claim were caused by using the pain-relief drug Vioxx. Read more here http://www.vioxxadvisor.com/4446.html Merck will start cutting checks for former users of its withdrawn painkiller Vioxx next month after announcing Thursday it will fund a $4.85 billion settlement expected to resolve roughly 50,000 lawsuits. ... http://www.vioxxadvisor.com/4445.html TRENTON, N.J. (AP) _ Merck & Co. will start cutting checks for former users of its withdrawn painkiller Vioxx next month after announcing Thursday that it will fund a $4.85 billion settlement expected to resolve roughly 50,000 lawsuits. ... http://www.vioxxadvisor.com/4444.html TRENTON, N.J. - Drugmaker Merck & Co. will start cutting checks for former users of its withdrawn painkiller Vioxx next month, after announcing Thursday that it will fund a $4.85 billion settlement expected to resolve roughly 50,000 lawsuits alleging harm from Vioxx. Click here for more info http://www.vioxxadvisor.com/4443.html Merck & Co. will start cutting checks for former users of its withdrawn painkiller Vioxx next month after announcing Thursday that it will fund a $4.85 billion settlement expected to resolve roughly 50,000 lawsuits. Read more here http://www.vioxxadvisor.com/4442.html Merck says it will fund the $4.85 billion settlement designed to resolve tens of thousands of lawsuits related to its Vioxx painkiller, waiving its right to walk away from the settlement deal. Read more here http://www.vioxxadvisor.com/4441.html Merck & Co said on Thursday that more than 97 percent of eligible U.S. claimants had elected to participate in its $4.85 billion proposed Vioxx settlement, an adequate number to trigger funding of the program. Link to original article http://www.vioxxadvisor.com/4440.html Associated Press - July 17, 2008 8:34 AM ET WHITEHOUSE STATION, N.J. (AP) - Merck says it will fund the $4.85 billion settlement designed to resolve tens of thousands of lawsuits related to its Read more here http://www.vioxxadvisor.com/4439.html Merck & Co. has dropped Lowenstein Sandler from its appeal of a $13.5 million Vioxx case to prevent recusal of a potentially pro-company New Jersey Supreme Court justice who the firm represents in a private matter. Lowenstein partner Douglas Eakeley won't argue for Merck at the state high court because ... http://www.vioxxadvisor.com/4438.html Nearly four years after Merck & Co. yanked the painkiller Vioxx off the market, beleaguered pharmaceutical industry executives say they are facing a tough new regulatory climate that is altering the landscape of drug development. Click here for more info http://www.vioxxadvisor.com/4437.html Nearly four years after Merck & Co. yanked the painkiller Vioxx off the market, beleaguered pharmaceutical-industry executives say they are facing a tough new regulatory climate that is altering the landscape of drug development. Over the past 16 months, Schering-Plough Corp. Chief Executive Fred Hassan and his top scientists have ... http://www.vioxxadvisor.com/4436.html More than 59,000 people have registered claims against drugmaker Merck & Co. for injury from painkiller Vioxx, and administrators have enough records to review about 9,100 of those claims. Read more here http://www.vioxxadvisor.com/4435.html More than 59,000 people have registered claims against Readington-based drugmaker Merck & Co. for injury from painkiller Vioxx, and administrators have enough records to review about 9,100 of those claims. More... http://www.vioxxadvisor.com/4433.html VIOXX CLAIMS: More than 59,000 people have registered claims in the $4.85-billion settlement against drugmaker Merck & Co. for injuries from its painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4434.html Lawyers say more than 59,000 people have registered for drugmaker Merck & Co.'s settlement of lawsuits claiming injury from the painkiller Vioxx. Administrators have enough records to review about 9,100 of those claims. Read more here http://www.vioxxadvisor.com/4431.html NEW ORLEANS -- More than 59,000 people hope to share in drugmaker Merck and Co.'s settlement of lawsuits claiming injury from the painkiller Vioxx, and administrators have enough Click here for more info http://www.vioxxadvisor.com/4432.html Malcolm MacMeikan, a kitchen and refrigeration consultant, first realised something was wrong when he had a panic attack during a building site visit at Canary Wharf. More... http://www.vioxxadvisor.com/4430.html Malcolm MacMeikan, a kitchen and refrigeration consultant, first realised something was wrong when he had a panic attack during a building site visit at Canary Wharf. Click here for more info http://www.vioxxadvisor.com/4429.html Biz Buzz: Is it hot in here, or is it just a climate-law blog? Lawyers are prodigious bloggers, posting on the progress of Vioxx litigation, shareholder suits and the vagaries of divorce law. So it was only a matter of time before they got to global warming. Link to original ... http://www.vioxxadvisor.com/4428.html The New Jersey Supreme Court ruled that Vioxx users who suffered no known personal injury could not sue the company to pay for electrocardiograms and follow-up consultations with cardiologists. Click here for more info http://www.vioxxadvisor.com/4427.html Appeals courts in two US states last week overturned verdicts favouring plaintiffs who had sued Merck, the pharmaceutical giant, over its painkiller Vioxx (rofecoxib). The drug was taken off the market in 2004 after a study showed it doubled the risk of heart attacks and strokes. Link to original article ... http://www.vioxxadvisor.com/4426.html TRENTON, N.J., June 4 (UPI) -- The New Jersey Supreme Court ruled Wednesday Merck is not obligated to pay for the medical monitoring of people who took Vioxx. More... http://www.vioxxadvisor.com/4424.html The New Jersey Supreme Court ruled that Vioxx users who suffered no known harm from the withdrawn pain drug cannot sue Merck & Co Inc to pay for medical tests and treatment by heart doctors, the drugmaker said on Wednesday. Link to original article http://www.vioxxadvisor.com/4425.html The New Jersey Supreme Court ruled that Vioxx users who suffered no known harm from the withdrawn pain drug cannot sue Merck & Co Inc to pay for medical tests and treatment by heart doctors, the drugmaker said on Wednesday. Link to original article http://www.vioxxadvisor.com/4422.html Drugmaker Merck & Co. is not liable for the medical monitoring of Vioxx users not claiming injury, the New Jersey Supreme Court ruled Wednesday. The 5-1 ruling by the state's highest court means a class-action lawsuit by people who used the once-popular ... http://www.vioxxadvisor.com/4420.html The New Jersey Supreme Court ruled Wednesday that Merck is not liable for the medical monitoring of Vioxx users not claiming injury. Link to original article http://www.vioxxadvisor.com/4421.html A ruling by the New Jersey Supreme Court dismisses a class-action lawsuit by people who used Vioxx. Read more here http://www.vioxxadvisor.com/4423.html http://www.vioxxadvisor.com/4415.html NEWARK, N.J. (AP) -- The New Jersey Supreme Courts has ruled that Merck is not liable for the medical monitoring of Vioxx users not claiming injury. The 5-1 ruling means a class-action lawsuit by people who used the once-popular painkiller will be dismissed. One justice did not participate. More... http://www.vioxxadvisor.com/4416.html NEWARK — The New Jersey Supreme Courts rules Merck is not liable for the medical monitoring of Vioxx users not claiming injury. The 5-1 ruling means a class-action lawsuit by people who used the once-popular painkiller will be dismissed. One justice did not participate. The court says the users are ... http://www.vioxxadvisor.com/4417.html The New Jersey Supreme Courts rules Merck is not liable for the medical monitoring of Vioxx users not claiming injury. The 5-1 ruling means a class-action lawsuit by people who used the once-popular painkiller will be dismissed. One justice did not participate. Click here for more info http://www.vioxxadvisor.com/4418.html The New Jersey Supreme Court ruled Readington-based Merck & Co. is not liable for the medical monitoring of Vioxx users not claiming injury. More... http://www.vioxxadvisor.com/4419.html Mark Lanier, the 47-year-old attorney who litigated his way to CNBC fame by taking on Merck’s dreaded Vioxx, and who’s now representing sugar-cane farmers in their suit against Splenda, is doubling the size of his footprint in Harry Macklowe ’s Tower 56 . ... http://www.vioxxadvisor.com/4414.html State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system -- at least at the appellate level," according to a Wall Street Journal editorial. More... ... http://www.vioxxadvisor.com/4413.html Merck & Co., Inc. said that it is gratified that a Texas appeals court overturned the August 2005 verdict of a state court jury in Brazoria County and rendered a judgment in favour of Merck in the Vioxx product liability case Ernst v. Merck. Click here for more info http://www.vioxxadvisor.com/4412.html SAN FRANCISCO (Thomson Financial) - Merck & Co.'s Merck Frosst Canada Ltd. late Friday said it planned to appeal a ruling by a Canadian court expanding the scope of the previously certified class-action lawsuit over its recalled painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4411.html SAN FRANCISCO (Thomson Financial) - Merck & Co.'s Merck Frosst Canada Ltd. late Friday said it planned to appeal a ruling by a Canadian court expanding the scope of the previously certified class-action lawsuit over its recalled painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4410.html State appeals courts in New Jersey and Texas on Thursday reversed two jury verdicts and a judgment on payment of legal fees in lawsuits related to the COX-2 inhibitor Vioxx that would have required Merck to pay about $37 million, Bloomberg/Washington Post reports (Van Voris/Voreacos, Bloomberg/Washington Post, 5/30). Link to ... http://www.vioxxadvisor.com/4409.html NEWARK, N.J. - Appeals courts in New Jersey and Texas yesterday scrapped verdicts against drugmaker Merck & Co. Inc. stemming from some of the earliest trials involving the company's now withdrawn pain reliever Vioxx. More... http://www.vioxxadvisor.com/4408.html Merck's persistence may be paying off. Appeals courts in Texas and New Jersey handed the drugmaker a series of victories in three Vioxx lawsuits yesterday, overturning an entire verdict in Texas and reversing key components of two New Jersey cases. Link to original article http://www.vioxxadvisor.com/4404.html The major victories for Merck pushed the litigation over Vioxx closer to conclusion and highlighted the difficulty that plaintiffs’ lawyers are having in winning lawsuits against big drug companies. Link to original article http://www.vioxxadvisor.com/4405.html A Houston appellate court Thursday overturned a $26 million Angleton jury finding that a 59-year-old triathlete died because of his use of the popular painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4406.html NEWARK — Appeals courts in New Jersey and Texas on Thursday scrapped verdicts against the drug maker Merck & Co. Inc. stemming from some of the earliest trials involving its once popular painkiller Vioxx. More... http://www.vioxxadvisor.com/4407.html HOUSTON, May 29 (UPI) -- A Texas appellate court Thursday rejected a $26.1 million award given to a woman for the death of her husband who was on the once-popular pain reliever Vioxx. Link to original article http://www.vioxxadvisor.com/4403.html A Houston appellate court today overturned a multimillion-dollar 2005 Angleton jury finding that a 59-year-old triathlete died because of his use of the painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4401.html W. Mark Lanier, the Houston plaintiffs lawyer who won a $234.4 million jury verdict in the nation's first Vioxx trial, isn't mincing words; he calls Thursday's Texas appeals court opinion reversing a $26.1 million judgment in that suit "judicial activism for corporate America." Lanier says he will appeal the Texas ... http://www.vioxxadvisor.com/4402.html The major victories for Merck pushed the litigation over Vioxx closer to conclusion and highlighted the difficulty that plaintiffs’ lawyers are having in winning lawsuits against big drug companies. Click here for more info http://www.vioxxadvisor.com/4400.html BOSTON (MarketWatch) -- A Texas appeals court has overturned what had initially been a staggering award against Merck & Co. over the marketing of its now-recalled painkiller Vioxx. ... http://www.vioxxadvisor.com/4398.html Appeals courts in New Jersey and Texas have scrapped verdicts against drugmaker Merck stemming from some of the earliest trials involving its once popular painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4399.html Appeals courts in New Jersey and Texas on Thursday scrapped verdicts against the drugmaker Merck stemming from some of the earliest trials involving its once popular painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4393.html A Texas appeals court reversed a $26.1 million decision against Merck, finding that its Vioxx painkiller did not cause the fatal heart attack suffered by a plaintiff's husband. More... http://www.vioxxadvisor.com/4394.html NEWARK, N.J. — A Texas appeals court has scrapped a $26-million verdict against the drugmaker Merck stemming from the first trial involving its once popular painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4395.html A Texas appeals court throws out a $26 million verdict against the drugmaker Merck in a case involving Vioxx. Click here for more info http://www.vioxxadvisor.com/4396.html Appeals courts in New Jersey and Texas today scrapped verdicts against the drugmaker Merck & Co. Inc. stemming from some of the earliest trials involving its once popular painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4397.html NEWARK, N.J. - Appeals courts in Texas and New Jersey on Thursday scrapped verdicts against the drugmaker Merck & Co. Inc. stemming from some of the earliest trials involving its once popular painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4390.html Appeals courts in New Jersey and Texas have scrapped verdicts against the drugmaker Merck stemming from some of the earliest trials involving its painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4391.html Appeals courts in New Jersey and Texas on Thursday scrapped verdicts against the drugmaker Merck & Co. Inc. stemming from some of the earliest trials involving its once popular painkiller Vioxx, including one in Keene. Link to original article http://www.vioxxadvisor.com/4392.html A South Texas jury found Merck & Co. liable for the death of a 71-year-old man and ordered the company to pay $32 million. More... http://www.vioxxadvisor.com/4385.html Associated Press - May 29, 2008 10:23 AM ET NEWARK, N.J. (AP) - A Texas appeals court has scrapped a $26 million verdict against the drugmaker Merck stemming from the first trial involving its Link to original article http://www.vioxxadvisor.com/4388.html Texas appeals court's decision stems from first trial involving Merck's once popular painkiller Read more here http://www.vioxxadvisor.com/4389.html Appeals courts in New Jersey and Texas have scrapped verdicts against drugmaker Merck stemming from some of the earliest trials involving its once popular painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4386.html Merck & Co said on Thursday a Texas appeals court reversed a decision against the company in the first trial involving alleged injuries caused by its withdrawn Vioxx painkiller. More... http://www.vioxxadvisor.com/4387.html A California jury on Wednesday cleared pharmaceutical company Merck & Co. of liability in the case of an elderly Northridge man who claimed his heart ailments were caused by the drug maker's once-popular painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4384.html http://www.vioxxadvisor.com/4383.html Hawaii's share of a $58 million multistate settlement with Vioxx drug maker Merck & Co. is $1.1 million, said state Office of Consumer Protection Executive Director Stephen Levins. Click here for more info http://www.vioxxadvisor.com/4382.html Merck & Co., Inc. has reached civil settlements with Attorneys General from 29 states and the District of Columbia to fully resolve previously disclosed investigations under state consumer protection laws related to past activities for Vioxx. Link to original article http://www.vioxxadvisor.com/4381.html Pierre - South Dakota will receive a little more than $1 million from a 30-state legal settlement with Merck and Co., Attorney General Larry Long said Wednesday. South Dakota and 29 other states went to court against the drug giant because of concerns about deceptive promotion of the painkiller Vioxx. ... http://www.vioxxadvisor.com/4380.html Drug giant Merck has agreed to pay Connecticut $1.35 million for deceptive marketing of its once popular painkilling drug Vioxx as part of a national $58 million settlement between Merck, 29 states, and the District of Columbia. Read more here http://www.vioxxadvisor.com/4379.html Texas and 28 other states will share a $58 million payment from pharmaceutical giant Merck & Co., which resolves longstanding claims that the company downplayed risks related to Vioxx, an anti-inflammatory drug that was linked to thousands of heart attack deaths. (MRK) Link to original article http://www.vioxxadvisor.com/4378.html Deceptive promotion of the drug Vioxx is costing drug company Merck $58 million in a judgment with 30 states, including $1.15 million that's going to Idaho. Click here for more info http://www.vioxxadvisor.com/4376.html Merck to pay out $58 million over television ads Merck & Co. has agreed to pay $58 million to multiple states, including Maryland, to settle allegations that its ads for the once-popular painkiller Vioxx deceptively played down the health risks. ... http://www.vioxxadvisor.com/4377.html New Jersey will receive $1.8 million as part of the $58 million Merck & Co. agreed to pay as a portion of a multistate settlement of allegations that its ads for the once-popular painkiller Vioxx deceptively played down the health risks. Click here for more info http://www.vioxxadvisor.com/4374.html Merck & Co. has agreed to pay $58 million as part of a multistate settlement of allegations that its ads for the once-popular painkiller Vioxx deceptively played down the health risks.The agreement announced Tuesday also calls for Merck to submit all new TV commercials for its drugs to the Food ... http://www.vioxxadvisor.com/4375.html HARRISBURG, Pa. -- Merck & Co. has agreed to pay $58 million as part of a multistate settlement of allegations that its ads for the once-popular painkiller Vioxx deceptively played down risks. The agreement announced yesterday also calls for Merck to submit all new TV commercials for its drugs to ... http://www.vioxxadvisor.com/4372.html Efforts to bring more scrutiny to drug research and promotion got a boost Tuesday when Merck settled claims from 29 states and the District of Columbia that it misled consumers in advertisements for its painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4373.html HARRISBURG, Pa. - Merck & Co. has agreed to pay $58 million as part of a multistate settlement of allegations that its ads for the once-popular painkiller Vioxx deceptively played down the health risks. Read more here http://www.vioxxadvisor.com/4368.html Merck & Co. has agreed to pay $58 million to 29 states, including Kansas, to settle deceptive marketing claims involving Vioxx. More... http://www.vioxxadvisor.com/4369.html Merck & Co. has agreed to pay $58 million as part of a multistate settlement of allegations that its ads for the once-popular painkiller Vioxx deceptively played down the health risks. The agreement announced Tuesday also calls for Merck to submit new TV commercials for its drugs to the Food ... http://www.vioxxadvisor.com/4370.html Washington will receive $1.6 million of a $58 million settlement from Merck & Co. over the marketing of the painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4371.html Merck agreed yesterday to a $58 million settlement with 29 states and the District of Columbia over advertising for the withdrawn painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4367.html Washington will receive $1.6 million of a $58 million settlement from Merck & Co. over the marketing of the painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4366.html Pennsylvania, New Jersey, 27 other states and the District of Columbia have reached a $58 million settlement with Merck over allegations that the company used deceptive practices to market the drug Vioxx. It's being called the largest-eversettlement for a multi-state consumer protection drug case. Link to original article http://www.vioxxadvisor.com/4364.html HARRISBURG, Pa. — Merck & Co. is paying $58 million as part of a multistate settlement concerning advertising of the now-withdrawn painkiller, Vioxx. More... http://www.vioxxadvisor.com/4365.html Merck & Co. is paying $58 million as part of a multistate settlement concerning advertising of the now-withdrawn painkiller, Vioxx, which addresses allegations that the New Jersey-based company deceptively downplayed the drug's health risk. Link to original article http://www.vioxxadvisor.com/4360.html HARRISBURG, Pa. (NEWS CENTER/AP) -- The civil settlement ends investigations by 29 states, including Maine, into Merck's advertising practices involving Vioxx. More... http://www.vioxxadvisor.com/4361.html http://www.vioxxadvisor.com/4362.html SAN FRANCISCO (Thomson Financial) - Merck & Co. will pay $58 million to 29 states and the District of Columbia to settle allegations of deceptive advertising related to its painkiller Vioxx, Pennsylvania's attorney general said Tuesday. Read more here http://www.vioxxadvisor.com/4363.html RIO GRANDE CITY -- A state appeals court overturned a Starr County jury's landmark verdict Wednesday against the makers of the painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4359.html SAN ANTONIO, May 16 (UPI) -- The Texas Fourth Court of Appeals overturned a $7.75 million verdict against Merck & Co. in a lawsuit over the heart risk of the painkiller Vioxx. More... http://www.vioxxadvisor.com/4358.html A Texas appeals court has overturned a multimillion-dollar verdict against Merck, the former maker of Vioxx. Read more here http://www.vioxxadvisor.com/4357.html TRENTON, N.J. — A Texas appeals court on Wednesday overturned a multimillion-dollar verdict against Merck & Co. in one of the few trials it lost over its withdrawn painkiller Vioxx. A jury in Rio Grande City, Texas, in April 2006 awarded $32 million to the widow of Leonel Garza, ... http://www.vioxxadvisor.com/4356.html A Texas appeals court on Wednesday overturned a multimillion-dollar verdict against Merck & Co. in a case involving its withdrawn painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4354.html TRENTON, N.J. (AP) - A Texas appeals court today overturned a multimillion-dollar verdict against Merck in a case over its withdrawn painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4355.html 14/05/2008 19:27:00 Business Wire Merck & Co., Inc. said today a Texas appellate court overturned the April 2006 verdict of a state court jury in Starr County, Texas, in the VIOXX product liability case Garza v. Read more here http://www.vioxxadvisor.com/4352.html TRENTON, N.J. (AP) - A Texas appeals court overturns a verdict that Merck & Co. lost in the Vioxx case. A Texas jury two years ago awarded the widow of 71-year-old Leonel Garza $32 million. That later was cut to about $7.75 million under Texas damage caps. Read more here ... http://www.vioxxadvisor.com/4353.html The case involves a jury award to the widow of a 71-year-old man who had a history of heart disease and died of a heart attack after taking Vioxx briefly. More... http://www.vioxxadvisor.com/4346.html A Texas appeals court on Wednesday overturned a multimillion-dollar verdict against Merck & Co. in a case involving its withdrawn painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4348.html An appeals court in Texas overturned a $7.75 million verdict against Merck & Co involving its withdrawn pain drug Vioxx on Wednesday, ruling that evidence presented at trial failed to prove the medicine caused the heart attack suffered by the plaintiff's husband. Click here for more info http://www.vioxxadvisor.com/4349.html A Texas appeals court has overturned a verdict that Merck & Co. lost in the Vioxx case. Click here for more info http://www.vioxxadvisor.com/4350.html Readington-based Merck & Co. says a Texas appeals court has overturned a verdict against the drugmaker in a case involving its withdrawn painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4351.html TRENTON, N.J. -- A Texas appeals court overturns a verdict that Merck and Co. lost in the Vioxx case. A Texas jury two years ago awarded the widow of 71-year-old Leonel Click here for more info http://www.vioxxadvisor.com/4345.html An appeals court overturned a verdict that Merck & Co. lost in the Vioxx case. More... http://www.vioxxadvisor.com/4347.html Americas Watchdog has just launched a national investigation into seeing if consumers, HMO's, health insurance companies, or health cooperatives were over charged with the drug called Vioxx, Trasylol or any other drugs, when much cheaper alternatives were available. Read more here http://www.vioxxadvisor.com/4344.html Merck & Co., Inc. said at least 94 per cent of eligible US claimants have elected to participate in its $4.85 billion Vioxx settlement and has extended until June 30 the deadline for registered participants to submit paperwork. Link to original article http://www.vioxxadvisor.com/4343.html Merck & Co said on Thursday at least 94 percent of eligible U.S. claimants have elected to participate in its $4.85 billion proposed Vioxx settlement, and the drugmaker extended the deadline for the remainder to join in. Read more here http://www.vioxxadvisor.com/4342.html Merck & Co., Inc. said today it has extended to June 30, 2008, the enrollment deadline for U.S. eligible Read more here http://www.vioxxadvisor.com/4341.html http://www.vioxxadvisor.com/4340.html Americas Watchdog has just launched a national investigation into seeing if HMO's, health insurance companies, or health cooperatives were over charged with the drug called Vioxx, when much cheaper alternatives were available. More... http://www.vioxxadvisor.com/4339.html A Merck’s internal communication talks of the drug being associated with an increased risk of causing deaths Link to original article http://www.vioxxadvisor.com/4338.html Two new reports involving the painkiller Vioxx raise fresh concerns about how drug companies influence the interpretation and publication of medical research. More... http://www.vioxxadvisor.com/4337.html The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion" in the U.S. Link to original article ... http://www.vioxxadvisor.com/4336.html N Maker of Vioxx facing multi-billion-dollar settlement over pain killer also More... http://www.vioxxadvisor.com/4335.html Merck, in the process of settling litigation over its withdrawn painkiller Vioxx, got hit with some new problems during the first quarter. Read more here http://www.vioxxadvisor.com/4334.html Sen. Chuck Grassley (R-Iowa) has sent a letter to Merck Chief Operating Officer Richard Clark requesting the company explain a recent report that found the company used employees or paid consultants rather than the physicians listed as lead authors to write several published studies of the COX-2 inhibitor Vioxx, CQ ... http://www.vioxxadvisor.com/4333.html Claims that the pharmaceutical company Merck hired ghostwriters for Vioxx articles has put heat on a U.S. proposal to loosen drug promotion rules. Read more here http://www.vioxxadvisor.com/4332.html Aetna Inc., Humana Inc., and more than 40 other providers of health insurance and managed-care plans sued the administrators of Merck & Co.'s $4.85 billion Vioxx settlement fund to determine who will get the money. More... http://www.vioxxadvisor.com/4331.html A report indicating that Merck used ghostwriters to produce articles in support of its drug Vioxx has galvanized opponents to a proposal that would relax some restrictions on drug promotion. More... http://www.vioxxadvisor.com/4330.html Merck employees or paid consultants, rather than the physicians listed as lead authors, wrote several published studies of the COX-2 inhibitor Vioxx, and the company downplayed evidence that the medication tripled risk for death in patients with Alzheimer's disease, according to two reports published on Wednesday in the Journal of ... http://www.vioxxadvisor.com/4329.html Pharmaceutical company Merck knew in 2001 that its arthritis drug Vioxx could harm patients and used staffers to "ghostwrite" favorable research on the drug, articles in the Journal of the American Medical Association report. Susan Dentzer examines the charges. Link to original article http://www.vioxxadvisor.com/4327.html WASHINGTON - Two teams of researchers with access to thousands of documents gathered in lawsuits over the painkiller Vioxx allege that Merck & Co. waged a campaign of deception to promote its drug, moving slowly to warn of possible hazards while at the same time dressing up in-house research as ... http://www.vioxxadvisor.com/4328.html Title: Vital Vioxx Details 'Manipulated' Category: Health News Created: 4/16/2008 Last Editorial Review: 4/16/2008 Read more here http://www.vioxxadvisor.com/4326.html Drugmaker Merck drafted dozens of research studies for its best-selling pain drug Vioxx, then lined up prestigious doctors to put their names on the reports, according to a leading medical journal. Read more here http://www.vioxxadvisor.com/4325.html Two new reports involving the painkiller Vioxx raise fresh concerns about how drug companies influence the interpretation and publication of medical research. The reports claim Merck & Co. frequently paid academic scientists to take credit for research ... http://www.vioxxadvisor.com/4323.html Merck & Co Inc suppressed evidence that its withdrawn arthritis pill Vioxx could harm patients, US researchers allege. More... http://www.vioxxadvisor.com/4324.html Merck played down the risk of death linked to the US pharmaceutical giant's anti-inflammatory drug Vioxx in trial studies the company made public, according to a study released Tuesday. Read more here http://www.vioxxadvisor.com/4322.html Two new reports involving the painkiller Vioxx raise fresh concerns about how drug companies influence the interpretation and publication of medical research. More... http://www.vioxxadvisor.com/4321.html MERCK & Co Inc suppressed evidence that its withdrawn arthritis pill Vioxx could harm patients, US researchers charged today. More... http://www.vioxxadvisor.com/4320.html TUESDAY, April 15 (HealthDay News) -- Industry documents reveal that pharmaceutical giant Merck & Co. paid academics to put their names on Vioxx research published in top medical journals while company employees often ghost-wrote the studies on the controversial cox-2 painkiller. Click here for more info http://www.vioxxadvisor.com/4317.html Two teams of researchers with access to thousands of documents gathered in lawsuits over the painkiller Vioxx allege that Merck & Co. waged a campaign of deception to promote its drug, moving slowly to warn of possible hazards while dressing up in-house research as the work of independent academic ... http://www.vioxxadvisor.com/4318.html A new controversy is brewing Tuesday over Merck and its embattled drug, Vioxx. Click here for more info http://www.vioxxadvisor.com/4319.html Merck and Co. may have misrepresented the risks of its now-withdrawn pain drug Vioxx and allowed a trial of the drug to continue for two years even though it knew it might be harming patients, U.S. researchers said on Tuesday. More... http://www.vioxxadvisor.com/4308.html Merck & Co Inc suppressed evidence that its withdrawn arthritis pill Vioxx could harm patients, U.S. researchers charged on Tuesday. Click here for more info http://www.vioxxadvisor.com/4309.html The risk of death linked to Merck's anti-inflammatory drug Vioxx was minimized in trial studies the company made public, according to a study out Tuesday. More... http://www.vioxxadvisor.com/4310.html April 15 (Bloomberg) -- Merck & Co . hired ghostwriters to pen reports about the pain pill Vioxx, allegedly allowing the company to manipulate scientific articles to promote the drug, according to a new analysis of court records. Read more here http://www.vioxxadvisor.com/4311.html Newly released legal documents spell out what Merck knew about Vioxx and when they knew it. Link to original article http://www.vioxxadvisor.com/4312.html There is new information about the drug Vioxx that was pulled from the market in 2004. Click here for more info http://www.vioxxadvisor.com/4313.html The maker of the controversial arthritis drug Vioxx knew of its dangers for as long as three years before a massive nationwide recall, but withheld the information and played down the number of deaths associated with the pain medication, according to an analysis published today by University of Washington professors. ... http://www.vioxxadvisor.com/4314.html CHICAGO - Two new reports involving the painkiller Vioxx raise fresh concerns about how drug companies influence the interpretation and publication of medical research. Click here for more info http://www.vioxxadvisor.com/4315.html The article, based on documents unearthed in lawsuits over the pain drug Vioxx, provides a rare, detailed look in the industry practice of ghostwriting medical research studies that are then published in academic journals. More... http://www.vioxxadvisor.com/4316.html CBS News reports Vioxx was one of the most popular anti-inflammatory drugs on the market, but it was quickly pulled from store shelves once several deaths were linked to it. Link to original article http://www.vioxxadvisor.com/4307.html NEW ORLEANS (Reuters) - More than 3,000 former users of Merck & Co's withdrawn Vioxx pain drug have already signed up to take part in a $4.85 billion settlement deal that a federal judge on Friday declared was in the best interests of both sides. ... http://www.vioxxadvisor.com/4306.html Richard Clark is used to chal lenges by now. As chief executive of Merck, Clark tackled a top-to-bottom restructuring of the Whitehouse Station-based drugmaker, steered the company through vex ing Vioxx court battles and guided the development of blockbuster cervical-cancer vaccine Gardasil. Click here for more info http://www.vioxxadvisor.com/4305.html On Monday, drug maker Merck's stock opened at its lowest point since the company pulled painkiller Vioxx off the market four years ago. This time the problem is Vytorin, a cholesterol-lowering medication that includes the drug Zetia. Read more here http://www.vioxxadvisor.com/4304.html Merck & Co. Inc. today saw the largest daily drop in its stock value since the pain reliever Vioxx was withdrawn in the fall of 2004. More... http://www.vioxxadvisor.com/4303.html WASHINGTON - Vioxx, Bextra, Rezulin, Baycol. Looking at drugs yanked off the market, Harvard researchers found a disturbing pattern: Medicines approved right on deadline by the Food and Drug Administration are more likely to cause safety problems later than those cleared with more time to spare. More... http://www.vioxxadvisor.com/4302.html The agency recently began notifying the public earlier about possible safety issues. The policy change came after the FDA was criticized for acting too slowly on information about the risks of Merck's painkiller Vioxx and, GlaxoSmithKline plc 's diabetes pill Avandia . Click here for more info http://www.vioxxadvisor.com/4301.html WASHINGTON - Vioxx, Bextra, Rezulin, Baycol. Looking at drugs yanked off the market, Harvard University researchers found a disturbing pattern: Medicines approved right on deadline by the Food and Drug Administration are more likely to cause safety problems later on than those cleared with more time to spare. Read more ... http://www.vioxxadvisor.com/4300.html WASHINGTON | Vioxx, Bextra, Rezulin, Baycol. Looking at drugs yanked off the market, Harvard researchers found a disturbing pattern: Click here for more info http://www.vioxxadvisor.com/4299.html Vioxx, Bextra, Rezulin, Baycol. Looking at drugs yanked off the market, Harvard researchers found a disturbing pattern: Medicines approved right on deadline by the Food and Drug Administration are more likely to cause safety problems later than those cleared with more time to spare. More... http://www.vioxxadvisor.com/4298.html People who think their heart attacks or strokes were caused by the once-popular painkiller Vioxx and want early partial payments now have an additional month to file paperwork backing up their claims under a settlement with manufacturer Merck & Co. More... http://www.vioxxadvisor.com/4296.html People who think their heart attacks or strokes were caused by the once-popular painkiller Vioxx now have until May 1 to file the paperwork to back up their claims under a settlement with Readington-based manufacturer Merck & Co. Click here for more info http://www.vioxxadvisor.com/4297.html People who think their heart attacks or strokes were caused by a once-popular painkiller now have another month to file the paperwork to back up their claims. More... http://www.vioxxadvisor.com/4295.html Tens of thousands are eligible to share in settlement. They claim stroke and heart attacks caused by the medicine. more Read more here http://www.vioxxadvisor.com/4294.html NEW ORLEANS -- People who think their heart attacks or strokes were caused by the once-popular painkiller Vioxx and want early partial payments now have another month to file paperwork Read more here http://www.vioxxadvisor.com/4292.html People who think their heart attacks or strokes were caused by the once-popular painkiller Vioxx now have another month to file the paperwork to back up their claims. more Click here for more info http://www.vioxxadvisor.com/4293.html People who think their heart attacks or strokes were caused by the once-popular painkiller Vioxx now have another month to file the paperwork to back up their claims under a settlement with manufacturer Merck & Company. Read more here http://www.vioxxadvisor.com/4291.html NEW ORLEANS People who think their heart attacks or strokes were caused by the once-popular painkiller Vioxx now have another month to file the paperwork to back up their claims under a settlement with manufacturer Merck & Company. Click here for more info http://www.vioxxadvisor.com/4290.html If one company's disaster can transform an industry, the withdrawal of Merck's $2.5 billion painkiller Vioxx in 2004 may become the textbook example. Primarily, the removal of Vioxx from the market due to heart risks spurred a sweeping examination of the ... http://www.vioxxadvisor.com/4289.html The chief executive of Merck, Richard T. Clark, received compensation valued at $14.5 million in 2007, despite Merck’s $4.85 billion loss to settle Vioxx litigation. Link to original article http://www.vioxxadvisor.com/4288.html TRENTON, N.J. - Merck & Co.'s chief executive officer, Richard T. Clark, got compensation valued at $14.5 million in 2007, an 80 percent raise in a year when the drugmaker took a $4.85 billion charge to settle much of the litigation over its former painkiller Vioxx. Link to original article ... http://www.vioxxadvisor.com/4287.html Merck & Co.'s chief executive officer, Richard T. Clark, got compensation valued at $14.5 million in 2007, an 80 percent raise in a year when the drugmaker took a $4.85 billion charge to settle much of the litigation over its former painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4286.html Merck's chief executive, Richard Clark, got compensation valued at $14.5 million in 2007, an 80 percent raise in a year when the drugmaker took a $4.85 billion charge to settle much of the litigation over its former painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4285.html The chief executive of Merck, Richard T. Clark, received compensation valued at $14.5 million in 2007, despite Merck?s $4.85 billion loss to settle Vioxx litigation. Read more here http://www.vioxxadvisor.com/4284.html The head of the New Jersey based drugmaker compensated $14.5M in 2007, a year when the company took a $4.85B charge to settle its Vioxx litigation. Read more here http://www.vioxxadvisor.com/4283.html Merck & Co.'s chief executive officer, Richard T. Clark, got compensation valued at $14.5 million in 2007, an 80 percent raise in a year when the drugmaker took a $4.85 billion charge to settle much of the litigation over its former painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4282.html TRENTON -- Merck & Co. is on the verge of settling its most serious personal injury lawsuits over Vioxx, but the drugmaker still faces substantial litigation over the onetime blockbuster painkiller it yanked from the market in 2004 because of cardiovascular risks. Click here for more info http://www.vioxxadvisor.com/4281.html Merck & Co. is on the verge of settling most serious personal injury lawsuits over Vioxx, but the drugmaker still faces substantial litigation over the one-time blockbuster painkiller it yanked from the market in 2004 because of cardiovascular risks. ... http://www.vioxxadvisor.com/4280.html A $4.5 billion settlement hasn't slowed new lawsuits over Vioxx. Link to original article http://www.vioxxadvisor.com/4279.html TRENTON, N.J. – Merck and Co. is on the verge of settling most serious personal injury lawsuits over Vioxx, but the drugmaker still faces substantial litigation over the one-time blockbuster painkiller it yanked from the market in 2004 because of cardiovascular risks. Read more here http://www.vioxxadvisor.com/4278.html TRENTON, N.J. — Merck & Co. is on the verge of settling most serious personal injury lawsuits over Vioxx, but the drugmaker still faces substantial litigation over the one-time blockbuster painkiller it yanked from the market in 2004 because of Link to original article http://www.vioxxadvisor.com/4276.html Merck is on the verge of settling most of the serious personal injury lawsuits over Vioxx, but the drugmaker still faces substantial litigation over the one-time blockbuster painkiller it yanked from the market in 2004 because of cardiovascular risks. Click here for more info http://www.vioxxadvisor.com/4277.html TRENTON, N.J. — Merck & Co. is on the verge of settling most serious personal injury lawsuits over Vioxx, but the drugmaker still faces substantial litigation over the one-time Read more here http://www.vioxxadvisor.com/4274.html Merck & Co. is on the verge of settling most serious personal injury lawsuits over Vioxx, but the drugmaker still faces substantial litigation over the one-time blockbuster painkiller it yanked from the market in 2004 because of cardiovascular risks. More than 44,000 plaintiffs have enrolled in a proposed $4.85 billion ... http://www.vioxxadvisor.com/4275.html Merck & Co. is on the verge of settling most serious personal injury lawsuits over Vioxx, but the drugmaker faces lots of litigation over the onetime blockbuster painkiller it yanked from the market in 2004 over cardiovascular risks. ... http://www.vioxxadvisor.com/4273.html Responsibilities Include Deciding Claimant Appeals Click here for more info http://www.vioxxadvisor.com/4270.html Merck is on the verge of settling most serious personal injury lawsuits over Vioxx, but it still faces substantial litigation. Click here for more info http://www.vioxxadvisor.com/4271.html More than 44,000 plaintiffs have enrolled in a proposed $4.85 billion settlement for U.S. personal injury cases involving a heart attack, stroke or death, the company said this week. Click here for more info http://www.vioxxadvisor.com/4272.html Merck & Co. is on the verge of settling most serious personal injury lawsuits over Vioxx, but the drugmaker still faces substantial litigation over the one-time blockbuster painkiller it yanked from the market in 2004 because of cardiovascular risks. Link to original article http://www.vioxxadvisor.com/4269.html The former chairman and CEO of the pharmaceutical giant Merck, Roy P. Vagelos , has bought a $21 million condo at 15 Central Park West, city records today show. At Merck until 1994, Mr. Vagelos was largely credited with sheperding the firm through its pre-Vioxx golden years. Since ... http://www.vioxxadvisor.com/4267.html The rheumatoid arthritis treatment market, held back somewhat in recent years by generic competition and the withdrawal of Vioxx and Bextra, is rebounding due to the performance of biologic treatments. Click here for more info http://www.vioxxadvisor.com/4268.html The pharmaceutical company Merck says it's ready to settle claims with more than 44,000 former Vioxx users. Merck agreed to hand out $4.85 billion if 85 percent of the potential claimants registered by last Friday, and Merck says it's received enough paperwork to move forward. Link to original article http://www.vioxxadvisor.com/4266.html A nearly five billion dollar settlement over the withdrawn painkiller Vioxx is on the track to move out to thousands of affected consumers. Drug company, Merck says more then 44,000 people have signed up to take part in the deal by submitting medical records and other documents. More... http://www.vioxxadvisor.com/4265.html More than 44,000 people have signed up for shares of a $4.85 billion settlement over the withdrawn painkiller Vioxx, a sign that the deal is on track to go forward, Merck & Co. announced Monday. Of roughly 47,000 people who registered for the settlement earlier this year, more than 44,000 ... http://www.vioxxadvisor.com/4264.html A proposed $4.8 billion agreement crafted to settle a majority of the remaining Vioxx-related lawsuits against Merck has drawn more than 44,000 plaintiffs, meeting a critical early requirement for the settlement to go into effect. Link to original article http://www.vioxxadvisor.com/4263.html More than 44,000 people have signed up for shares of a $4.85 billion settlement over the withdrawn painkiller Vioxx, a sign that the deal is on track to go forward, Merck & Co. announced Monday More... http://www.vioxxadvisor.com/4261.html More than 44,000 people have signed up for a piece of a $4.85 billion settlement over the withdrawn painkiller Vioxx, a sign that the deal is on track to go forward. More... http://www.vioxxadvisor.com/4262.html A nearly $5 billion settlement over the withdrawn painkiller Vioxx is on track to move forward. Merck says more than 44,000 people have signed up to take part in the deal by submitting medical records and other necessary paperwork. Read more here http://www.vioxxadvisor.com/4260.html More than 44,000 people have signed up for shares of a $4.85 billion settlement over the withdrawn painkiller Vioxx, a sign that the deal is on track to go forward, Merck & Co. announced Monday. Read more here http://www.vioxxadvisor.com/4259.html Merck & Co on Monday said it has moved closer to resolving thousands of claims arising from its 2004 withdrawal of arthritis pill Vioxx, with 93 percent of people alleging the drug caused a heart attack or stroke submitting documents in a $4.85 billion settlement. Click here for more info ... http://www.vioxxadvisor.com/4258.html Merck said that more than 93 percent of the 47,000 people who allege that the arthritis drug Vioxx caused their heart attack or stroke have submitted claims in the company’s settlement offer. More... http://www.vioxxadvisor.com/4256.html NEW YORK (Thomson Financial) - Merck & Co. Monday said more than 44,000 of the 47,000 people who registered eligible injuries have submitted some or all of the material for enrollment that could qualify them for an interim payment in the program to resolve legal claims filed against the company ... http://www.vioxxadvisor.com/4257.html NEW YORK (MarketWatch) -- Merck & Co. said Monday that more than 44,000 of the 47,000 Vioxx patients who claim unhealthy side-effects from the pain reliever filed "some or all" of the paperwork needed to participate in a $4.85 billion settlement. ... http://www.vioxxadvisor.com/4255.html NEW ORLEANS -- More than 44,000 people have signed up for shares of a $4.85 billion settlement over the withdrawn painkiller Vioxx, a sign that the deal is on track to go forward, More... http://www.vioxxadvisor.com/4252.html Merck & Co. Inc. said Monday it continues to make progress on its $4.85 billion Vioxx settlement agreement. (MRK) Click here for more info http://www.vioxxadvisor.com/4253.html More than 44,000 people have signed up for shares of a $4.85 billion settlement over the withdrawn painkiller Vioxx, a sign that the deal is on track to go forward, Merck & Co. announced Monday. Click here for more info http://www.vioxxadvisor.com/4254.html http://www.vioxxadvisor.com/4246.html NEW YORK (Thomson Financial) - Merck & Co. Monday said more than 44,000 of the 47,000 people who registered eligible injuries have submitted some or all of the material for enrollment that could qualify them for an interim payment in the program to resolve legal claims filed against the company ... http://www.vioxxadvisor.com/4247.html Associated Press - March 3, 2008 8:44 AM ET NEW ORLEANS (AP) - More than 44,000 people have signed up for shares of a $4.85 billion settlement over the withdrawn painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4248.html http://www.vioxxadvisor.com/4249.html More than 44,000 people have signed up for shares of a $4.85 billion settlement over the withdrawn painkiller Vioxx. Merck & Company says those enrollment figures, released Monday, indicate that the settlement is on track to proceed. Merck says that of the roughly 47,000 people who registered for the settlement, ... http://www.vioxxadvisor.com/4250.html The drugmaker Merck says more than 44,000 people have signed up for part of a $4.85 billion settlement over the withdrawn painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4251.html Justices could shield FDA-backed drugs from suits, as they did for devices. Critics say the agency is fallible. Years of high-profile court battles over drugs such as Vioxx and Celebrex, along with billion-dollar settlements and jury verdicts, could soon be a thing of the past. ... http://www.vioxxadvisor.com/4245.html The coffers of the Missouri Medicaid program grew by $3.1 million through a settlement over a fraud complaint against pharmaceutical maker Merck, Missouri Attorney General Jay Nixon announced today. The settlement resolves allegations Merck shortchanged rebates paid to the Medicaid program for Zocor and Vioxx. The total settlement came to ... http://www.vioxxadvisor.com/4244.html Lawyers will have an extra month to send in paperwork for people who want early payment from a $4.85 billion federal court settlement involving the painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4243.html Associated Press - February 21, 2008 4:44 PM ET NEW ORLEANS (AP) - Lawyers will have an extra month to send in paperwork for people who want early payment from a $4.85 billion federal court Click here for more info http://www.vioxxadvisor.com/4242.html REGINA - A Saskatchewan court has certified a class-action lawsuit against the makers of the painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4241.html http://www.vioxxadvisor.com/4240.html Pharmaceutical giant Merck has agreed to pay a whopping $650 million in fines to the federal government. The case involves Merck routinely overbilling Medicaid for eight years for some of its most-prescribed medications, such as the arthritis drug Vioxx and cholesterol fighter Zocor. More... http://www.vioxxadvisor.com/4239.html Philadelphia law firm Dechert has cut its stable of contract attorneys almost in half, legal recruiters say, as the Vioxx products liability case they were involved in winds down. About 75 lawyers were looking for work, in many cases after three years of stable employment. Click here for more info ... http://www.vioxxadvisor.com/4238.html A sales manager who "just couldn't abide" by the way Merck wanted him to market the drugs Vioxx and Zocor to doctors took the lonely step of filing a whistleblower suit against his employer. Seven years later, Merck & Co. will pay $671 million to settle complaints it overcharged government ... http://www.vioxxadvisor.com/4237.html PHILADELPHIA - Merck & Co. has agreed to pay $671 million to settle claims that it overcharged Medicaid programs for two big-selling drugs, Vioxx and Zocor, and to resolve allegations of improper marketing to doctors, U.S. prosecutors and company officials announced Thursday. More... http://www.vioxxadvisor.com/4235.html Philadelphia | A sales manager who "just couldn't abide" by the way Merck wanted him to market the drugs Vioxx and Zocor to doctors took the lonely step of filing a whistleblower suit against his employer. More... http://www.vioxxadvisor.com/4236.html A sales manager who "just couldn't abide" by the way Merck wanted him to market the drugs Vioxx and Zocor to doctors took the lonely step of filing a whistle-blower suit against his employer. More... http://www.vioxxadvisor.com/4234.html A sales manager who "just couldn't abide" the way Merck wanted him to market the drugs Vioxx and Zocor to doctors took the lonely step of filing a whistle-blower lawsuit against his employer. Seven years later, Merck & Co. will pay $671 million to settle ... http://www.vioxxadvisor.com/4233.html PHILADELPHIA -- A sales manager who "just couldn't abide" by the way Merck wanted him to market the drugs Vioxx and Zocor to doctors took the lonely step of filing a whistleblower suit More... http://www.vioxxadvisor.com/4232.html Drug company, reeling from nine-figure settlements for Vioxx, Vytorin, and Zetia, agrees to stump up another $650 million in a new case. Read more here http://www.vioxxadvisor.com/4230.html A sales manager who "just couldn't abide" by the way Merck wanted him to market the drugs Vioxx and Zocor to doctors took the lonely step of filing a whistleblower suit against his employer. Seven years later, Merck & Co. will pay $671 million to ... http://www.vioxxadvisor.com/4231.html Merck and Co. has agreed to pay $671 million to settle claims that it overcharged Medicaid programs for four drugs, including Vioxx and Zocor, and to resolve allegations of improper marketing to doctors, U.S. prosecutors and company officials announced Thursday. Link to original article http://www.vioxxadvisor.com/4229.html PHILADELPHIA - U.S. prosecutors say Merck & Co. has agreed to pay $671 million to settle claims that it overcharged Medicaid programs for two big-selling drugs, Vioxx and Zocor. Click here for more info http://www.vioxxadvisor.com/4228.html PHILADELPHIA, PA -- Merck has agreed to pay $671 million to settle claims that it overcharged Medicaid programs for two big-selling drugs, Vioxx and Zocor, and to resolve allegations of improper marketing to doctors, U.S. prosecutors and company officials announced today. Link to original article http://www.vioxxadvisor.com/4226.html Merck & Co agreed to pay more than $649 million to resolve litigation related to its cholesterol drug Zocor and painkiller Vioxx, a federal prosecutor said on Thursday. Link to original article http://www.vioxxadvisor.com/4227.html Merck & Co. has agreed to pay a total of $399 million to the federal government, 49 states and the District of Columbia to settle Medicaid fraud claims involving the company's withdrawn painkiller Vioxx and its anticholestrol drug Zocor, the U.S. Attorney's office in Philadelphia said today. Read more here ... http://www.vioxxadvisor.com/4223.html The company allegedly paid kickbacks to doctors to prescribe Vioxx. Read more here http://www.vioxxadvisor.com/4224.html Merck & Co. has agreed to pay $671 million to settle claims that it overcharged Medicaid programs for two big-selling drugs, Vioxx and Zocor, and to resolve allegations of improper marketing to doctors, U.S. prosecutors and company officials announced Thursday. Read more here http://www.vioxxadvisor.com/4225.html Readington-based Merck & Co. has agreed to pay $671 million to settle claims that it overcharged Medicaid programs for two big-selling drugs, Vioxx and Zocor, and to resolve allegations of improper marketing to doctors, U.S. prosecutors and company officials announced today. Link to original article http://www.vioxxadvisor.com/4222.html Merck & Co. has agreed to pay a combined total of $671 million to settle claims that it overcharged Medicaid programs for two big-selling drugs, Vioxx and Zocor, and to resolve allegations of improper marketing to doctor. More... http://www.vioxxadvisor.com/4221.html A federal grand jury in Massachusetts is investigating the alleged illegal promotion by Merck & Co. of the painkiller Vioxx, a report said.The U.S. Attorney's Office is probing Merck & Co. for allegedly promoting Vioxx, which came off the market in 2004, to medical professionals for purposes unauthorized by the ... http://www.vioxxadvisor.com/4220.html The Whitehouse Station drugmaker withdrew Vioxx from the market in 2004, after a study linked the drug to an elevated risk of heart attack or stroke. More... http://www.vioxxadvisor.com/4219.html TRENTON, N.J. — Merck & Co. posted a $1.63 billion fourth-quarter loss Wednesday as a whopping charge for its Vioxx litigation settlement dragged down results. More... http://www.vioxxadvisor.com/4217.html NEW ORLEANS (AP) - Hundreds of Florida residents who claim the painkiller Vioxx caused their strokes or heart attacks were squeezed out of a federal court settlement and should be included, their lawyers say. If the motion they filed in U.S. District Court succeeds, people in a half-dozen other states ... http://www.vioxxadvisor.com/4218.html Hundreds of Florida residents who claim the painkiller Vioxx caused their strokes or heart attacks were squeezed out of a federal-court settlement and should be included, their lawyers say. More... http://www.vioxxadvisor.com/4216.html TRENTON, N.J.– Merck & Co. posted a $1.63 billion (U.S.) fourth-quarter loss yesterday as whopping charges, mainly for its Vioxx litigation settlement, dragged down results – and share prices. Link to original article http://www.vioxxadvisor.com/4215.html BOSTON (Dow Jones) -- Merck & Co. swung to a fourth-quarter loss, mostly because of charges it recorded to settle the bulk of litigation stemming from the recall of its blockbuster pain reliever Vioxx. Read more here http://www.vioxxadvisor.com/4214.html Merck posted a $1.63 billion fourth-quarter loss on Wednesday as charges for its Vioxx litigation settlement dragged down results and share prices. Click here for more info http://www.vioxxadvisor.com/4213.html Merck swung to a net loss for the fourth quarter, on the US drugmaker’s big costs to resolve litigation including a $4.85bn settlement of lawsuits over its withdrawn painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4212.html Merck & Co. posted a $1.63 billion fourth-quarter loss Wednesday as a whopping charge for its Vioxx litigation settlement dragged down results. Read more here http://www.vioxxadvisor.com/4210.html BOSTON (Dow Jones) -- Merck & Co. reported a dramatic drop in fourth-quarter earnings early Wednesday, due primarily to massive accounting charges relating to the settlement of bulk of the litigation stemming from the recall of its blockbuster pain reliever Vioxx. Click here for more info http://www.vioxxadvisor.com/4211.html Merck & Co. on Tuesday posted a $1.63 billion loss in the fourth quarter as whopping charges, mainly for its Vioxx litigation settlement, dragged down results. More... http://www.vioxxadvisor.com/4209.html Readington-based Merck & Co. on Tuesday posted a $1.63 billion loss in the fourth quarter as whopping charges, mainly for its Vioxx litigation settlement, dragged down results.` More... http://www.vioxxadvisor.com/4207.html WHITEHOUSE STATION, N.J. - Merck & Co. on Tuesday posted a US$1.63-billion loss in the fourth quarter as whopping charges for its Vioxx litigation settlement and other items dragged down results. Click here for more info http://www.vioxxadvisor.com/4208.html WHITEHOUSE STATION, N.J.–Merck & Co. posted a $1.63 billion loss in the fourth quarter as whopping charges for its Vioxx litigation settlement and other items dragged down results. Read more here http://www.vioxxadvisor.com/4205.html Merck and Co on Wednesday reported a fourth-quarter loss due to a number of charges, including for a costly settlement related to its withdrawn Vioxx arthritis drug. Click here for more info http://www.vioxxadvisor.com/4202.html Jan. 30 (Bloomberg) -- Merck & Co., the third-largest U.S. drugmaker, reported a fourth-quarter loss after taking a $4.85 billion charge to settle lawsuits over its painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4203.html Merck & Co. reported a dramatic drop in fourth-quarter earnings early Wednesday, due primarily to massive accounting charges relating to the settlement of bulk of the litigation stemming from the recall of its blockbuster pain reliever Vioxx. ... http://www.vioxxadvisor.com/4204.html Merck & Co. (MRK) swung to a fourth-quarter loss on charges for settling the bulk of Vioxx liability cases, as the pharmaceuticals company saw strong sales growth of its allergy and cholesterol treatments. Read more here http://www.vioxxadvisor.com/4206.html Hundreds of Florida residents who claim the painkiller Vioxx caused their strokes or heart attacks were squeezed out of a federal court settlement and should be included, their lawyers say in a motion filed in U.S. District Court. Link to original article http://www.vioxxadvisor.com/4201.html NEW ORLEANS -- Hundreds of Florida residents who claim the painkiller Vioxx caused their strokes or heart attacks were squeezed out of a federal court settlement and should be included, Click here for more info http://www.vioxxadvisor.com/4200.html NEW ORLEANS -- Hundreds of Florida residents who claim the painkiller Vioxx caused their strokes or heart attacks were squeezed out of a federal court settlement and should be included, Link to original article http://www.vioxxadvisor.com/4199.html Hundreds of Florida residents who claim the painkiller Vioxx caused their strokes or heart attacks were squeezed out of a federal court settlement and should be included, their lawyers say in a motion filed in U.S. Click here for more info http://www.vioxxadvisor.com/4198.html Celebrex, an arthritis drug in the same class as the recalled painkiller Vioxx, caused irregular heartbeats in fruit flies and in heart cells taken from laboratory rats, U.S. researchers said on Friday. Click here for more info http://www.vioxxadvisor.com/4197.html Is an attorney?s fierce devotion to an individual client?s interests a passé concept? Click here for more info http://www.vioxxadvisor.com/4196.html A federal judge overseeing a $4.85 billion settlement with Merck & Co. over its withdrawn Vioxx painkiller expressed confidence Friday that lawyers have resolved ethical concerns about the agreement. Link to original article http://www.vioxxadvisor.com/4195.html A federal judge overseeing a $4.85 billion settlement with Merck & Co. over its withdrawn Vioxx painkiller expressed confidence Friday that lawyers have resolved ethical concerns about the agreement. Some lawyers for Vioxx patients have challenged a provision of the settlement that bars attorneys with clients who participate in the ... http://www.vioxxadvisor.com/4194.html A federal judge overseeing a $4.85 billion settlement with Merck & Co. over its withdrawn Vioxx painkiller expressed confidence Friday that lawyers have resolved ethical concerns about the agreement. Read more here http://www.vioxxadvisor.com/4192.html NEW ORLEANS - A federal judge overseeing a $4.85 billion settlement with Merck & Co. over its withdrawn painkiller Vioxx expressed confidence yesterday that lawyers had resolved ethical concerns about the agreement. Link to original article http://www.vioxxadvisor.com/4193.html A federal judge overseeing a $4.85 billion settlement with Merck & Co. over its withdrawn Vioxx painkiller expressed confidence Friday that lawyers have resolved ethical concerns about the agreement. Click here for more info http://www.vioxxadvisor.com/4190.html NEW ORLEANS (AP) - A federal judge overseeing a $4.9 billion settlement with Merck involving its withdrawn Vioxx painkiller is expressing confidence that lawyers have resolved ethical concerns about the agreement. Read more here http://www.vioxxadvisor.com/4191.html More than 3,000 former users of Merck & Co's withdrawn Vioxx pain drug have already signed up to take part in a $4.85 billion settlement deal that a federal judge said on Friday was in the best interests of both sides. Click here for more info http://www.vioxxadvisor.com/4189.html A federal judge overseeing a $4.85 billion settlement with Merck & Co. involving its withdrawn Vioxx painkiller expressed confidence Friday that lawyers have resolved ethical concerns about the agreement. Click here for more info http://www.vioxxadvisor.com/4187.html Attorneys who had challenged a provision in the Vioxx settlement say they are satisfied. Click here for more info http://www.vioxxadvisor.com/4188.html Associated Press - January 18, 2008 11:44 AM ET NEW ORLEANS (AP) - A federal judge overseeing a $4.85 billion settlement with Merck over its withdrawn Vioxx painkiller expressed confidence Link to original article http://www.vioxxadvisor.com/4185.html More than 3,000 former users of Merck & Co's withdrawn Vioxx pain drug have already signed up to take part in a $4.85 billion settlement deal that a federal judge on Friday declared was in the best interests of both sides. Read more here http://www.vioxxadvisor.com/4186.html Major business events and economic events scheduled for Friday: NEW ORLEANS -- Hearing at which Merck & Co. is expected to update the number of plaintiffs participating in its landmark Vioxx settlement. Link to original article http://www.vioxxadvisor.com/4184.html More than 50,000 people with lawsuits claiming Merck & Company's withdrawn painkiller Vioxx caused them to have heart attacks and strokes have served notice they want in on a proposed 4.85 billion dollar settlement deal. more Read more here http://www.vioxxadvisor.com/4183.html More than 50,000 people with lawsuits claiming Merck & Co.'s withdrawn painkiller Vioxx caused them to have heart attacks and strokes have served notice they want in on a proposed $4.85 billion settlement deal, a showing that has attorneys on both sides predicting it will go forward. Click here for ... http://www.vioxxadvisor.com/4182.html With tens of thousands of Vioxx claimants tentatively signed on to a $4.85 billion settlement and more claims pouring in just under the wire Tuesday, their lawyers and drugmaker Merck & Co. predicted the deal will proceed. Link to original article http://www.vioxxadvisor.com/4181.html TRENTON -- With tens of thousands of Vioxx claimants tentatively signed on to a $4.85 billion settlement and more claims pouring in just under the wire Tuesday, their lawyers and drugmaker Merck & Co. predicted the deal will proceed. Link to original article http://www.vioxxadvisor.com/4180.html With tens of thousands of Vioxx claimants tentatively signed on to a $4.85 billion settlement and more claims pouring in just under the wire today, their lawyers and drugmaker Merck predicted the deal will proceed, the Associated Press reported. Link to original article http://www.vioxxadvisor.com/4179.html With tens of thousands of Vioxx claimants tentatively signed on to a $4.85 billion settlement and more claims pouring in just under the wire Tuesday, their lawyers and drug maker Merck & Co. predicted the deal will proceed. More... http://www.vioxxadvisor.com/4178.html The volume of claims by Vioxx patients hoping to get a piece of a $4.85 billion settlement makes it appear likely that the deal will go forward, lawyers and drug maker Merck & Co. said Monday. Read more here http://www.vioxxadvisor.com/4177.html Jan. 15 (Bloomberg) -- About 30,000 plaintiffs who sued drugmaker Merck & Co. over its Vioxx painkiller have until the end of the day to register for payouts under a $4.85 billion settlement, the company said. More... http://www.vioxxadvisor.com/4175.html The arrival of the first deadline imposed as part of Merck's $4.85 billion Vioxx settlement is expected to provide a strong signal about whether the agreement ultimately goes into effect. Read more here http://www.vioxxadvisor.com/4176.html The volume of claims by Vioxx patients hoping to get a piece of a $4.85 billion settlement makes it appear likely that the deal will go forward, lawyers and Readington-based drug maker Merck & Co. said today. Link to original article http://www.vioxxadvisor.com/4174.html The volume of claims by Vioxx patients hoping to get a piece of a $4.85 billion settlement makes it appear likely that the deal will go forward, according to lawyers and drug maker Merck & Co. Read more here http://www.vioxxadvisor.com/4173.html Attorneys for hundreds of people who sued Merck & Co. over its withdrawn painkiller Vioxx are challenging a key provision of a proposed $4.85 billion settlement that requires lawyers to advise all or none of their clients to accept the deal. Link to original article http://www.vioxxadvisor.com/4172.html As studies continue to be released that explore the cardiovascular risks of Vioxx, Celebrex, Bextra, and other pharmaceuticals, the FDA has come under widespread criticism for failing to protect the public from “unsafe” drugs. Click here for more info http://www.vioxxadvisor.com/4171.html Her smile and directness catch your attention and tell you right away that she could click her heels together and go anywhere. Link to original article http://www.vioxxadvisor.com/4170.html 79833. Did any of you notice the Vioxx statement Clemens pushed in the 60 Minutes interview? Read more here http://www.vioxxadvisor.com/4169.html Lawyers for hundreds of people who sued Merck because of its withdrawn painkiller Vioxx are challenging a key provision of a proposed $4.85 billion settlement that requires lawyers to advise all or none of their clients to accept the deal. More... http://www.vioxxadvisor.com/4168.html NEW ORLEANS - Lawyers for hundreds of people who sued Merck over its withdrawn painkiller Vioxx are challenging a key provision of a proposed 4.85 billion-dollar settlement. The lawyers are based in Illinois and Missouri and represent about 2,600 plaintiffs. Click here for more info http://www.vioxxadvisor.com/4167.html Plaintiffs lawyers who negotiated the settlement said Friday they expect the challenge will be withdrawn, as a similar one filed last month was. More... http://www.vioxxadvisor.com/4166.html NEW ORLEANS - Lawyers for hundreds of people who sued Merck & Co. over its withdrawn painkiller Vioxx are challenging a key provision of a proposed US$4.85 billion settlement that requires lawyers to advise all or none of their clients to accept the deal. Read more here http://www.vioxxadvisor.com/4165.html Lawyers for hundreds of people who sued Merck & Co. over its withdrawn painkiller Vioxx are challenging a key provision of a proposed $4.85 billion settlement that requires lawyers to advise all or none of their clients to accept the deal. Link to original article http://www.vioxxadvisor.com/4164.html The Fort Lauderdale-based law firm, Kelley / Uustal, is reminding people who suffered Vioxx-induced heart attacks and strokes and are participants of the recently announced $4.85 billion Merck settlement that they have options if their settlements are too low. Link to original article http://www.vioxxadvisor.com/4163.html Shares of drug maker Merck & Co. spiked 34 percent during 2007 to become the sector's biggest gainer after the company negotiated an end to Vioxx lawsuits and had strong launches of key drugs, but shareholders of peer King Pharmaceuticals Inc. saw the value of their investment drop 35 percent ... http://www.vioxxadvisor.com/4162.html Bruce Kuhlik became Merck's top attorney five months ago. Link to original article http://www.vioxxadvisor.com/4161.html A proposed $4.85 billion pact between Merck & Co Inc and users of painkiller Vioxx would force plaintiffs' lawyers to make recommendations to clients that may not be in their best interests, according to attorneys who are challenging the pact's terms. Link to original article http://www.vioxxadvisor.com/4160.html Several plaintiffs? lawyers have asked the judge overseeing the $4.85 billion settlement to allow them to keep some of their clients outside the settlement while others accept it. Click here for more info http://www.vioxxadvisor.com/4159.html Vioxx Payout Link to original article http://www.vioxxadvisor.com/4158.html Posted: Monday, December 17, 2007 at 6:45 p.m. More than 1,000 michigan residents could end up getting part of a $4.85 billion national settlement if they or a loved one took the painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4157.html VIOXX : Despite the law, more than 1,000 Michigan residents could end up benefiting from a $4.85 billion settlement announced last month by Merck and Co., maker of the painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4155.html More than 1,000 Michigan residents could end up getting part of a $4.85 billion national settlement if they or their loved ones took the painkiller Vioxx. But that hasn't squelched a firestorm ove Click here for more info http://www.vioxxadvisor.com/4156.html LANSING -- More than 1,000 Michigan residents could get part of a $4.85 billion national settlement if they or their loved ones took the painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4154.html Fight over Michigan drug law intensifies after Vioxx settlement. More... http://www.vioxxadvisor.com/4153.html LANSING, Mich. -- More than 1,000 Michigan residents could end up getting part of a $4.85 billion national settlement if they or their loved ones took the painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4152.html Always buying cameras & photo gear -working or not. Buy, Trade, Consign. Refills. Guaranteed. $3.60 per 100mg. Why pay more? We have the answer! Vioxx, Celebrex, Lipitor, more! Prescription Buyers Group. 1-866-887-7283. More... http://www.vioxxadvisor.com/4151.html Settle up to 50,000 Vioxx lawsuits for $4.85 billion, an amount expected to save the company millions in trial costs. Its stock price has more than recovered from its post-Vioxx slump, a 2-year-old restructuring plan is going well, and profits are up. Link to original article http://www.vioxxadvisor.com/4150.html Richard Clark, chief executive of Merck, acknowledged he is relieved at the prospect of settling the majority of Vioxx-related lawsuits in the United States. More... http://www.vioxxadvisor.com/4149.html Merck, based in Whitehouse Station , N.J. , is one of the few drug makers that produces a significant number of vaccines. While the company took a black eye with its September 2004 withdrawal of the painkiller Vioxx due to increased risk of heart attacks and strokes, the company has ... http://www.vioxxadvisor.com/4148.html Dozens of plaintiff lawyers gathered here Monday for a briefing on a landmark $4.85 billion settlement with Merck & Co. that ends thousands of personal-injury lawsuits over its Vioxx painkiller. Read more here http://www.vioxxadvisor.com/4147.html NEW ORLEANS Dozens of plaintiff lawyers gathered here Monday for a briefing on a landmark $4.85 billion settlement with Merck & Co. that ends thousands of personal-injury lawsuits over its Vioxx painkiller. Link to original article http://www.vioxxadvisor.com/4146.html While Merck & Co. have to pay out $4.85 billion over Vioxx, OxyContin manufacturer Purdue Pharma executives agreed to pay only a $634.5 million fine, even after admitting in a federal lawsuit to making false and misleading statements that OxyContin was not as addictive or as likely to be abused ... http://www.vioxxadvisor.com/4145.html Two years ago the stock was $25 and people were talking like Vioxx would bankrupt the company. Click here for more info http://www.vioxxadvisor.com/4144.html TRENTON: The state Supreme Court denied a request by Merck & Co. to hear an immediate appeal of a jury's $13.5 million damage award to a man who blamed his heart attack on the company's Vioxx painkiller. Link to original article http://www.vioxxadvisor.com/4143.html The projections came less than a month after Merck announced it would pay US$4.85 billion to settle tens of thousands of lawsuits stemming from its painkiller Vioxx, which it pulled from the market in 2004. More... http://www.vioxxadvisor.com/4142.html The projections came less than a month after Merck announced it would pay $4.85 billion to settle tens of thousands of lawsuits stemming from its painkiller Vioxx, which it pulled from the market in 2004. Read more here http://www.vioxxadvisor.com/4141.html New York state's attorney general and New York City's mayor filed a joint lawsuit against Merck in mid-September that accused the company of misrepresenting the dangers of its pain reliever Vioxx to users of the drug. Link to original article http://www.vioxxadvisor.com/4140.html A former commissioner of the Food and Drug Administration on Wednesday praised a recently enacted plan to overhaul the monitoring of drug safety in the United States. Link to original article http://www.vioxxadvisor.com/4139.html The Vioxx episode has resulted in long-needed reforms in how the industry addresses safety issues. More... http://www.vioxxadvisor.com/4138.html The Vioxx episode has resulted in long-needed reforms in how the industry addresses safety issues. Click here for more info http://www.vioxxadvisor.com/4137.html The Vioxx episode has resulted in long-needed reforms in how the industry addresses safety issues. Behind-the-headlines pharmaceutical global sales + marketing news and analysis every other Wednesday, helping you break down breaking news from an industry perspective. Link to original article http://www.vioxxadvisor.com/4136.html Will the Vioxx settlement stick? That's what savvy Monday-morning quarterbacks were asking following Merck's announcement last Friday that it would pay $4.85 billion to resolve the lion's share of injury claims related to its star-crossed painkiller. Link to original article http://www.vioxxadvisor.com/4135.html How could one little digital deletion build up such a head of steam? It's a question of trust. Would you recommend this page to a friend? The Vioxx episode has resulted in long-needed reforms in how the industry addresses safety issues. More... http://www.vioxxadvisor.com/4134.html Good Site! Thanks! vioxx attorney [URL=http://tpehep.info/vioxx-attorney.html]vioxx attorney[/URL] vioxx celebrex [URL=http://tpehep.info/vioxx-celebrex.html]vioxx celebrex[/URL] vioxx claim [URL=http://tpehep.info/vioxx-claim.html]vioxx claim[/URL] vioxx heart [URL=http://tpehep.info/vioxx-heart.html]vioxx heart[/URL] vioxx lawsuit [URL=http://tpehep.info/vioxx-lawsuit.html]vioxx More... http://www.vioxxadvisor.com/4133.html Leslie Richter of Lansing has no doubt that Vioxx killed her husband, Richard. Link to original article http://www.vioxxadvisor.com/4132.html Why the Vioxx settlement could signal an end to worries about giant drug torts. Click here for more info http://www.vioxxadvisor.com/4131.html Is the proposed $4.85 billion settlement of Merck's Vioxx litigation a cause for gloom or cheer? A major settlement agreement often gives a quick psychological profile of lawyers, law professors and pundits' optimism level. The Vioxx Settlement Agreement announced ten days ago is no exception. Click here for more info ... http://www.vioxxadvisor.com/4130.html Would you recommend this page to a friend? The Vioxx episode has resulted in long-needed reforms in how the industry addresses safety issues. Read more here http://www.vioxxadvisor.com/4129.html The $4.85-billion settlement offered by pharmaceutical giant Merck & Co. to patients stricken by heart attacks and strokes after taking the company's painkiller Vioxx could mean the end to one of the most unpleasant and costliest chapters in the pharmaceutical industry's history. Read more here http://www.vioxxadvisor.com/4128.html The settlement announced last week in which the makers of Vioxx will pay out $4.8 billion for heart attacks or strokes linked to the painkilling drug is a sad reminder of some legislative cleanup that's needed in Michigan: Repeal of the law that shields drugmakers from just about any suit ... http://www.vioxxadvisor.com/4127.html Even as a new round of Vioxx trials was being scheduled in the courts last summer, three judges inundated with the bulk of the complicated litigation were privately coaxing attorneys for Merck and the plaintiffs to work toward a settlement. Read more here http://www.vioxxadvisor.com/4126.html The pace has certainly slowed since the Vioxx recall. Click here for more info http://www.vioxxadvisor.com/4125.html An unusual provision in Merck & Co Inc's settlement agreement concerning the painkiller Vioxx means many plaintiffs may have little choice but to accept the deal, the Wall Street Journal said Friday in its online edition. Link to original article http://www.vioxxadvisor.com/4124.html http://www.vioxxadvisor.com/4123.html Some legal analysts are hailing Merck & Co’s agreement last week to settle the bulk of its Vioxx claims as a new dawn for US product liability cases. Click here for more info http://www.vioxxadvisor.com/4121.html The $4.85-billion settlement offered last week by pharmaceutical giant Merck & Co. to patients stricken by heart attacks and strokes after taking the company's painkiller Vioxx could mean the end to one of the most unpleasant and costliest chapters in the pharmaceutical industry's history. ... http://www.vioxxadvisor.com/4122.html Almost five billion dollars will be paid to thousands of people hurt by the drug Vioxx and some of those people live right here in East Texas. Last week, we reported pharmaceutical-giant Merck agreed to pay 4.85 billion dollars in one of the nation's largest civil suit settlements. Two sisters from Tyler who ... http://www.vioxxadvisor.com/4120.html Counsel Financial Services , the nation's largest provider of working capital credit lines exclusively to attorneys, announced today that it will provide loans to litigators representing Vioxx plaintiffs, in the wake of Merck & Co.'s recent announcement that it has established a $4.85 billion victim fund to settle thousands of ... http://www.vioxxadvisor.com/4119.html A Montgomery law firm took the charge against pharmaceutical giant Merck & Co., winning a $4.85 billion settlement for thousands nationwide who took the arthritis painkiller Vioxx. More... http://www.vioxxadvisor.com/4118.html Several factors to shape payments. Link to original article http://www.vioxxadvisor.com/4117.html IN announcing it will pay almost $5 billion to settle 27,000 cases brought by Vioxx users, Merck said last week it is not admitting any wrongdoing. It called the huge settlement "reasonable and responsible." More... http://www.vioxxadvisor.com/4116.html RESERVE - When the national pharmaceutical company Merck announced last week that they have agreed to pay $4.85 billion to 27,000 plaintiffs in the class action lawsuit over the pain medication Vioxx, the phones began to ring more than normal in the law office of St. John Parish attorney Daniel ... http://www.vioxxadvisor.com/4115.html Expect Merck to spend a lot more than $4.8 billion before it's done. Here's why. Read more here http://www.vioxxadvisor.com/4114.html What we said In "Merck Is on the Mend" (Feb. 5), we recommended a second look at the pharma giant, which was recovering from the low it reached in 2004 amid the Vioxx debacle. We mentioned that Merck was winning approvals for a host of new drugs, including cervical-cancer vaccine ... http://www.vioxxadvisor.com/4113.html Merck & Co. will pay $4.85 billion to settle thousands of lawsuits over the painkiller Vioxx in one of the largest civil cases ever, the company said Friday. More... http://www.vioxxadvisor.com/4111.html Former users of withdrawn painkiller Vioxx will be eligible for a piece of manufacturer Merck & Co.'s $4.85 billion nationwide settlement if they meet strict criteria meant to weed out people with bogus claims. They must: -- Have had Link to original article http://www.vioxxadvisor.com/4112.html Merck agrees to pay nearly $5 billion to settle lawsuits from consumers contending the painkiller Vioxx caused heart attacks and strokes. The safety problems of Vioxx and the withdrawal of Vioxx from the market was a watershed event in regulating prescription drugs in the U.S. Link to original article http://www.vioxxadvisor.com/4110.html It's a sign of the times that a company can express relief after agreeing to settle a massive set of lawsuits for $4.85 billion. But Merck's decision to end the Vioxx wars seems to be a victory for a company facing $20 billion in liability, and a validation of its ... http://www.vioxxadvisor.com/4109.html The round of Vioxx litigation has moved nearer to a close, with US drugmaker Merck agreeing to settle for $4.85bn the bulk of the threatening lawsuits over the painkiller it withdrew in 2004 because of its links to heart and stroke risks. More... http://www.vioxxadvisor.com/4108.html TRENTON, N.J. - Merck & Co. said Friday it will pay $4.85 billion to end thousands of state and federal lawsuits over its painkiller Vioxx in one of the largest drug settlements ever. Read more here http://www.vioxxadvisor.com/4107.html Merck has reached a $4.85bn deal that would allow the US pharmaceutical giant to settle more than 95% of lawsuits over its anti-inflammatory Vioxx. Click here for more info http://www.vioxxadvisor.com/4106.html In a surprise move, Merck & Co. Inc. agreed to pay up to $4.85 billion to settle more than 26,000 federal and state lawsuits involving its pain-reliever Vioxx. The settlement was far below initial projections of what litigation related to the 2004 withdrawal of Vioxx would ultimately cost the drug ... http://www.vioxxadvisor.com/4104.html TRENTON, N.J. - Merck & Co. said yesterday it will pay $4.85 billion to end thousands of state and federal lawsuits over its painkiller Vioxx in one of the largest drug settlements ever. Click here for more info http://www.vioxxadvisor.com/4105.html Three years after withdrawing its blockbuster painkiller Vioxx from the market and vowing to fight every lawsuit claiming users got heart attacks and strokes, Merck & Co. agreed to pay $4.85 billion to settle some 60,000 cases. Click here for more info http://www.vioxxadvisor.com/4103.html In a dramatic stroke, Merck & Co. Inc. yesterday agreed to pay up to $4.85 billion to settle more than 26,000 lawsuits involving the company's discontinued pain reliever Vioxx. The settlement was far below initial projections of what the company would pay after it pulled the drug off the market ... http://www.vioxxadvisor.com/4101.html The lawyer for 15 New Zealanders seeking to sue US drugs giant Merck & Co over its faulty painkiller Vioxx will not benefit from the $6. Click here for more info http://www.vioxxadvisor.com/4102.html Merck said on Friday it had reached a US$4.85 billion deal that would allow the US pharmaceutical giant to settle more than 95 percent of lawsuits over its anti-inflammatory Vioxx. More... http://www.vioxxadvisor.com/4100.html Deal's 'reasonable' cost means company's risky strategy may pay off 47,000 plaintiff groups - 26,600 lawsuits - $4.85 billion settlement reached In the darkest moments of Merck & Co.'s legal nightmare over its painkiller Vioxx, the drugmaker was staring down thousands of personal injury claims that could have ... http://www.vioxxadvisor.com/4099.html Three years after withdrawing its blockbuster painkiller Vioxx from the market and vowing to fight every lawsuit claiming users got heart attacks and strokes, Merck & Co. agreed to pay $4.85 billion to settle some 60,000 cases. Read more here http://www.vioxxadvisor.com/4098.html A glance at the $4.85 billion settlement Merck & Co. made with Vioxx users: Link to original article http://www.vioxxadvisor.com/4097.html After 10 hospitalizations and a triple-bypass since his heart attack in 2000, lawyer Gilbert Tietz is confident he 'll get a share of Merck & Co.'s $4.85 billion settlement with thousands of Vioxx users. More... http://www.vioxxadvisor.com/4096.html While Friday?s settlement of Vioxx lawsuits at $4.85 billion seems steep, two years ago, some analysts estimated that it would cost Merck as much as $25 billion. More... http://www.vioxxadvisor.com/4095.html FRIDAY, Nov. 9 (HealthDay News) -- With Friday's announcement of almost $5 billion to be paid out to those people claiming they were hurt by the now-withdrawn painkiller Vioxx, the drug's maker, Merck & Co., may have hoped to end the glare of publicity on these types of drugs. Link ... http://www.vioxxadvisor.com/4094.html After 10 hospitalizations and a triple-bypass since his heart attack in 2000, lawyer Gilbert Tietz is confident he 'll get a share of Merck & Co.'s $4.85 billion settlement with thousands of Vioxx users. Link to original article http://www.vioxxadvisor.com/4093.html Shares of pharmaceutical rise after announcing a $4.85 billion to settle Vioxx claims. Read more here http://www.vioxxadvisor.com/4092.html The maker of Vioxx agrees to pay $4.85bn to settle claims the drug caused strokes and heart failure in many users. Link to original article http://www.vioxxadvisor.com/4088.html CHANGE OF COURSE: Reversing a vow to fight thousands of lawsuits individually, Merck & Co. will pay $4.85 billion to tens of thousands of Vioxx users who can show proof they suffered a heart attack or stroke. More... http://www.vioxxadvisor.com/4089.html Shares of pharmaceutical rise after announcing a $4.85 billion to settle Vioxx claims. Click here for more info http://www.vioxxadvisor.com/4090.html Merck announced Friday it had reached a 4.85-billion-dollar deal that would allow the US pharmaceutical to settle more than 95 percent of lawsuits over its anti-inflammatory Vioxx. More... http://www.vioxxadvisor.com/4091.html BOSTON (MarketWatch) --- Drug stocks moved lower in early action Friday as shares of Merck & Co. jumped on news that it plans to settle about 85% of the outstanding lawsuits filed against it by users of its recalled drug Vioxx. ... http://www.vioxxadvisor.com/4087.html The maker of the painkiller Vioxx has agreed to pay $4.85 billion to settle thousands of lawsuits in one of the largest civil cases ever, according to published reports Friday. The drugmaker faced about 26,600 lawsuits representing 47,000 plaintiffs, and about 265 potential class action cases filed by people or ... http://www.vioxxadvisor.com/4086.html The maker of the painkiller Vioxx has agreed to pay $4.85 billion to settle thousands of lawsuits in one of the largest civil cases ever, according to published reports Friday. Link to original article http://www.vioxxadvisor.com/4085.html Drug maker Merck will pay $4.85 billion to settle thousands of Vioxx lawsuits in one of the largest civil cases ever, the company said Friday. Link to original article http://www.vioxxadvisor.com/4082.html Merck & Co. said Friday it will pay $4.85 billion to end thousands of lawsuits over its painkiller Vioxx in what is believed to be the largest drug settlement ever. Link to original article http://www.vioxxadvisor.com/4083.html The maker of the painkiller Vioxx has agreed to pay $4.85 billion to settle thousands of lawsuits in one of the largest civil cases ever, according to published reports Friday. Link to original article http://www.vioxxadvisor.com/4084.html Merck, the third-largest U.S. drugmaker, may pay about $5 billion to settle claims that it hid the health risks of its Vioxx painkiller Click here for more info http://www.vioxxadvisor.com/4081.html Merck & Co is expected to announce a deal to pay $4.85 billion to settle a significant portion of claims over injuries allegedly linked to its Vioxx painkiller, the Wall Street Journal said on Friday, citing a person familiar with the matter. More... http://www.vioxxadvisor.com/4080.html Merck has agreed to pay $4.85 billion to settle up to 27,000 claims over injuries linked to its Vioxx painkiller, according to published reports. More... http://www.vioxxadvisor.com/4079.html The company will spend nearly $5 billion. More... http://www.vioxxadvisor.com/4078.html A federal judge in New Orleans is scheduled to announce Friday morning that the maker of Vioxx, a popular painkiller withdrawn from the market in 2004, has settled a class-action lawsuit with plaintiffs nationwide for $5 billion -- the third-highest litigation award in U.S. history, a source close to the ... http://www.vioxxadvisor.com/4076.html LONDON (Thomson Financial) - Merck & Co agreed to pay about 4.85 bln usd to settle a large portion of the claims over injuries allegedly linked to its Vioxx painkiller, after insisting for years that it would fight all 27,000 cases filed rather than compromise, the Wall Street Journal reported. ... http://www.vioxxadvisor.com/4077.html Merck has agreed to settle 45,000 lawsuits by people who claim they or their family members suffered injury or died after taking the pain medication. More... http://www.vioxxadvisor.com/4075.html Nov. 9 (Bloomberg) -- Merck & Co., after setting aside nothing to resolve liability over its Vioxx painkiller, may pay about $5 billion to settle claims that it hid the health risks of its withdrawn drug, three lawyers with direct knowledge of the accord said. Read more here http://www.vioxxadvisor.com/4074.html SAN FRANCISCO (MarketWatch) -- Merck & Co. is expected to announce Friday that it will settle all claims relating to its withdrawn Vioxx pain killer for about $4.85 billion, according to a media report. ... http://www.vioxxadvisor.com/4073.html THURSDAY, Nov. 8 (HealthDay News) -- Pulling the painkillers Vioxx and Bextra off the market to spare patients' hearts may have ended up harming their stomachs, a new study suggests. Click here for more info http://www.vioxxadvisor.com/4072.html A man who risked his reputation to alert the public to the dangers of drugs he believes to be unsafe the painkillers Vioxx and Celebrex, the diabetes drug Avandia now finds himself defending a class of drugs whose leading candidate proved to be a killer. Click here for more info ... http://www.vioxxadvisor.com/4071.html Painful recovery After Merck recalled Vioxx, a painkiller linked to heart attacks and deaths, in September 2004, it took more than two years Click here for more info http://www.vioxxadvisor.com/4070.html New Jersey justices are mulling a case that will decide whether Merck must pay a projected $35 million tab for medical monitoring of people who may have had "silent heart attacks" from using Vioxx. The putative class action was filed on behalf of about 233,000 people who took the painkiller ... http://www.vioxxadvisor.com/4069.html The pre-VIOXX Merck is back, double-digit sales growth shows. More... http://www.vioxxadvisor.com/4068.html Merck & Co. Inc. is coming back. Two years ago, the company was reeling from its failed pain reliever, Vioxx, and from the impending loss of one of its most profitable drugs. Analysts were openly skeptical about the company's prospects. Read more here http://www.vioxxadvisor.com/4067.html TRENTON (AP) -- Merck & Co. should pay for one-time medical tests of people who might unknowingly have suffered heart damage by taking the drugmaker's since-withdrawn painkiller Vioxx, lawyers argued before New Jersey's top court on Monday. Read more here http://www.vioxxadvisor.com/4066.html Some of the 20 million people who took the withdrawn arthritis treatment Vioxx deserve a medical exam to find out if it caused a "silent heart attack." And Merck, the company that made the drug, should pay for it, lawyers argued before the state's highest court yesterday. Click here for ... http://www.vioxxadvisor.com/4065.html BOSTON (Dow Jones) -- Merck & Co. reported substantially higher third-quarter earnings early Monday, due largely to strong sales and a hefty charge taken during last year's quarter related to its ongoing Vioxx litigation. Link to original article http://www.vioxxadvisor.com/4064.html Merck & Co. should pay for one-time medical tests of people who might unknowingly have suffered heart damage by taking the drugmaker's since-withdrawn painkiller Vioxx, lawyers argued before New Jersey's top court today. Click here for more info http://www.vioxxadvisor.com/4063.html Erie County has filed a lawsuit against Merck & Co., the maker of the prescription drug, Vioxx, alleging the pharmaceutical maker defrauded the Medicaid program of an estimated $6 million dollars. (MRK) Link to original article http://www.vioxxadvisor.com/4062.html BOSTON (MarketWatch) -- Merck & Co. reported substantially higher third-quarter earnings early Monday, due largely to strong sales and a hefty charge taken during last year's quarter related to its ongoing Vioxx litigation. ... http://www.vioxxadvisor.com/4061.html The state Supreme Court hears arguments today about whether people who took Vioxx can file a class-action lawsuit to get Merck to pay for medical monitoring. More... http://www.vioxxadvisor.com/4060.html TRENTON, N.J. - The state Supreme Court hears arguments Monday about whether people who took Vioxx can file a class-action lawsuit to get Merck to pay for medical monitoring. Read more here http://www.vioxxadvisor.com/4059.html About 20 million people across the nation took the arthritis treatment Vioxx before it was pulled from shelves three years ago because of health risks. Link to original article http://www.vioxxadvisor.com/4058.html Erie County on Thursday filed a lawsuit against Merck & Co., the maker of Vioxx, for allegedly misrepresenting the safety of the drug. Click here for more info http://www.vioxxadvisor.com/4057.html WHITEHOUSE STATION (AP) -- Drug maker Merck & Co. Inc. said Friday the jury in a Florida liability case involving its painkiller Vioxx decided in the company's favor. Link to original article http://www.vioxxadvisor.com/4056.html Drug maker Merck & Co. Inc. said Friday the jury in a Florida liability case involving its painkiller Vioxx decided in the company's favor. The company said the jury found it was not liable for pla Link to original article http://www.vioxxadvisor.com/4055.html WHITEHOUSE STATION, N.J. - Drug maker Merck & Co. Inc. said Friday the jury in a Florida liability case involving its painkiller Vioxx decided in the company's favor. More... http://www.vioxxadvisor.com/4054.html This letter is to warn the public on the dangers of the pharmaceutical industry. Just because the FDA approves a drug/vaccine doesn’t mean it’s safe. The drug company Merck and its drug Vioxx that killed 60,000 before being taken off of the market. Click here for more info http://www.vioxxadvisor.com/4053.html Drug maker Merck & Co. Inc. said Friday the jury in a Florida liability case involving its painkiller Vioxx decided in the company’s favor. The company said the jury found it was not liable for plaintiff Refik Kozic’s heart attack. Kozic alleged that he used Vioxx for about nine weeks ... http://www.vioxxadvisor.com/4052.html Drug maker Merck & Co. Inc. said today the jury in a Florida liability case involving its painkiller Vioxx decided in the company's favor. Read more here http://www.vioxxadvisor.com/4051.html BOSTON (MarketWatch) -- Merck & Co. said Friday that it has won a product liability case brought against it in the state of Florida by a former Vioxx user who claimed he suffered a heart attack after taking the recalled pain reliever for nine weeks. ... http://www.vioxxadvisor.com/4050.html Drug maker Merck & Co. Inc. said Friday the jury in a Florida liability case involving its painkiller Vioxx decided in the company's favor. Read more here http://www.vioxxadvisor.com/4049.html A Florida jury on Friday found Merck & Co's withdrawn painkiller Vioxx did not cause a former professional soccer player's heart attack and that the company did not conceal safety risks associated with the medicine. Click here for more info http://www.vioxxadvisor.com/4048.html After three years, lawsuits drag on. Link to original article http://www.vioxxadvisor.com/4047.html Trenton, N.J. -- Three years after Merck & Co. pulled its blockbuster painkiller Vioxx from the market due to increased heart attack and stroke risk, there's no end in sight for the massive litigation it ignited. Read more here http://www.vioxxadvisor.com/4046.html TRENTON -- Three years after Merck & Co. pulled its blockbuster painkiller Vioxx from the market due to increased heart attack and stroke risk, there's no end in sight for the massive litigation it ignited. Link to original article http://www.vioxxadvisor.com/4044.html Drug giant has little time to savor legal victories Three years after Merck & Co. pulled its blockbuster painkiller Vioxx from the market due to increased heart attack and stroke risk, there's no end in sight for the massive litigation it ignited. ... http://www.vioxxadvisor.com/4045.html TRENTON, N.J. - Three years after Merck & Co. pulled its blockbuster painkiller Vioxx from the market due to increased heart attack and stroke risk, there's no end in sight for the massive litigation it ignited. Link to original article http://www.vioxxadvisor.com/4043.html Three years after Merck & Co. pulled its blockbuster painkiller Vioxx from the market due to increased heart attack and stroke risk, there's no end in sight for the massive litigation it ignited. Shortly after Vioxx was withdrawn Sept. 30, 2004, stock analysts said Merck's liability could reach $50 billion, ... http://www.vioxxadvisor.com/4041.html Three years after Merck & Co. pulled its blockbuster painkiller Vioxx from the market due to increased heart attack and stroke risk, there's no end in sight for the massive litigation it ignited. More... http://www.vioxxadvisor.com/4042.html Inside | 3D Some Avon reps growing mustaches Growing number of beauty company's sales representatives are men. Inside | 3D Vioxx anniversary Three years later, there's no end in sight for the massive litigation it ignited. Coming Sunday Adjustments ... http://www.vioxxadvisor.com/4040.html TRENTON, N.J. — Three years after Merck & Co. pulled its blockbuster painkiller Vioxx from the market because of increased heart attack and stroke risk, there's no end in sight for the massive litigation it ignited More... http://www.vioxxadvisor.com/4039.html Three years after Merck & Co. pulled the painkiller Vioxx from the market, there's no end in sight for the massive litigation it ignited. Click here for more info http://www.vioxxadvisor.com/4038.html Shortly after Vioxx was withdrawn on Sept. 30, 2004, stock analysts said Merck's liability could reach US$50 billion, and doomsayers predicted Merck's demise. Read more here http://www.vioxxadvisor.com/4037.html TRENTON, N.J. -- Three years after Merck and Co. pulled its blockbuster painkiller Vioxx from the market due to increased heart attack and stroke risk, there's no end in sight for the Read more here http://www.vioxxadvisor.com/4035.html Three years after Merck & Co. pulled its blockbuster painkiller Vioxx from the market due to increased heart atttack and stroke risk, there's no end in sight for the massive litigation it ignited. Link to original article http://www.vioxxadvisor.com/4036.html WASHINGTON (AP) - The Food and Drug Administration on Thursday gained broad new powers to ensure the safety of prescription drugs used by millions of Americans under a bill President Bush signed into law. More... http://www.vioxxadvisor.com/4034.html Measure increases government's power over drugs, drug makers President Bush signed into law today sweeping new measures for protecting Americans from unsafe drugs, a concern since Vioxx sales were halted in 2004 after reports of deaths and other serious side effects. More... http://www.vioxxadvisor.com/4033.html Mark Robinson's cases read like the inventory of a medical clinic: Baycol, fen-phen, Rezulin, Vioxx, Propulsid, Bextra, Celebrex and Zyprexa. In almost every case, Robinson, founder of Robinson, Calcagnie & Robinson in Newport Beach, Calif., has served as lead or liaison counsel for plaintiffs lawyers in California. But the 15-lawyer ... http://www.vioxxadvisor.com/4032.html In my last column , I wrote about the case of International Union of Operating Engineers Local No. 68 v. Merck Co. Inc. A lower New Jersey court had previously certified the case, which centers on the drug Vioxx, as a nationwide class action. Click here for more info http://www.vioxxadvisor.com/4031.html You wouldn't know it from the lack of press, but a major coda to the Vioxx scandal is about to happen. More... http://www.vioxxadvisor.com/4030.html FDA gets sweeping powers to better protect consumers Congress overhauled the government's drug-safety system yesterday, giving the Food and Drug Administration sweeping new powers in a bid to better protect patients from harm caused by drugs such as the painkiller Vioxx. Read more here http://www.vioxxadvisor.com/4029.html Congress sent President Bush legislation Thursday giving the Food and Drug Administration new powers to ensure the safety of prescription drugs. The Senate passed the FDA bill by voice vote Thursday, a day after the House approved it by an overwhelming margin. Bush is expected to sign the bill. ... http://www.vioxxadvisor.com/4028.html WASHINGTON - The Food and Drug Administration would gain new authority to ensure the safety of prescription drugs, including the power to mandate label changes that warn of newly emerging risks, under a bill passed Wednesday by the House. Link to original article http://www.vioxxadvisor.com/4027.html GIVEN THAT New Jersey's highest court has been accused of reflexive liberalism, one of its decisions this month was bound to turn some heads. It denied nationwide class-action status for plaintiffs suing Merck & Co. over marketing of the since withdrawn painkiller Vioxx. More... http://www.vioxxadvisor.com/4026.html The state and city have sued Merck & Co. Inc., joining thousands of others who say the drug maker cheated government insurance programs by hiding the dangers of heart problems associated with its pain medication Vioxx. Read more here http://www.vioxxadvisor.com/4025.html (New York, NY) -- New York Attorney General Andrew Cuomo and Mayor Michael Bloomberg have filed a joint lawsuit against the maker of Vioxx for allegedly "misrepresenting the dangers" the drug posed to its users. More... http://www.vioxxadvisor.com/4024.html The state and city sued the drugmaker Merck yesterday, accusing it of defrauding Medicaid and other government insurance programs by hiding the degree to which its pain medication Vioxx was linked to heart problems. The state Supreme Court suit Click here for more info http://www.vioxxadvisor.com/4023.html NEW YORK, September 18 (newratings.com) – New York State and New York City have together filed a suit against Merck & Co Inc ( MRK.NYS ) alleging that the company had intentionally concealed the risks of withdrawn painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/4022.html The state and city sued Merck, accusing the drugmaker of defrauding Medicaid and other government insurance programs by hiding the risks of heart problems associated with its pain medication Vioxx. More... http://www.vioxxadvisor.com/4021.html The state and city have sued Merck & Co. Inc., joining thousands of others who say the drug maker cheated government insurance programs by hiding the dangers of heart problems associated with its pain medication Vioxx. More... http://www.vioxxadvisor.com/4020.html Attorney General Cuomo and Mayor Bloomberg filed a joint lawsuit yesterday against the maker of the painkiller Vioxx for allegedly withholding information about cardiovascular risks associated with the drug. The civil suit, filed in state Supreme Court in Manhattan, accuses Merck & Co. Inc. of deliberately misrepresenting Vioxx, which Merck ... http://www.vioxxadvisor.com/4019.html The state and city sued Merck & Co. Inc. on Monday, accusing the drugmaker of defrauding Medicaid and other government insurance programs by hiding the risks of heart problems associated with its pain medication Vioxx. Link to original article http://www.vioxxadvisor.com/4018.html The state and city sued Merck & Co. Inc. today, accusing the drugmaker of defrauding Medicaid and other government insurance programs by hiding the risks of heart problems associated with its pain medication Vioxx. Link to original article http://www.vioxxadvisor.com/4017.html NEW YORK—New York State Attorney General Andrew M. Cuomo and New York City Mayor Michael Bloomberg filed a joint lawsuit Monday against Vioxx maker Merck & Co. Link to original article http://www.vioxxadvisor.com/4016.html The suit accuses Merck of deliberately concealing information about the seriousness of cardiovascular risks associated with its Vioxx painkiller. Link to original article http://www.vioxxadvisor.com/4015.html State Attorney General Andrew Cuomo announced a lawsuit filed jointly with New York City Mayor Michael Bloomberg Monday against the makers of the drug Vioxx. (MRK) Read more here http://www.vioxxadvisor.com/4014.html The state and city sued Merck & Co. Inc. on Monday, accusing the drugmaker of defrauding Medicaid and other government insurance programs by hiding the risks of heart problems associated with its pain medication Vioxx. Read more here http://www.vioxxadvisor.com/4012.html State Attorney General Andrew Cuomo announced a lawsuit filed jointly with New York City Mayor Michael Bloomberg Monday against the maker of the drug Vioxx. (MRK) Click here for more info http://www.vioxxadvisor.com/4013.html NEW YORK (Reuters) - New York State Attorney General Andrew Cuomo and New York City Mayor Michael Bloomberg on Monday filed suit against Merck & Co. Inc., claiming the drugmaker concealed the withdrawn arthritis treatment's risks, the Attorney General's office said. More... http://www.vioxxadvisor.com/4011.html Spurred by the Vioxx fiasco, CEO Clark is trying to revamp the drug giant's culture More... http://www.vioxxadvisor.com/4010.html Last week, the Supreme Court of New Jersey handed Merck, the giant pharmaceutical company, some good news: It reversed the certification of a class action against Merck, brought on behalf of unions and health plans that had bought Vioxx for their members. More... http://www.vioxxadvisor.com/4009.html Merck & Co., Inc. is pleased that the New Jersey Supreme Court reversed a lower court ruling that granted nationwide class-action status to insurance companies and HMOs seeking reimbursement for Vioxx expenditures. Merck had opposed class-action status in the case. Read more here http://www.vioxxadvisor.com/4008.html New Jersey's Supreme Court has rejected a class-action lawsuit against Merck & Co. over its withdrawn painkiller Vioxx. The ruling is a huge legal victory for the drugmaker, which faces nearly 27,0 Link to original article http://www.vioxxadvisor.com/4007.html New Jersey Supreme Court rules against the possibility of a national class action Vioxx lawsuit. More... http://www.vioxxadvisor.com/4006.html Merck won a crucial legal victory on Thursday and removed a cloud that had been hanging over the US drugmaker and its investors over the withdrawn painkiller Vioxx. More... http://www.vioxxadvisor.com/4005.html NEW YORK, September 7 (newratings.com) – New Jersey’s Supreme Court Thursday rejected a class action suit against Merck Co Inc ( MRK.NYS ) over the company’s recalled drug, Vioxx. Link to original article http://www.vioxxadvisor.com/4004.html In a victory for drugmaker Merck, the New Jersey Supreme Court yesterday turned back a massive class-action case over the once-popular arthritis treatment Vioxx. Link to original article http://www.vioxxadvisor.com/4003.html TRENTON, N.J.–New Jersey's Supreme Court yesterday rejected a class-action lawsuit against Merck & Co. over its withdrawn painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/4001.html In a major legal victory for Merck & Co. in its massive Vioxx litigation, New Jersey's Supreme Court on Thursday rejected a potential class-action lawsuit that could have cost the drug maker up to $18 billion. Link to original article http://www.vioxxadvisor.com/4002.html Unions and health insurers cannot pursue a nationwide class action consumer fraud case for millions of dollars spent on the painkiller Vioxx, the New Jersey Supreme Court says. The justices on Thursday reversed lower court rulings that certified the suit by third-party payors against Merck & Co. The plaintiff, a ... http://www.vioxxadvisor.com/4000.html TRENTON, N.J. — In a major legal victory for Merck & Co. in its massive Vioxx litigation, New Jersey’s Supreme Court yesterday rejected a potential class-action lawsuit that could have cost the drugmaker up to $18 billion. Read more here http://www.vioxxadvisor.com/3999.html Key events in the saga of Vioxx, once a blockbuster painkiller and now the subject of nearly 27,000 lawsuits: Read more here http://www.vioxxadvisor.com/3998.html THE RULING: New Jersey's Supreme Court rejected a potential class-action lawsuit brought on behalf of health insurance plans that paid for Vioxx, the blockbuster painkiller withdrawn from the market in 2004 because of cardiovascular risks. Click here for more info http://www.vioxxadvisor.com/3997.html BOSTON (MarketWatch) -- The New Jersey Supreme Court has ruled that lawsuits filed by health management organizations and insurers over Merck & Co.'s recalled drug Vioxx can't be consolidated into a class action suit, the drugmaker said Thursday. ... http://www.vioxxadvisor.com/3996.html Sept. 6 (Bloomberg) -- Merck & Co. doesn't have to defend a national class-action lawsuit seeking as much as $9 billion over claims it misled health insurers about the safety of its painkiller Vioxx, the New Jersey Supreme Court ruled. Click here for more info http://www.vioxxadvisor.com/3995.html Merck & Co Inc said on Thursday the New Jersey Supreme Court has reversed a lower court ruling that granted nationwide class-action status to insurers seeking reimbursement for past spending on Vioxx, the drugmaker's withdrawn arthritis treatment. Click here for more info http://www.vioxxadvisor.com/3994.html TRENTON, N.J. - New Jersey's Supreme Court today rejected a class-action lawsuit against Merck & Co. over its withdrawn painkiller Vioxx. The ruling is a huge legal victory for the drugmaker, which faces nearly 27,000 individual lawsuits from people claiming Vioxx harmed them. Click here for more info http://www.vioxxadvisor.com/3993.html Arcoxia, a painkiller proposed as a successor to Vioxx, should not be approved, a panel of federal health advisers recommended. Link to original article http://www.vioxxadvisor.com/3992.html New Jersey's Supreme Court on Thursday rejected a class-action lawsuit against Merck & Co. over its withdrawn painkiller Vioxx. The ruling is a huge legal victory for the drugmaker, which faces nearly 27,000 individual lawsuits from people claiming ... http://www.vioxxadvisor.com/3991.html New Jersey's Supreme Court rejected a huge class-action lawsuit against drugmaker Merck & Co. over its withdrawn painkiller Vioxx, reversing two previous lower-court decisions. The suit could have been worth as much as $15 billion. More... http://www.vioxxadvisor.com/3990.html A huge legal victory for Whitehouse Station-based Merck. New Jersey's Supreme Court has rejected a potential class-action lawsuit over Merck's withdrawn painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/3989.html New Jersey's Supreme Court has rejected a huge class-action lawsuit against drugmaker Merck & Co. over its withdrawn painkiller Vioxx. More... http://www.vioxxadvisor.com/3987.html http://www.vioxxadvisor.com/3988.html Dayton, Ohio — Vioxx is the most notorious of medications that turned out to be dangerous after widespread use by people who didn't need them. Link to original article http://www.vioxxadvisor.com/3986.html Vioxx and related pain medications were taken off the market in 2004 because they caused dangerous heart problems in some people. A group of scientists, led by Timothy Hla at the University of Connecticut, may now have figured out how these drugs trigger these life-threatening side-effects. The new study is ... http://www.vioxxadvisor.com/3985.html Merck has enjoyed a strong comeback since the messy Vioxx blowout nearly three years ago. But you might be surprised by how well Merck has done since it pulled its arthritis drug from the market. Link to original article http://www.vioxxadvisor.com/3984.html The pharmaceutical industry has garnered more than its fair share of media attention following headlines exposing the recent Vioxx drug recall, elderly American patients purchasing drugs from Canada, accusations of drug manufacturers price gouging in the face of the AIDS epidemic and Fen-Phen anti-obesity drug lawsuits. Read more here http://www.vioxxadvisor.com/3983.html Vioxx and related pain medications were taken off the market in 2004 because they caused dangerous heart problems in some people. Link to original article http://www.vioxxadvisor.com/3982.html Researchers believe they have zeroed in on what caused the drug Vioxx to boost a users heart risks. Read more here http://www.vioxxadvisor.com/3981.html Vioxx and related pain medications were taken off the market in 2004 because they caused dangerous heart problems in some people. Scientists may now have figured out how these drugs trigger these life-threatening side-effects. Click here for more info http://www.vioxxadvisor.com/3979.html MONDAY, Aug. 27 (HealthDay News) -- Researchers believe they've zeroed in on what caused Vioxx to boost users' heart risks. Link to original article http://www.vioxxadvisor.com/3980.html Vioxx and related pain medications were taken off the market in 2004 because they caused dangerous heart problems in some people. A group of scientists, led by Timothy Hla at the University of Connecticut, may now have figured out how these drugs trigger these life-threatening side-effects. Read more here http://www.vioxxadvisor.com/3978.html TRENTON -- Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. More... http://www.vioxxadvisor.com/3977.html A widely used diabetes pill raises the risk of heart attack and possibly death, according to findings by Cleveland Clinic analysts. Some experts said the analysis exposes another Vioxx-like example of the government failing to protect the public from an unsafe drug. Click here for more info http://www.vioxxadvisor.com/3976.html TRENTON, N.J. (AP) — Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Click here for more info http://www.vioxxadvisor.com/3975.html Lawsuits over Merck's pain- relief drug Vioxx could end up consuming state Superior Court in Atlantic City early next year. In an effort to move the sheer volume of lawsuits, Judge Carol Higbee is proposing four simultaneous trials at the courthouse. More... http://www.vioxxadvisor.com/3974.html FDA in recent months has rejected a "slew" of new drug applications or delayed approval of experimental medications and required more data, as the agency faces increasing concern over drug safety since the painkiller Vioxx was pulled from the market in 2004, the AP/Baltimore Sun reports. [click link for full ... http://www.vioxxadvisor.com/3973.html Merck's challenges to every lawsuit over its painkiller Vioxx have resulted in its winning most of the cases that reach a jury. Read more here http://www.vioxxadvisor.com/3972.html Lawsuits related to the painkiller Vioxx have little prospect of resolution for the thousands who have sued the drug company Merck, it was reported.An estimated 45,000 people have sued Merck, contending the drug caused heart attacks and strokes. Merck has spent more than $1 billion on legal fees during the ... http://www.vioxxadvisor.com/3971.html Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Click here for more info http://www.vioxxadvisor.com/3970.html None of the 45,000 people who have sued Merck over its painkiller Vioxx have received payment. More... http://www.vioxxadvisor.com/3969.html TRENTON, N.J. | Under scrutiny since the painkiller Vioxx was pulled from the market, the FDA has rejected numerous experimental drugs or delayed their approval and required more data. Read more here http://www.vioxxadvisor.com/3968.html TRENTON, N.J. — Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Read more here http://www.vioxxadvisor.com/3967.html By LINDA A. JOHNSON Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market in 2004, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. The impact Besides ... http://www.vioxxadvisor.com/3966.html TRENTON, N.J. - Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a host of experimental drugs or delayed their approval and required more data. Read more here http://www.vioxxadvisor.com/3965.html Drug approval slowed since Vioxx was pulled from the market. Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. More... ... http://www.vioxxadvisor.com/3964.html Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Besides keeping drugs some patients might desperately need off the market, the rejections have ... http://www.vioxxadvisor.com/3962.html TRENTON, N.J. - Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market in 2004, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Link to original article http://www.vioxxadvisor.com/3963.html Under growing scrutiny since Vioxx was pulled from the market, the FDA in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. More... http://www.vioxxadvisor.com/3961.html TRENTON, N.J. - Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration (FDA) in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Besides keeping drugs some patients might desperately need off the ... http://www.vioxxadvisor.com/3960.html FDA CRACKDOWN Under growing scrutiny since Vioxx was pulled from the market, the FDA in recent months has rejected a slew of experimental drugs or delayed their approval. FTC TRIES TO BLOCK SALE Federal regulators appealed a court ruling that allowed Whole Foods Market Inc. to buy ... http://www.vioxxadvisor.com/3959.html TRENTON, N.J. -- Under scrutiny since the painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Besides keeping drugs some patients might desperately need off the market, the rejections ... http://www.vioxxadvisor.com/3958.html FDA is rejecting more new drugs Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Click here for more info http://www.vioxxadvisor.com/3957.html Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Click here for more info http://www.vioxxadvisor.com/3955.html FDA is rejecting more new drugs Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Click here for more info http://www.vioxxadvisor.com/3956.html TRENTON, N.J. (AP) - Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the U.S. Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Click here for more info http://www.vioxxadvisor.com/3954.html Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Besides keeping drugs some patients might desperately need off the market, the rejections have ... http://www.vioxxadvisor.com/3953.html Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Click here for more info http://www.vioxxadvisor.com/3952.html Australia has cancelled the registration of Novartis' Prexige, a painkiller in the same group as Vioxx, after receiving reports of serious liver damage. More... http://www.vioxxadvisor.com/3951.html A New Jersey judge has upheld a $13.5 million verdict against drugmaker Merck & Co., won by a couple who sued over injuries the man sustained after he took the company's Vioxx painkiller. Read more here http://www.vioxxadvisor.com/3950.html Vioxx ruling A New Jersey judge upheld a $13.5 million verdict against drug maker Merck, won by a couple who sued over injuries the man sus tained after he took the company's Vioxx pain killer. The ruling denied Merck's request for a new trial or a Click here for ... http://www.vioxxadvisor.com/3949.html On July 31, 2007, the Appellate Division of the New Jersey Superior Court affirmed the forum non conveniens dismissal of pharmaceutical product liability claims filed by 95 U.K. plaintiffs in In re Vioxx Litigation , Docket No. A-1731-06T1. Link to original article http://www.vioxxadvisor.com/3948.html Nearly three years after Merck pulled Vioxx off the market because of alarming safety data, patients continue to write letters and send e-mails urging the drugmaker's executives to reconsider their decision. Link to original article http://www.vioxxadvisor.com/3947.html Merck's Vioxx caseload just got a little smaller. Read more here http://www.vioxxadvisor.com/3946.html (MRK 50.93 +1.28). The stock is higher following a court ruling that states English and Welsh patients cannot sue Merck for vioxx-related health problems. Link to original article http://www.vioxxadvisor.com/3945.html The withdrawal of Vioxx signaled a sea change. Welcome to the Culture of Drug Safety. Click here for more info http://www.vioxxadvisor.com/3944.html A New Jersey appeals panel has handed Merck & Co. a victory in mass litigation over its painkiller Vioxx by barring 98 English and Welsh users of the drug from suing in the state's courts. The plaintiffs wanted to take advantage of New Jersey's plaintiff-friendly laws and fee-switching rules that ... http://www.vioxxadvisor.com/3943.html An appellate court in the United States has upheld a ruling that 98 people from England and Wales cannot sue a painkiller manufacturer in the US. They wanted to sue Merck & Co in New Jersey for health claims arising from their use of painkiller Vioxx. Link to original article ... http://www.vioxxadvisor.com/3942.html A state appellate court on Tuesday ruled that 98 people from the England and Wales cannot sue Merck & Co. in New Jersey for health claims arising from their use of the once-popular painkiller Vioxx. Read more here http://www.vioxxadvisor.com/3941.html NEWARK -- A New Jersey appellate court on Tuesday ruled that 98 people from the England and Wales cannot sue Merck & Co. in New Jersey for health claims arising from their use of the once-popular painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/3940.html July 30 (Bloomberg) -- GlaxoSmithKline Plc's diabetes pill Avandia should be removed from the market because of heart risks, said the U.S. drug safety scientist who spurred the withdrawal of the painkiller Vioxx. More... http://www.vioxxadvisor.com/3939.html Next year's federal Vioxx trials may focus on people who had strokes after taking the once popular painkiller, the judge assigned to handle pretrial matters in all 8,575 federal lawsuits said last Fri More... http://www.vioxxadvisor.com/3938.html Next year's federal Vioxx trials may focus on people who had strokes after taking the once popular painkiller, the judge assigned to handle pretrial matters in all 8,575 federal lawsuits said Friday. Link to original article http://www.vioxxadvisor.com/3937.html Next year's federal Vioxx trials may focus on people who had strokes after taking the popular painkiller, the judge assigned to handle pretrial matters in all 8,575 federal lawsuits said Friday. Link to original article http://www.vioxxadvisor.com/3936.html A federal judge usurped a jury's job when he proposed a $1.6 million award to replace the $51 million judgment he had thrown out as excessive for a retired FBI agent who won a lawsuit claiming the painkiller Vioxx caused his heart attack, the manufacturer contends. Click here for more ... http://www.vioxxadvisor.com/3935.html Next year's federal Vioxx trials may focus on people who had strokes after taking the once popular painkiller, the judge assigned to handle pretrial matters in all 8,575 federal lawsuits said Friday. Link to original article http://www.vioxxadvisor.com/3934.html The maker of the painkiller Vioxx says a federal judge did a jury's job when he proposed a $1.6 million award to replace the $51 million judgment he said was excessive. More... http://www.vioxxadvisor.com/3933.html NEW ORLEANS Next year's federal Vioxx trials may focus on people who had strokes after taking the once popular painkiller, the judge assigned to handle pretrial matters in all 8,575 federal lawsuits said Friday. Read more here http://www.vioxxadvisor.com/3932.html Associated Press - July 27, 2007 12:34 PM ET NEW ORLEANS (AP) - Arguments on two questions in federal Vioxx cases may wait on testimony from two governors who have worked in or for the drug Read more here http://www.vioxxadvisor.com/3931.html NEW ORLEANS - A federal judge usurped a jury's job when he proposed a $1.6 million award to replace the $51 million judgment he had thrown out as excessive for a retired FBI agent who won a lawsuit claiming the painkiller Vioxx caused his heart attack, the manufacturer contends. Click ... http://www.vioxxadvisor.com/3930.html Associated Press - July 27, 2007 9:54 AM ET NEW ORLEANS (AP) - A drug manufacturer contends tat a federal judge usurped a jury's job when he proposed a $1.6 million award to replace the $51 Link to original article http://www.vioxxadvisor.com/3929.html Merck & Co. named top attorney Kenneth Frazier, who has directed the company's Vioxx defense strategy for the past three years, to lead worldwide marketing of its pharmaceutical and vaccine businesses. More... http://www.vioxxadvisor.com/3928.html TRENTON, N.J. - Merck & Co. has named its longtime general counsel, one of the architects of its strategy of fighting thousands of lawsuits over withdrawn painkiller Vioxx one by one, to head the drugmaker's global marketing and sales organizations. More... http://www.vioxxadvisor.com/3927.html http://www.vioxxadvisor.com/3926.html Associated Press - July 25, 2007 6:14 PM ET NEW ORLEANS (AP) - Governors Mitch Daniels of Indiana and Haley Barbour of Mississippi are being subpoenaed by lawyers for people who blame heart More... http://www.vioxxadvisor.com/3925.html Governors Mitch Daniels of Indiana and Haley Barbour of Mississippi are being subpoenaed by lawyers for people who blame heart attacks on the once-popular painkiller Vioxx. Read more here http://www.vioxxadvisor.com/3924.html Mississippi governor also faces questions about FDA consultations on labeling pain killer. Link to original article http://www.vioxxadvisor.com/3923.html Govs. Haley Barbour of Mississippi and Mitch Daniels of Indiana have been subpoenaed by lawyers for people who blame their heart attacks or those of family members on the once-popular painkiller Vioxx. More... http://www.vioxxadvisor.com/3919.html The heart problems associated with the painkiller Vioxx may increase soon after beginning treatment, finds a new study published in the New England Journal of Medicine. Read more here http://www.vioxxadvisor.com/3920.html Associated Press - July 25, 2007 6:14 PM ET NEW ORLEANS (AP) - Governors Haley Barbour of Mississippi and Mitch Daniels of Indiana are being subpoenaed by lawyers for people who blame their Link to original article http://www.vioxxadvisor.com/3921.html Study contradicts drugmaker's assertions, says heart risks associated with Merck's withdrawn arthritis medicine appeared before 18 months of use. Link to original article http://www.vioxxadvisor.com/3922.html NEW ORLEANS -- Govs. Haley Barbour of Mississippi and Mitch Daniels of Indiana have been subpoenaed by lawyers for people who blame their heart attacks or those of family members on the Link to original article http://www.vioxxadvisor.com/3916.html A study suggests the drug increases the risk of heart problems faster than the company says. ... http://www.vioxxadvisor.com/3917.html The increased heart risk from Vioxx, Merck & Co's withdrawn arthritis medicine, begins much earlier than after 18 months of use, according to a study that contradicts assertions by the drug maker and its scientists. Click here for more info http://www.vioxxadvisor.com/3918.html Readington-based Merck & Co., the third-largest U.S. drugmaker, said today it has set aside $810 million to cover costs stemming from lawsuits by customers claiming injuries from using the company's Vioxx painkiller. Click here for more info http://www.vioxxadvisor.com/3915.html However, it took another charge to cover costs of its massive Vioxx litigation. Whitehouse Station, N.J.-based Merck earned $1.68 billion, or 77 cents per share, compared with a net income of $1.5 billion, or 69 cents per share, during the same period a year prior. Link to original article http://www.vioxxadvisor.com/3914.html Much of Merck & Co.'s ( MRK ) success in fighting lawsuits related to Vioxx has centered around the argument that the drug posed cardiovascular risks only to those who took it for 18 months or longer. Click here for more info http://www.vioxxadvisor.com/3913.html Shareholders who saw billions wiped off the value of the drugmaker Merck when it withdrew its painkiller Vioxx in 2004 have been given new hope of compensation, following an appeal court ruling in New Jersey. Link to original article http://www.vioxxadvisor.com/3911.html Spurred by the Vioxx fiasco, CEO Clark is trying to revamp the drug giant's culture Click here for more info http://www.vioxxadvisor.com/3912.html A US court revives shareholder lawsuits against drugs giant Merck over the health risks of its painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/3910.html PHILADELPHIA (AP) - A federal appeals court in Philadelphia has revived a group of lawsuits from shareholders of Merck and Company. The lawsuits accuse officers and directors of violating their duties by concealing the health risks of the company's Vioxx painkiller. More... http://www.vioxxadvisor.com/3909.html A federal appeals court revived a group of shareholder lawsuits that accused Merck & Co. officers and directors of violating their duties by concealing the health risks of the company's Vioxx painkiller. More... http://www.vioxxadvisor.com/3908.html TRENTON -- A lawyer for Merck & Co. on Friday urged a New Jersey judge to slash a jury's $47.5 million award to an Idaho postal worker who successfully sued the drugmaker over a 2001 heart attack he blamed on Merck's since-withdrawn painkiller Vioxx. Read more here http://www.vioxxadvisor.com/3907.html Merck & Co. on Friday urged a New Jersey judge to slash a jury's $47.5 million award to an Idaho postal worker who successfully sued the drugmaker over a heart attack he blamed on Merck's since-withdrawn Vioxx painkiller. Link to original article http://www.vioxxadvisor.com/3906.html WASHINGTON (AP) -- Seeking to avoid another Vioxx debacle, the House voted overwhelmingly Wednesday to give federal health officials more money and power to police the safety of prescription drugs. Click here for more info http://www.vioxxadvisor.com/3905.html THURSDAY, July 12 (HealthDay News) -- Following recent drug-safety scandals, including the 2004 Vioxx withdrawal, the U.S. House of Representatives has voted in favor of giving health officials more resources to do their job. More... http://www.vioxxadvisor.com/3904.html The House of Representatives approved new Food and Drug Administration reforms Wednesday evening, calling on the agency to step up its monitoring of drug safety in the wake of problems with Vioxx and other drugs. Link to original article http://www.vioxxadvisor.com/3903.html WASHINGTON - Seeking to avoid another Vioxx debacle, the House voted overwhelmingly yesterday to give federal health officials more money and power to police the safety of prescription drugs. More... http://www.vioxxadvisor.com/3902.html Seeking to avoid another Vioxx debacle, the House voted overwhelmingly Wednesday to give federal health officials more money and power to police the Read more here http://www.vioxxadvisor.com/3901.html Seeking to avoid another Vioxx debacle, the House voted overwhelmingly Wednesday to give federal health officials more money and power to police the safety of prescription drugs. Link to original article http://www.vioxxadvisor.com/3900.html Congress is moving to give federal health officials more money to monitor prescription drug safety, part of an effort to avoid another Vioxx debacle. The House was expected to approve legislation Wednesday that would give the Food and Drug Administration nearly $400 million, collected as fees from the drug industry, ... http://www.vioxxadvisor.com/3899.html Consumers Union is urging the House of Representatives Wednesday to pass the first major prescription drug safety improvements in nearly half a century and work on sending a strong bill to the President to help prevent future Vioxx-type disasters. Link to original article http://www.vioxxadvisor.com/3898.html A personal injury/product liability case against Merck & Co. and a drugstore chain involving the company's painkiller Vioxx has been transferred to Sangamon County from Madison County. Click here for more info http://www.vioxxadvisor.com/3897.html NEW ORLEANS, July 3 -- The Food and Drug Administration's approval of warnings on a drug label doesn't clear the manufacturer of claims that the warnings were inadequate, a judge ruled Tuesday in a decision affecting thousands of federal lawsuits against Merck over the painkiller Vioxx. Click here for more ... http://www.vioxxadvisor.com/3896.html NEW ORLEANS: U.S. Food and Drug Administration approval of a drug label doesn't clear the manufacturer of claims that its warnings were inadequate, a judge ruled Tuesday in a decision potentially affecting thousands of federal suits against Merck & Co. for the painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/3895.html http://www.vioxxadvisor.com/3894.html The U.S. Food and Drug Administration approval of a drug label doesn't clear the manufacturer of claims that its warnings were inadequate, a judge ruled in a decision potentially affecting thousands of federal suits against Merck & Co. for the painkiller Vioxx. ... http://www.vioxxadvisor.com/3893.html NEW ORLEANS --Food and Drug Administration approval of warnings on a drug label doesn't clear the manufacturer of claims that the warnings were inadequate, a judge ruled in a decision affecting thousands of federal suits against Merck & Co. for the painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/3892.html U.S. Food and Drug Administration approval of warnings on a drug label doesn't clear the manufacturer of claims that the warnings were inadequate, a judge ruled in a decision affecting thousands of federal suits against Merck & Co. for the painkiller Vioxx. More... http://www.vioxxadvisor.com/3891.html U.S. Food and Drug Administration approval of a drug label doesn't clear the manufacturer of claims that its warnings were inadequate, a judge ruled in a decision potentially affecting thousands of federal suits against Merck & Co. for the painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/3890.html NEW YORK (Reuters)—A judge overseeing federal Vioxx litigation Tuesday rejected Merck & Co.'s bid to throw out two lawsuits against the drugmaker over its withdrawn painkiller. More... http://www.vioxxadvisor.com/3889.html A lawyer who represents Merck & Co. in its litigation over Vioxx said on Tuesday that an unpublished study that reportedly shows heart risks with the withdrawn painkiller in short-term use is not supported by other data. Link to original article http://www.vioxxadvisor.com/3888.html Heart risks associated with Merck & Co.'s painkiller Vioxx began much sooner than the company has claimed, The Wall Street Journal Online reported on Tuesday, citing a new study. Click here for more info http://www.vioxxadvisor.com/3887.html Results from an unpublished study suggest increased heart risks associated with Merck's Vioxx began immediately, and not after 18 months as the company has suggested -- a discovery which could bode ill for its ongoing litigation. Read more here http://www.vioxxadvisor.com/3886.html New versions of drugs like buffered aspirin and Vioxx could produce fewer harmful side effects thanks to research being done at Kansas State University's College of Veterinary Medicine.K-State researchers are examining how nonsteroidal anti-inflammatory drugs, or NSAIDs, damage the tissue that lines the gastrointestinal tract. [click link for full article] ... http://www.vioxxadvisor.com/3885.html New versions of drugs like buffered aspirin and Vioxx could produce fewer harmful side effects, say researchers at Kansas State University. Click here for more info http://www.vioxxadvisor.com/3884.html New versions of drugs like buffered aspirin and Vioxx could produce fewer harmful side effects thanks to research being done at Kansas State University's College of Veterinary Medicine. Read more here http://www.vioxxadvisor.com/3883.html New versions of drugs like buffered aspirin and Vioxx could be made to produce fewer harmful side effects according to scientists. Researchers are examining how nonsteroidal anti-inflammatory drugs, or NSAIDs, damage the tissue that lines the gastrointestinal tract. Link to original article http://www.vioxxadvisor.com/3882.html NEW ORLEANS -- A South Carolina man whose $51 million Vioxx damage award was overturned as excessive will accept the $1.6 million suggested by the trial judge rather than go to a second Read more here http://www.vioxxadvisor.com/3880.html MANHATTAN, KAN. -- New versions of drugs like buffered aspirin and Vioxx could produce fewer harmful side effects thanks to research being done at Kansas State University's College of Veterinary Medicine. More... http://www.vioxxadvisor.com/3881.html Lawyers who helped a heart attack victim win a $13.5 million jury verdict in a Vioxx liability case should be paid about $4 million in legal fees by Merck & Co., a New Jersey judge has ruled. Merc More... http://www.vioxxadvisor.com/3879.html Merck & Co. has been ordered to pay about $4 million in legal fees in the cases of retired Park Ridge insurance salesman John McDarby and another man, both of whom used the painkiller Vioxx and later suffered heart attacks. Click here for more info http://www.vioxxadvisor.com/3878.html Lawyers who helped a heart attack victim win a $13.5 million jury verdict in a Vioxx liability case should be paid about $4 million in legal fees by Merck & Co., a state judge has ruled. Link to original article http://www.vioxxadvisor.com/3877.html New Jersey Superior Court judge Carol E. Higbee has ordered pharmaceutical giant Merck & Co. to pay fees and costs to a group of attorneys who proved in court that Merck committed fraud by deceiving doctors about the cardiovascular risks of the popular painkiller VIOXX® and deliberately hiding information about ... http://www.vioxxadvisor.com/3876.html Almost two years after Hurricane Katrina, it's time for Louisiana residents who claim they had heart attacks or other cardiovascular problems because of the painkiller Vioxx to get their paperwork together, the judge ruled Friday. More... http://www.vioxxadvisor.com/3875.html Almost two years after Hurricane Katrina, it's time for Louisiana residents who claim they had heart attacks or other cardiovascular problems because of the painkiller Vioxx to get their paperwork together, the judge ruled Friday. Click here for more info http://www.vioxxadvisor.com/3874.html A widely used diabetes pill raises the risk of heart attacks and possibly death, according to a scientific analysis that reveals what some experts are calling another Vioxx-like example of the government failing to protect the public from an unsafe drug. Read more here http://www.vioxxadvisor.com/3873.html NEW ORLEANS — A South Carolina man whose $51 million Vioxx-damage award was overturned as excessive should accept the $1.6 million proposed by the judge rather than go to a second jury, his lawyer said Wednesday. More... http://www.vioxxadvisor.com/3872.html An attorney for a South Carolina man whose 51 million dollar Vioxx damage award was overturned as excessive says his client should accept a smaller amount proposed by a judge. Click here for more info http://www.vioxxadvisor.com/3871.html A Myrtle Beach man whose $51 million Vioxx damage award was overturned as excessive should accept the $1.6 million proposed by the judge rather than go to a second jury, his lawyer said Wednesday. More... http://www.vioxxadvisor.com/3870.html A South Carolina man whose $51 million Vioxx damage award was overturned as excessive should accept the $1.6 million proposed by the judge rather than go to a second jury, his lawyer said Wednesday. Click here for more info http://www.vioxxadvisor.com/3869.html A South Carolina man whose $51million Vioxx damage award was overturned as excessive should accept the $1.6million proposed by the judge rather than go to a second jury, his lawyer said yesterday. More... http://www.vioxxadvisor.com/3868.html NEW ORLEANS (AP) - A retired FBI agent who says the once-popular painkiller Vioxx caused his heart attack in 2002 can either accept US$1.6 million in damages or have a new jury decide what his damages should be, a U.S. judge has ruled. Click here for more info http://www.vioxxadvisor.com/3867.html A retired FBI agent who says the once-popular painkiller Vioxx caused his heart attack in 2002 can either accept $1.6 million in damages or have a new jury decide what his damages should be, a federal judge has ruled. Link to original article http://www.vioxxadvisor.com/3864.html A retired FBI agent who says the once-popular painkiller Vioxx made by Readington-based Merck & Co. caused his heart attack in 2002 can either accept $1.6 million in damages or have a new jury decide what his damages should be, a federal judge has ruled. More... http://www.vioxxadvisor.com/3865.html NEW ORLEANS - A retired FBI agent who says the once-popular painkiller Vioxx caused his heart attack in 2002 can either accept $1.6 million in damages or have a new jury decide what his damages should Click here for more info http://www.vioxxadvisor.com/3866.html NEW ORLEANS -- A retired FBI agent who says the once-popular painkiller Vioxx caused his heart attack in 2002 can either accept $1.6 million in damages or have a new jury decide what Click here for more info http://www.vioxxadvisor.com/3863.html Some Oregonians could sue Merck, the maker of the now-withdrawn pain medication Vioxx, under a bill that is headed for the desk of Gov. Ted Kulongoski. Read more here http://www.vioxxadvisor.com/3862.html A judge reversed himself and awarded $1.6 million to a former F.B.I. agent who blamed the drug for his heart attack. Click here for more info http://www.vioxxadvisor.com/3861.html A judge who threw out a $51 million damage award against Merck & Co. last year over its Vioxx painkiller reversed himself and awarded $1.6 million to a former FBI agent who blamed his heart attack on the drug. Read more here http://www.vioxxadvisor.com/3860.html Vioxx . Ritalin. Drug-eluting stents . Those popular drugs and medical devices are on a growing list of therapies used by millions of people that have shown up on the radar of Dr. Steven E. Nissen , a prominent heart specialist. Link to original article http://www.vioxxadvisor.com/3859.html http://www.vioxxadvisor.com/3858.html The Lessons of Avandia, Vioxx, Bextra and Baycol Click here for more info http://www.vioxxadvisor.com/3857.html http://www.vioxxadvisor.com/3856.html When Andrew von Eschenbach took over the Food and Drug Administration in 2005, the federal agency had a crisis over drug approvals that had missed or ignored dangerous side effects in Vioxx, antidepressants and other prominent medications. Von ... http://www.vioxxadvisor.com/3855.html A federal judge in New Orleans has ordered a third trial in a lawsuit by a woman who blamed Merck's painkiller Vioxx for the heart attack that killed her husband. Click here for more info http://www.vioxxadvisor.com/3854.html A federal judge has ordered a third trial in a lawsuit by a woman who blamed Merck?s painkiller Vioxx for the heart attack that killed her husband. Read more here http://www.vioxxadvisor.com/3853.html A federal judge in New Orleans has thrown out a court victory for Merck & Co. , allowing a new, third trial for a widow who claims the company's blockbuster painkiller Vioxx caused her husband's fatal heart attack. Read more here http://www.vioxxadvisor.com/3849.html A federal judge has ordered a third trial in a lawsuit by a woman who blamed Merck & Co.'s painkiller Vioxx for the heart attack that killed her husband. More... http://www.vioxxadvisor.com/3850.html May 30 (Bloomberg) -- Merck & Co. faces a third trial over claims that its Vioxx painkiller caused a Florida man's death, after a judge ruled that a witness misrepresented his credentials. Read more here http://www.vioxxadvisor.com/3851.html Associated Press - May 30, 2007 7:54 PM ET NEW ORLEANS (AP) - A federal judge in New Orleans has ordered a third trial in a lawsuit by a woman who blamed Merck and Company's painkiller Vioxx Link to original article http://www.vioxxadvisor.com/3852.html David Phillips submits: Former chair of the FDA's Cardiovascular& Renal Drugs Advisory, Dr. Steven Nissen, whose challenges to the safety of several prescription medicinesboth best-selling, Vioxx , and drugs awaiting approval, Pargluva limited or derailed their use, now has turned his sights on Avandia , a $2.2 billion diabetes drug ... http://www.vioxxadvisor.com/3848.html Merck & Co., the drug maker defending about 27,000 lawsuits filed by users of the painkiller Vioxx, was accused in a Canadian lawsuit of failing to warn consumers its bone drug Fosamax may damage jaw bones, a law firm said. Read more here http://www.vioxxadvisor.com/3847.html May 28 (Bloomberg) -- Merck & Co., the drugmaker defending about 27,000 lawsuits filed by users of the painkiller Vioxx, was accused in a Canadian lawsuit of failing to warn consumers its bone drug Fosamax may damage jaw bones, a law firm said. Read more here http://www.vioxxadvisor.com/3845.html Mumbai May 28 Safety-concerns over GlaxoSmithKline's diabetes drug Avandia, after reports linked it to a potential heart risk, have brought back memories of Merck's arthritis drug Vioxx (Rofecoxib), globally recalled in 2004. More... http://www.vioxxadvisor.com/3846.html A widely used diabetes pill raises the risk of heart attacks and possibly death, according to a scientific analysis that reveals what some experts are calling another Vioxx-like example of the government failing to protect the public from an unsafe drug. Click here for more info http://www.vioxxadvisor.com/3844.html The handling of Avandia, a top-selling diabetes drug, by the manufacturer and the Food and Drug Administration bears disturbing resemblances to the Vioxx debacle. Read more here http://www.vioxxadvisor.com/3843.html A study suggesting that aspirin might prevent some colon cancer tumors also has resurrected discussion about the benefit of drugs like Vioxx and Celebrex. More... http://www.vioxxadvisor.com/3842.html How did drugs like Vioxx or Avandia get approved? Drugs typically are tested on small groups of people, and with narrow and sometimes flawed definitions of success. Such studies often are not large or long- lasting enough to reveal rare side effects. Click here for more info http://www.vioxxadvisor.com/3841.html How does a drug go from blockbuster to bust? How can big safety problems go undetected in medicines taken by millions of people for many years, as happened this week with the diabetes pill Avandia and a few years ago with the painkiller Vioxx? Click here for more info http://www.vioxxadvisor.com/3840.html (AP) - How does a drug go from blockbuster to bust? Read more here http://www.vioxxadvisor.com/3839.html How does a drug go from blockbuster to bust? How can big safety issues go undetected in medicines taken by millions of people for many years, as happened this week with the diabetes pill Avandia and a few years ago with the painkiller Vioxx? More... http://www.vioxxadvisor.com/3838.html Bombay May 7, 2007: Large number of products to support Osteoarthritis were launched last couple of years on the US and European markets either as Dietary Supplements or Phytomedicines riding on the less than positive consumer perception of NSAIDs following the withdrawal of Merck’s brand Vioxx. Link to original article ... http://www.vioxxadvisor.com/3837.html By Marilynn Marchione A widely used diabetes pill raises the risk of heart attacks and possibly death, according to a scientific analysis that reveals what some experts are calling another Vioxx-like example of the government failing to protect the public from an unsafe drug. Read more here http://www.vioxxadvisor.com/3836.html Our view on pharmaceutical safety: Latest drug scare shows need for FDA overhaul First Vioxx, now Avandia? Diabetes patients face frightening dilemma. Americans ought to be able to feel secure that the medications they take are thoroughly monitored for safety Link to original article http://www.vioxxadvisor.com/3835.html A widely used diabetes pill raises the risk of heart attacks and possibly death, according to a scientific analysis that reveals what some experts are calling another Vioxx-like example of the government failing to protect the public from an unsafe drug. The drug, Avandia and Avandamet, is prescribed for thousands ... http://www.vioxxadvisor.com/3834.html Critics say the FDA is not vigilant. First the painkiller Vioxx; now the diabetes drug Avandia. Another big drug safety issue has consumer groups, doctors and congressmen calling for an overhaul of the U.S. Food and Drug Administration. Click here for more info http://www.vioxxadvisor.com/3833.html First the painkiller Vioxx; now the diabetes drug Avandia. Another big drug safety issue has consumer groups, doctors and congressmen calling for an overhaul of the U.S. Food and Drug Administration. Click here for more info http://www.vioxxadvisor.com/3831.html A widely used diabetes pill raises the risk of heart attacks and possibly death, according to a scientific analysis that reveals what some experts are calling another Vioxx-like example of the U.S. government failing to protect the public from an unsafe drug. Click here for more info http://www.vioxxadvisor.com/3832.html First the painkiller Vioxx; now the diabetes drug Avandia. Another big drug safety issue has consumer groups, doctors and congressmen calling for an overhaul of the U.S. Food and Drug Administration. Click here for more info http://www.vioxxadvisor.com/3830.html First the painkiller Vioxx; now the diabetes drug Avandia. Another big drug safety issue has consumer groups, doctors and people in Congress calling for an overhaul of the U.S. Food and Drug Administration. Link to original article http://www.vioxxadvisor.com/3827.html Avandia is the World's top selling diabetes pill. Concerns about the drug are being fueled by new research from the same doctor who uncovered heart problems linked to the arthritis drug Vioxx. More... http://www.vioxxadvisor.com/3828.html A widely used diabetes pill raises the risk of heart attack and possibly death, according to a scientific analysis that reveals what some experts are calling another Vioxx-like example of the government failing to protect the public from an unsafe drug. Link to original article http://www.vioxxadvisor.com/3829.html First the painkiller Vioxx; now the diabetes drug Avandia. Another big drug safety issue has consumer groups, doctors and congressmen calling for an overhaul of the U.S. Food and Drug Administration. Link to original article http://www.vioxxadvisor.com/3826.html With concerns raised about heart risks of a popular diabetes drug, GloxoSmithKline and the FDA scramble to respond Click here for more info http://www.vioxxadvisor.com/3825.html Some Oregon lawsuits against the manufacturer of Vioxx could proceed under a bill that the Oregon House passed Tuesday. Read more here http://www.vioxxadvisor.com/3824.html Authorities and pet owners are beginning to raise serious questions about the safety and effectiveness of animal medicines, mirroring worries over human drugs such as the painkiller Vioxx. Link to original article http://www.vioxxadvisor.com/3823.html The Senate overwhelmingly approved a landmark drug-safety bill Wednesday, doubling the number of government scientists assigned to ferret out risky side effects in medicines already on the market. The bill also would create a computerized network to ... http://www.vioxxadvisor.com/3822.html Legislation calls for closer monitoring of medications for side effects such as those of the painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/3821.html Prescription drugs would be monitored more closely for side effects under legislation the Senate approved Wednesday. Federal health officials were criticized for not reacting sooner when serious problems were linked to the painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/3820.html The Senate today overwhelmingly passed significant prescription drug safety reforms to give the Food and Drug Administration more power to deal with unsafe medicines on the market, moving the issue of drug safety to the House, where a strong bill has been introduced but has yet to be considered. More... ... http://www.vioxxadvisor.com/3819.html The Senate today approved a major overhaul of the nation's drug safety system, designed to fix the problems revealed by the withdrawal of the painkiller Vioxx and other recent lapses. Read more here http://www.vioxxadvisor.com/3818.html An arthritis drug billed as Merck's replacement to its discredited Vioxx may be just as risky to the heart, a growing number of doctors say. More... http://www.vioxxadvisor.com/3817.html After Cox-2 drugs such as Vioxx and Bextra were removed from the market in 2004 and 2005, there was a 125% surge in knee replacement surgeries - but there didn't have to be. There are proven non-surgical and non-pharmaceutical treatment options for osteoarthritis patients including, exercise, lifestyle changes and OA ... http://www.vioxxadvisor.com/3816.html A West Virginia civil trial in a lawsuit that blames the death of a Mingo County man on Merck & Co.'s prescription pain medicine Vioxx is scheduled for October. The lawsuit is similar to thousands More... http://www.vioxxadvisor.com/3815.html Williamson could gain national attention in October, when a jury trial is scheduled to begin there in a lawsuit blaming a Mingo County man’s death on the prescription painkiller Vioxx. Click here for more info http://www.vioxxadvisor.com/3814.html US regulators yesterday refused to approve Arcoxia, Merck's successor drug to withdrawn painkiller Vioxx, as drug safety concerns continue to tighten regulation for drugmakers. Click here for more info http://www.vioxxadvisor.com/3813.html In a widely expected move, Merck & Co.'s arthritis drug Arcoxia was rejected by U.S. regulators yesterday amid concerns that it could pose some of the same cardiovascular risks as the company's withdrawn pain-reliever Vioxx. Read more here http://www.vioxxadvisor.com/3812.html TRENTON -- The Food and Drug Administration rejected Merck & Co.'s request to market a successor to its withdrawn arthritis drug Vioxx in the United States, the drug maker said Friday. Read more here http://www.vioxxadvisor.com/3811.html The Food and Drug Administration (FDA) rejected Merck's request to market a successor to its withdrawn arthritis drug Vioxx in the United Click here for more info http://www.vioxxadvisor.com/3810.html The Food and Drug Administration yesterday rejected Merck & Co.'s new Vioxx-like painkiller because of some of the same heart concerns that pushed the blockbuster from the market. Read more here http://www.vioxxadvisor.com/3809.html PHILADELPHIA _ In a widely expected move, Merck & Co.'s arthritis drug Arcoxia was rejected by U.S. regulators amid concerns it could pose some of the same cardiovascular risks as the company's withdrawn pain-reliever Vioxx. Read more here http://www.vioxxadvisor.com/3808.html The FDA has nixed the approval bid for the Vioxx-like osteoarthritis drug Arcoxia. Merck will keep selling Arcoxia in 63 other countries. Link to original article http://www.vioxxadvisor.com/3806.html FRIDAY, April 27 (HealthDay News) -- The U.S. Food and Drug Administration on Friday turned down Merck & Co.'s request to market Arcoxia, a successor to its banned arthritis drug Vioxx. Link to original article http://www.vioxxadvisor.com/3807.html Merck & Co. says the FDA has turned down its request to market its planned successor to Vioxx, osteoarthritis drug Arcoxia, in the United States. More... http://www.vioxxadvisor.com/3804.html US regulators on Friday refused to approve Arcoxia, Merck’s successor drug to withdrawn painkiller Vioxx, as drug safety concerns continue to tighten regulation for drugmakers. Read more here http://www.vioxxadvisor.com/3805.html WHITEHOUSE STATION, N.J. - The Food and Drug Administration rejected Merck & Co.'s request to market a successor to its withdrawn arthritis drug Vioxx, the drugmaker said Friday. Link to original article http://www.vioxxadvisor.com/3802.html The Food and Drug Administration rejected Merck & Co.'s request to market a successor to its withdrawn arthritis drug Vioxx in the United States, the drugmaker said Friday. CBS News Interactive: About Your Health Read more here http://www.vioxxadvisor.com/3803.html The Food and Drug Administration rejected Merck's request to market a successor to its withdrawn arthritis drug Vioxx in the United States, the drugmaker said Friday. The move was widely expected, after a panel of FDA advisers two weeks ago voted 20-1 against approving the drug, Arcoxia. Click here for ... http://www.vioxxadvisor.com/3800.html The FDA rejected Merck & Co.'s request to market a successor to its withdrawn arthritis drug Vioxx, the drugmaker said. The move was widely expected, after a panel of FDA advisors voted against approving Arcoxia by a 20-1 vote. Link to original article http://www.vioxxadvisor.com/3801.html Merck & Co. executives told shareholders Tuesday they will keep trying to get a successor to withdrawn painkiller Vioxx on the U.S. market and that the company's stable of drugs in late-stage testing will bring another big wave of product approvals. Link to original article http://www.vioxxadvisor.com/3799.html Merck & Co. executives told shareholders Tuesday they will keep trying to get a successor to withdrawn painkiller Vioxx on the U.S. market and that the company's stable of drugs in late-stage testing will bring another big wave of product approvals. Link to original article http://www.vioxxadvisor.com/3798.html NEW ORLEANS A lawyer argued today that a woman whose husband died of a heart attack after taking the painkiller Vioxx deserves another chance to convince a jury Link to original article http://www.vioxxadvisor.com/3797.html The judge in charge of all federal Vioxx cases has made it almost impossible for people who believe the once-popular painkiller caused a heart attack to produce an expert to testify that is what happened, attorneys say in court papers. Click here for more info http://www.vioxxadvisor.com/3796.html More than 1,000 personal injury lawsuits filed in Texas over the once-popular pain medication Vioxx were put on hold Friday after a judge ruled the drug's manufacturer had given adequate warnings about the drug. Click here for more info http://www.vioxxadvisor.com/3795.html HOUSTON (AP) - More than 1,000 personal injury lawsuits filed in Texas over the once-popular pain medication Vioxx were put on hold Friday after a judge ruled the drug's manufacturer had given adequate warnings about the drug. Link to original article http://www.vioxxadvisor.com/3794.html Houston (AP) - More than 1,000 personal injury lawsuits filed in Texas over the once-popular pain medication Vioxx were put on hold Friday after a Click here for more info http://www.vioxxadvisor.com/3793.html A Harris County judge Friday dismissed part of a woman's Vioxx lawsuit against painkiller maker Merck & Co., setting in motion an appellate process that could change the legal landscape for all Texas pharmaceutical lawsuits. Click here for more info http://www.vioxxadvisor.com/3792.html HOUSTON A Houston judge today put more than one thousand Texas lawsuits surrounding the once-popular pain pill Vioxx on hold. Those lawsuits are now question More... http://www.vioxxadvisor.com/3791.html State District Judge Randy Wilson ruled that Ruby Ledbetter, who had a heart attack after using the drug, may not sue Merck claiming it failed to properly warn her of the drug's risks. Link to original article http://www.vioxxadvisor.com/3790.html More than 1,000 personal injury lawsuits filed in Texas over the once-popular pain medication Vioxx were put on hold Friday after a judge ruled the drug's manufacturer had given adequate warnings about the drug. More... http://www.vioxxadvisor.com/3789.html Merck&Co., ( Nachrichten / Aktienkurs ) Inc. said today that a Texas court overseeing the Texas litigation rejected a plaintiff ' s claim that she was not properly informed of the medicine ' s alleged risks because, in fact, the VIOXX label contained a U.S. Food and Drug Administration (FDA)-approved ... http://www.vioxxadvisor.com/3788.html U.S. health insurers, whose patient records helped uncover heart risks of the withdrawn arthritis drug Vioxx, called on Thursday for a new body to compare the safety and effectiveness of new drugs versus older treatments. More... http://www.vioxxadvisor.com/3787.html U.S. health insurers, whose patient records helped uncover heart risks of the withdrawn arthritis drug Vioxx, called on Thursday for a new body to compare the safety and effectiveness of new drugs versus older treatments. More... http://www.vioxxadvisor.com/3786.html Meanwhile, the number of personal injury lawsuits in the massive litigation over the painkiller Vioxx, which Merck withdrew from the market in September 2004 due to increased risk of heart attack and stroke, declined slightly for the first time. Click here for more info http://www.vioxxadvisor.com/3785.html Meanwhile, the number of personal injury lawsuits in the massive litigation over the painkiller Vioxx, which Merck withdrew from the market in September 2004 due to increased risk of heart attack and stroke, declined slightly for the first time. More... http://www.vioxxadvisor.com/3784.html Jeffrey Drazen, editor-in-chief of the New England Journal of Medicine, called on medical researchers to report their data accurately and comprehensively in an address Wednesday afternoon analyzing the lessons learned from the Vioxx case. Speaking before an audience of both professors and students in the Alpert Medical ... http://www.vioxxadvisor.com/3783.html Call it Merck's comeback. Shares of the venerable drugmaker, which were crushed by the 2004 withdrawal of the blockbuster pain medicine Vioxx, have been hovering around $50 since the company surprised Wall Street last week with a rosier-than-expected first-quarter earnings forecast. More... http://www.vioxxadvisor.com/3782.html A Food and Drug Administration panel voted overwhelmingly not to approve the Merck painkiller Arcoxia last week. This is bad news for consumers for many reasons. The 20 of 21 panel members who recommended against approval, presumably, reasoned that this Cox-2 inhibitor, like its ... http://www.vioxxadvisor.com/3781.html • Merck's Vioxx Case May See Victory Merck could score a major victory in the court this week. • GE Quarterly Profits Climbed General Electric's quarterly profit rose by two percent. Click here for more info http://www.vioxxadvisor.com/3780.html JOHN Edwards discussing fund-raising options with his pal, lawyer Chris Seeger, in Seeger's William Street offices after the lawyer's $47.5 million victory verdict against Merck and the drug Vioxx . . . GLORIA Steinem refusing to take her black Read more here http://www.vioxxadvisor.com/3779.html It's been two years since the painkiller was pulled from shelves, and the FDA is more skittish than ever Click here for more info http://www.vioxxadvisor.com/3778.html If a Harris County judge is right, a 2003 Texas law could not only gut the nearly 900 Vioxx cases pending in this state, but it could raise the bar for pharmaceutical cases of any kind here. Read more here http://www.vioxxadvisor.com/3777.html Merck & Co. Inc. said, a federal judge in New Jersey dismissed with prejudice a consolidated securities class action filed by investors against the company in connection with disclosures regarding Vioxx. Click here for more info http://www.vioxxadvisor.com/3776.html A federal judge in New Jersey has dismissed a securities class action lawsuit brought against Merck & Co. by investors over its one-time blockbuster drug Vioxx because the statute of limitations has run out. Click here for more info http://www.vioxxadvisor.com/3775.html